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Background: Natural experiments and related study designs such as regression 
discontinuity (RD) are of increasing interest to researchers and decision makers 
because of their potential to address confounding and selection effects better 
than other observational study designs, with potentially greater generalisability 
than controlled experiments. Research methods in health have been relatively 
slow to incorporate natural experiments compared to other fields such as 
economics and political science, but interest in these methods is growing 
rapidly. 
Objectives: This thesis aimed to (1) investigate the contribution of natural 
experimental designs to public health research, specifically the evaluation of 
public health interventions and environmental causes of disease and (2) explore 
how systematic review methods might be applied to make better use of natural 
experiments to inform public health and policy. 
Methods: The thesis comprises four case studies, including a systematic review 
of RD studies of health outcomes, a systematic review of RD studies of minimum 
legal drinking age (MLDA) legislation, development of a critical appraisal tool for 
RD studies, and a meta-review of endocrine-disrupting chemicals (EDCs) and 
breast cancer risk. Review protocols were registered in the PROSPERO database.  
Results: The first systematic review identified 181 RD studies of health outcomes 
which spanned a wide range of public health and policy questions, showing that 
this natural experimental design has been more widely applied than previously 
appreciated. Thematic analysis of the forcing variables and threshold rules 
identified patterns of implementation which will aid in future applications of the 
design. The MLDA review of 17 econometric analyses identified challenges in the 
synthesis of natural experimental studies. The review identified evidence that 
MLDA legislation has a causal effect on mortality and on alcohol-related hospital 
admissions. A ten-item checklist specific to the methodological requirements of 
RD designs was developed based on standards for RD produced by the What 
Works Clearinghouse; only 5% of the 181 studies met all ten criteria. The meta-
review included 15 systematic reviews of EDCs and breast cancer risk; no 
primary studies in these reviews were identified as natural experiments. 
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Conclusions: Natural experiments have the potential to support stronger causal 
inference through designs that address selection effects and confounding. For 
these designs to be translated into better evidence to inform decision-making, 
systematic reviews need to be able to identify and represent in detail the 
differences among non-randomised study designs. To do this requires further 
development of systematic review methods in order to synthesise results from 
econometric models and assess the quality of natural experimental studies. 
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1 Introduction to the thesis 
This thesis investigates the potential for natural experiments to be used more 
widely and more effectively in evidence synthesis in order to better inform 
public health policy and practice. This investigation uses systematic review 
methods to determine the contribution of natural experiments to selected areas 
of the public health evidence base, while also considering how these methods 
can be applied to ensure that evidence from natural experiments can be 
recognised, evaluated, and used to inform decision making. The thesis consists 
of four case studies drawn from three different types of systematic reviews.  
The first case study consists of a systematic review of primary studies that use a 
robust natural experimental design, regression discontinuity (RD), to investigate 
the health outcomes of interventions or environmental exposures and to 
consider the applicability of this natural experimental design in public health. 
This large systematic review is then drawn on and developed to present two 
further case studies.  
The second case study in this thesis focuses on the example of minimum legal 
drinking age (MLDA) legislation and examines how the results of RD studies can 
be synthesised and interpreted in the context of systematic reviews of 
effectiveness.  
The third case study considers a specific aspect of systematic review 
methodology, namely quality assessment, and reports on the development of a 
critical appraisal checklist for RD studies.  
The fourth case study is a meta-review or overview of systematic reviews which 
considers the environmental causes of disease, specifically the evidence for 
endocrine disrupting chemicals (EDCs) as a cause of breast cancer. As a case 
study of the potential use of natural experiments within evidence synthesis, the 
meta-review examines how previous systematic reviews have identified, 
evaluated, synthesised, and presented evidence on environmental causes of 
disease, and with what impact on the strength of evidence and conclusions of 
the review.  
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Finally, the discussion chapter considers the implications of the findings for 
future public health research and evaluation as well as areas for further 
methodological developments. 
Topics for these systematic reviews were selected because they served two 
purposes. The first was to illustrate the potential for natural experiments to 
provide robust evidence for questions of importance to public health; the 
prevention of breast cancer and of alcohol-related harm are of undoubted 
relevance to policy and practice. These topics were also illustrative of the two 
types of questions to which natural experimental methods may usefully be 
applied in public health, namely (1) the evaluation of interventions not 
amenable to randomisation and (2) the assessment of the environmental causes 
of disease. At the same time, the topics were chosen to serve a second purpose, 
namely to demonstrate how systematic review methods can be applied and 
further developed in order to translate this evidence into a synthesis that 
represents, in a thorough and balanced way, the findings, strengths, and 
limitations of natural experiments, given that these studies may come from 
diverse disciplines and use a variety of methods that are not yet in common use 
in public health or epidemiology.  
Regression discontinuity was chosen as a focus for the first review because it is 
considered the non-experimental design closest to a randomised trial and 
therefore has good potential to produce strong evidence of causal effects that 
should be of interest to decision makers, yet it is also unfamiliar enough within 
epidemiology and public health research that it is likely to illustrate some of the 
areas in which existing systematic review methods require development and 
innovation in order to incorporate evidence from natural experiments.  
MLDA was chosen as the focus for the second review on the basis of the protocol 
for the RD review, which specified that further analyses would be undertaken if 
a meaningful number of reviews on the same substantive public health topic 
were identified. MLDA proved to be a fruitful topic for a systematic review of RD 
studies because the included papers described similar natural experiments with 
many outcomes in common; furthermore, the studies were reported in sufficient 
detail to make further synthesis worthwhile and informative in terms of the 
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challenges of incorporating findings from natural experimental studies into 
systematic reviews.  
Finally, the environmental causes of disease was identified as a focus for the 
third review on the basis of an Academy of Medical Sciences report (Academy of 
Medical Sciences and Rutter, 2007). This report recommended natural 
experimental designs be used to investigate environmental causes of disease and 
was one of the earliest publications to put forth the argument for greater 
consideration of natural experiments in the public health evidence base. 
1.1 Research question and aims 
The overall research question addressed by this thesis is: 
• How can natural experiments be incorporated into systematic reviews to 
provide better evidence for public health policy and practice? 
This thesis aims to: 
• Identify how RD has been used to investigate research questions of public 
health relevance 
• Investigate the issues RD studies present for a systematic review of the 
effectiveness of an intervention and how might these be resolved 
• Synthesise evidence from RD studies of the effectiveness of MLDA 
legislation in reducing alcohol-related harms 
• Develop methods of assessing the quality of regression discontinuity 
studies of health outcomes 
• Examine how natural experiments have been used in systematic reviews 
to investigate environmental causes of disease 
• Synthesise evidence from systematic reviews of endocrine-disrupting 
chemicals as a cause of breast cancer 
Chapter 1 Page 19 
 
• Apply and further develop systematic review methodology in order to 
make better use of natural experiments. 
 
1.2 Overview of the thesis 
This section briefly outlines the content of the ensuing chapters of the thesis 
and the appendices. 
Chapter 2 defines natural experiments and describes the different study designs 
that have been used to investigate them. The strengths and limitations of these 
designs are considered in the context of an account of the development of 
evidence-based public health. The chapter reviews the literature that has 
argued for changes to the evidence-based paradigm and greater use of natural 
experiments in public health research and policy evaluation.  
Chapter 3 reports the methods and findings of a systematic review of regression 
discontinuity studies of health outcomes. This review demonstrates the 
relevance of this natural experimental design to public health and policy by 
showing the broad range of topic areas and evaluation questions to which RD has 
been applied. An analysis of the cut-off rules used for treatment assignment 
identifies the types of situations in which RD can be used and should facilitate 
the identification of natural experiments for future research. 
Chapter 4 analyses a subset of RD studies from chapter 3 which evaluate 
minimum legal drinking age (MLDA) legislation as a natural experiment. The 
chapter presents a synthesis on the protective effects of MLDA laws with regard 
to mortality and alcohol-related harms including hospital admissions and motor 
vehicle accidents. The chapter identifies the issues that RD studies present for 
data extraction, synthesis, and interpretation of findings within a systematic 
review of health outcomes.  
Chapter 5 describes the development of a critical appraisal method for 
regression discontinuity studies. Existing standards for RD are applied to a 
sample of studies and adapted into a ten-item checklist which is then applied to 
the studies identified in chapter 3. The results of appraisal give a comprehensive 
Chapter 1 Page 20 
 
picture of the strengths and limitations of this literature and point out the need 
for improved conduct and reporting of RD studies in health. 
Chapter 6 investigates what contribution natural experiments might make to 
understanding environmental causes of disease by presenting the findings from a 
meta-review on endocrine-disrupting chemicals (EDCs) as a cause of breast 
cancer. This meta-review describes how systematic reviews have evaluated and 
presented evidence from different study designs in reaching their conclusions 
about EDCs, how the reviews vary in their methods, and how review methods 
may affect the inclusion and presentation of results from natural experiments. 
Chapter 7 discusses the implications of these findings for evidence-based public 
health. It summarises the findings of the thesis and reflects on the strengths and 
limitations of the research that has been undertaken. It contains 
recommendations for additions to the methods of the Cochrane Collaboration, 
GRADE, and guideline developers such as NICE and SIGN. It offers suggestions for 
further research and describes future developments of systematic review 
methodology that would enable those who conduct and use systematic reviews 
to make better use of natural experiments within evidence syntheses and 
decision making. 
Some details of the methodology and results are supplied in appendices. Review 
protocols are reproduced in appendices 1 and 4. Appendix 2 provides detailed 
study characteristics for the 181 RD studies included in the systematic review 
reported in chapter 3. Appendices 3 and 6 report detailed critical appraisal 
results. Appendix 5 records literature search strategies. 
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2 Literature review: Natural experimental methods 
and public health research 
2.1 Chapter overview 
This chapter presents a literature review on natural experimental methods and 
their role in public health research. The chapter begins by providing definitions 
of public health, evidence-based public health, and natural experiments. It 
summarises the MRC guidance published in 2012 that raised awareness of the use 
of natural experiments in evaluating population health interventions. The 
chapter then describes five methods that can be used to analyse natural 
experiments: regression discontinuity, instrumental variables, interrupted time 
series, difference in differences, and propensity score analysis. These methods 
are of interest because their ability to address selection effects and confounding 
have the potential to support stronger causal inference than traditional 
observational methods under certain assumptions. The description of each 
method is followed by a discussion of its strengths and weaknesses along with 
examples of application drawn from public health research. The chapter 
concludes by considering how systematic reviews can further contribute to 
knowledge of these methods and their use in public health. 
2.2 Evidence-based public health 
As the thesis addresses the use of natural experiments as evidence for public 
health decisions, a few definitions are necessary before focussing on natural 
experiments.  
2.2.1 Public health 
Public health has been defined as “the art and science of preventing disease, 
prolonging life and promoting health through the organised efforts of society” 
(Acheson, 1988). The scope of public health intervention and research therefore 
encompasses not only disease prevention and health promotion but also the 
organisation, delivery, evaluation, improvement, and funding of programmes, 
services, and infrastructure that affect health, together with the policies and 
legislation that influence and guide these activities. Together with an 
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understanding of the social determinants of health and the recognition of 
persistent inequalities in health, public health can be seen as a crossroads or 
meeting-place of numerous academic disciplines and policy areas. As a 
discipline, public health has “a long tradition of drawing successfully on other 
forms of knowledge and insight beyond its own boundaries”, which is an asset in 
dealing with complex problems and emerging threats (Hanlon et al., 2012, p. 9).  
2.2.2 Evidence-based public health 
Given the broad scope and interdisciplinary character of public health, it follows 
that the evidence needed to inform public health decisions is likely to be equally 
wide-ranging. In a public health context, evidence has been defined as “some 
form of data—including epidemiologic (quantitative) data, results of program or 
policy evaluations, and qualitative data—to use in making judgments or 
decisions” (Brownson et al., 2011, p. 6). This definition links evidence (data) to 
its utility and application, namely in supporting decision-making. Arguably, 
however, data are of limited utility for decision-making unless they have been 
analysed and presented in a useable and condensed form, ideally supported by 
information about their contextual meaning and interpretation, as in a research 
study or systematic review.   
The idea that decisions should be based on “evidence” or empirical research as 
opposed to anecdote, tradition, habitual practice, or popular belief originated in 
medicine and subsequently spread to other areas of professional practice and 
policy (Smith, 2013, p. 42). The originators of evidence-based medicine (EBM) 
defined it as “the conscientious, explicit, and judicious use of current best 
evidence in making decisions about the care of individual patients” (Sackett et 
al., 1996). Jenicek (1997) responded to Sackett’s definition of EBM by offering a 
definition of evidence-based public health (EBPH): “the conscientious, explicit, 
and judicious use of current best evidence in making decisions about the care of 
communities and populations in the domain of health protection, disease 
prevention, health maintenance and improvement (health promotion)”. Sackett 
subsequently revised the definition of EBM as “the integration of best research 
evidence with clinical expertise and patient values”, to which Kohatsu et al. 
responded with a new definition of EBPH: “the process of integrating science-
based interventions with community preferences to improve the health of 
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populations” (2004, p. 419). These definitions all have in common the idea that 
decision-making benefits from a combination of contextual knowledge relevant 
to the decision and research evidence that has been assessed for quality. 
The importance of taking an evidence-based approach and the perceived poverty 
of evidence in public health has led to repeated calls to either improve the 
evidence base or reconsider what may constitute ‘best evidence’ (Petticrew, 
2013). As randomised controlled trials (RCTs) are held to be the highest-quality 
or ‘gold standard’ evidence within the hierarchy of evidence-based medicine 
(Sackett et al., 1996), some have argued that more RCTs ought to be conducted 
in public health and public policy (Haynes et al., 2012, Macintyre, 2011). The 
chief benefit of the RCT in terms of supporting decision-making is that random 
allocation to intervention and comparison groups, performed in a manner not 
open to bias, is understood to prevent known and unknown confounders from 
influencing the estimate of the effect of the intervention (Fisher, 1935), thereby 
producing the evidence most able to support causal inference, that is, the 
conclusion that the intervention in question independently caused any observed 
difference in outcome between groups. With evidence from reliable RCTs, 
decision-makers can be confident that they are choosing to implement and fund 
interventions that are likely to achieve the desired outcomes. 
The obstacles to conducting RCTs in public health are well known and relate to 
the potential lack of equipoise, feasibility, ethical acceptability, and/or political 
will (Bonell et al., 2011, Moore and Moore, 2011). Although these barriers are 
not always insurmountable (Macintyre, 2011, Moore and Moore, 2011), a 
fundamental problem of public health evaluation and research is how to achieve 
strong causal inference when a randomised controlled trial is not feasible. 
Whether the question is one of the causal relationship between an 
environmental exposure and a disease, or the effectiveness of a policy 
intervention in changing a particular outcome, non-randomised studies can offer 
valuable evidence. However, the validity of any non-experimental research is 
threatened by the potential influence of unobserved factors on the outcome of 
interest (Academy of Medical Sciences and Rutter, 2007).  
Instead of (or in addition to) conducting more RCTs, an alternative approach to 
improving the public health evidence base is to take advantage of other research 
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methods and study designs while giving full consideration to their strengths, 
weaknesses, and reporting quality (Petticrew and Roberts, 2003). Indeed, 
Sackett et al. (1996) specifically did not restrict the concept of “best evidence” 
to randomised controlled trials (RCTs) and meta-analyses, or to decisions about 
interventions, although EBM and its institutions such as Cochrane have become 
strongly associated with both. Rather, finding the best evidence involves 
recognising that different study designs provide answers to different types of 
(clinical) questions, and that the best available evidence may need to be used in 
the absence of the best possible evidence. In a public health and policy context, 
natural experimental methods have the potential to incorporate desirable 
characteristics of the RCT – random allocation, avoidance of selection on 
observed and unobserved characteristics, control of confounding, and support 
for causal inference – while overcoming some of the obstacles to conducting 
RCTs in population health (Petticrew et al., 2005) and providing additional 
contextual information about real-world implementation and other social or 
environmental conditions relevant to decision-making. 
2.3 Natural experiments: better evidence to inform public 
health decisions 
Definitions of natural experiments vary but have in common the premise that 
the allocation or delivery of an intervention (such as a policy, programme, or 
legislative change) is not within the control of the researcher, who instead 
observes and estimates its effect (Craig et al., 2011, Dunning, 2012, Petticrew et 
al., 2005). Allocation to the intervention may indeed be random, as when a 
programme is specifically implemented by a lottery, or it may be held to be ‘as 
good as random’ when the researcher can make a strong case that the 
intervention was randomly taken up by participants (Dunning, 2012). In such 
situations, the case for causal inference is strong and indeed, Dunning (2012) 
limits his definition of natural experiments to situations involving random or ‘as 
good as random’ allocation; however, this is a narrow definition likely to be 
realised in only a small number of situations.  
A broader definition of a natural experiment is “any event not under the control 
of a researcher that divides a population into exposed and unexposed groups” 
(Craig et al., 2017). In this thesis, the term ‘natural experiment’ refers to such 
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an event; ‘natural experimental study’ refers to the report of an analysis of such 
an event by researchers; and ‘natural experimental design’ or ‘natural 
experimental methods’ refer to the approaches that can be taken in conducting 
such a study. 
2.3.1 Medical Research Council guidance on natural experiments 
To support those who conduct, fund, and use such research, the Medical 
Research Council (MRC) issued guidance on the use of natural experiments to 
evaluate public health interventions (Craig et al., 2011). The guidance presents 
seven case studies to demonstrate existing applications of natural experimental 
methods to a range of public health topics, including child poverty, suicide 
prevention, alcohol pricing, smoke-free legislation, antenatal care, health 
service organisation, and early years interventions. The guidance gives priority 
to building up experience of these methods and notes that systematic review of 
natural experiments, although demanding, is important to identify and aid in the 
understanding of promising interventions. 
The guidance also provides recommendations for improving the design and 
analysis, and strengthening causal inference from natural experiments. The 
guidance recommends three methods – difference in differences, instrumental 
variables, and regression discontinuity – as representing “a potentially valuable 
advance” (p. 19) in the analysis of observational data because of their ability to 
address selection on unobserved variables. These and other key methods used to 
analyse natural experiments will now be described briefly, including their 
strengths and limitations, along with examples of their application to public 
health. 
2.3.2 Regression-discontinuity analysis 
Regression-discontinuity analysis was first proposed in education research as an 
alternative to the use of matching to produce a quasi-experimental control 
group (Thistlethwaite and Campbell, 1960). In this design, subjects are 
‘allocated’ to the treatment or control group according to whether or not they 
meet a threshold value of a ‘forcing variable’ (Imbens and Lemieux, 2008). A 
forcing variable is a measurement of some attribute whose value can be used to 
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determine whether or not a subject receives an intervention or exposure. At the 
defined cut-off value for intervention or exposure, there is a sharp 
‘discontinuity’ in the probability of group allocation. If subjects cannot 
manipulate the measurement of the forcing variable, and administrators of an 
intervention cannot manipulate the value of the cut-off, then within a certain 
range of values or ‘bandwidth’ of the threshold value, allocation to treatment or 
control is considered to be essentially random (Dunning, 2012).  
The relevance of the RD design to health research has been demonstrated 
through its application to early versus delayed initiation of antiretroviral therapy 
in HIV according to CD4 count (Bor et al., 2014) and the prescription of statins 
according to risk score (O'Keeffe et al., 2014). Indeed, the assignment to 
treatment according to threshold values or guideline-based rules is common 
enough in healthcare that regression-discontinuity analysis may be at present 
underused (Vandenbroucke and le Cessie, 2014). Moscoe, Bor, and Bärnighausen 
(2015) reviewed the use of regression-discontinuity analysis in epidemiology and 
public health research. Their search, restricted to a single database (PubMed), 
identified 18 studies, the majority of which addressed economic or education-
related questions. 
The chief strength of the regression-discontinuity design is that the element of 
randomness within the bandwidth on either side of the threshold value supports 
strong causal inference, at least in theory (Cook and Wong, 2008), negating the 
effects of both known and unknown confounders (Bor et al., 2014). Additionally, 
the design can be implemented with routinely collected data, can provide 
information on the optimisation of clinical treatment thresholds (Bor et al., 
2014), and can be used to evaluate policies that impose cut-off values for 
access, such as age or income level (Imbens and Lemieux, 2008). The limitations 
of the regression-discontinuity design are that the ‘as-if random’ quality only 
applies within the bandwidth close to the threshold, and that performance bias 
may occur when participants are not blinded to their allocation (Craig et al., 
2011). 
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2.3.3 Instrumental variables 
Like regression discontinuity, instrumental variables are used to strengthen 
causal inference within observational studies, although they are also used in 
randomised studies, for example to isolate the active ingredient of a complex 
intervention (Marcus et al., 2012). An instrumental variable or ‘instrument’ is a 
variable that meets three criteria: (1) it is correlated with or is a cause of 
exposure to the independent variable; (2) it does not have a causal influence on 
the dependent variable, other than through its influence on the independent 
variable; and (3) it is not correlated with other confounders (Cousens et al., 
2011, Dunning, 2012). Economist P.G. Wright is credited with the development 
of this method in a 1928 analysis of factors affecting supply and demand for 
flaxseed (Angrist and Krueger, 2001). Instrumental variables are of particular 
interest in epidemiology because they can be used to adjust for both observed 
and unobserved confounders (Martens et al., 2006). An example of application to 
a public health question is a study of the effect of poverty on mental health in 
Indonesia (Hanandita and Tampubolon, 2014). This study addresses the question 
of whether the relationship between poverty and increased risk of mental illness 
is causal or associational by using variability in rainfall as an instrument, on the 
assumption that rainfall will (in a predominantly agrarian economy) have an 
effect on poverty but not on mental health. The method is increasingly used in 
epidemiology; a systematic review identified 90 studies using instrumental 
variables published between 1994 and 2012 and indexed in either Medline or 
Embase (Davies et al., 2013). 
The idea that an instrumental variable can account for unmeasured or unknown 
confounders has been described as “an epidemiologist’s dream” (Hernán and 
Robins, 2006) because of the potential to support causal inference from 
observational data; however, the limitations of the method are not insignificant. 
In addition to the problem of identifying a suitable instrument and obtaining 
reliable data for it, the conditions for its use relating to its relationships with 
other variables and unmeasured confounders cannot ever be entirely empirically 
verified (Cousens et al., 2011), meaning that the method relies on strong 
assumptions that cannot be tested from the data (Dunning, 2012). In the view of 
Hernán and Robins, instrumental variables replace “the unverifiable assumption 
of no unmeasured confounding…with other unverifiable assumptions” and thus 
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simply shift the problem of causal inference “to another realm” (2006, p. 364). 
An articulation of the ‘story’ or model informing the choice of instrument and 
the underlying causal theories is therefore necessary (Angrist and Krueger, 
2001); however, the previously cited systematic review found poor reporting of 
the basis for causal inference as well as a number of flaws in the statistical 
reporting of instrumental variable studies (Davies et al., 2013). 
2.3.4 Interrupted time series 
A time series is a set of sequential observations or measurements of an outcome 
taken repeatedly over a period of time. An interrupted time series (ITS) is a type 
of quasi-experimental design which can be used to analyse a natural experiment 
in which an event occurs at a defined timepoint and is plausibly expected to 
have an effect on an outcome, for which time series data are available before 
and after the event (Lopez Bernal, Cummins, and Gasparrini, 2017). In the 
simplest ITS design, when the outcome is plotted over time and a segmented 
regression fitted, a change in the intercept or slope in the post-event period 
may represent a treatment effect (Shadish, Cook, and Campbell, 2002). 
The design is well suited to investigate the effects of policy changes, legislation, 
and changes to the organisation and delivery of healthcare (such as the 
introduction of new treatments, quality improvement initiatives, and new 
models of care). The design was described in a 1968 paper by Donald Campbell 
and H. Laurence Ross that investigated whether a crackdown on speeding in 
Connecticut had the effect of reducing road traffic fatalities (Campbell and 
Ross, 1968). Some recent examples that demonstrate the range of applications 
in public health include evaluations of the effects of introducing guidelines for 
antibiotic prophylaxis on the incidence of infective endocarditis (Dayer et al., 
2015); the effect of introducing child restraint legislation on child injuries and 
fatalities in motor vehicle accidents in Chile (Nazif-Munoz, Falconer, and Gong, 
2017); the introduction and withdrawal of the Health in Pregnancy grant in 
England (Adams et al., 2018); and the effect of introducing a surcharge for 
sugar-sweetened beverages on drinks consumption at leisure centres in Sheffield 
(Breeze et al., 2018). 
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The strengths of ITS include the use of administrative and other real-world 
datasets, with the attendant potential for good external validity, and production 
of estimates that are not biased by variables that remain constant over time, or 
that can be adjusted for those variables where data are available and change 
slowly over time (Lopez Bernal, Cummins, and Gasparrini, 2017). However, the 
design is also subject to several threats to validity. The most obvious is the 
possibility that another intervention or change was introduced at the same time 
as the event of interest and which also affected the outcome, leading to a 
confounded estimate of the treatment effect. This situation is one specific type 
of time-varying confounder; another is seasonality or other fluctuations that 
regularly occur at different times of the day, week, month, or year, such as rush 
hour traffic or seasonal flu outbreaks, which need to be understood and, if 
relevant, controlled for in the analysis (Lopez Bernal, Cummins, and Gasparrini, 
2017). A further threat to validity is instrumentation if the method of outcome 
measurement changed during the time period under investigation (Shadish, 
Cook, and Campbell, 2002).  
2.3.5 Difference in differences 
The difference in differences (DiD) design involves a comparison of the change in 
an outcome over time between exposed and unexposed groups following an 
intervention or change in exposure at a particular point in time (Craig et al., 
2012). The effect of the exposure may be estimated additively, as the name 
suggests, or from a regression that can be adjusted for covariates including 
time-varying confounders, to which DiD, like ITS, is vulnerable (Angrist and 
Pischke, 2009). 
The design is thought to originate with 19th-century physician John Snow in his 
classic investigation of the causes of epidemic cholera in London (Angrist and 
Pischke, 2009, p. 227). Snow was able to show that contaminated water 
transmitted cholera by comparing death rates between households supplied by 
two different water companies, one of which moved its water supply further up 
the Thames and therefore farther from sewage contamination. Importantly, 
households were not able to choose which company provided their water supply, 
which had been haphazardly allocated over time (Dunning, 2012), thus ensuring 
that the analysis of this natural experiment was free from selection effects. 
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DiD is widely used in econometrics (Imbens and Rubin, 2015) and, with ITS, is 
one of the most commonly used methods to analyse natural experiments (Craig 
et al., 2017). Also like ITS, DiD has been used to evaluate a wide range of policy 
changes, legislation, changes to health systems, and public health interventions. 
Recent examples include DiD analyses of the effect of achieving Foundation 
Trust status on hospital performance in England (Verzulli, Jacobs, and Goddard, 
2018), the impact of the Affordable Care Act on contraceptive prescriptions 
(Becker, 2018), and the effect of a school-based public health outreach 
programme on insurance enrolment and well-child exam uptake (Jenkins, 2018). 
2.3.6 Propensity score analysis 
A further approach to strengthening the causal inference possible from 
observational data involves the extension of regression modelling to investigate 
and adjust for selection on observables in non-random treatment assignment. 
The methods were developed within econometric structural equation modelling 
by Heckman in the 1970s, for which he was eventually awarded a Nobel Prize in 
economics, and within statistics in the 1980s by Rosenbaum and Rubin (Guo and 
Fraser, 2010, Rosenbaum and Rubin, 1983). These methods are known 
collectively as propensity score analysis, reflecting the central element of 
probabilistic modelling of participants’ propensity to choose or be allocated to 
treatment or control groups. In a nonrandomised study, a propensity score can 
estimate the probability of a participant’s group allocation given the values of a 
set of covariates measured prior to the start of the study (Shadish and Steiner, 
2010). This information can then be used in regression modelling of the outcome 
data to match controls or adjust for selection bias in an attempt to imitate the 
same balance on pretest covariates that would be achieved through 
randomisation (Shadish and Steiner, 2010). Rosenbaum and Rubin (1983) argued 
that such adjustment can produce an unbiased estimate of treatment effects. 
Systematic reviews of the use of propensity score methods indicate that the 
primary application of these methods in the health literature has been in 
surgical and pharmacological studies (D'Ascenzo et al., 2012, Gayat et al., 2010, 
Weitzen et al., 2004) – which was also the finding of the systematic review of 
instrumental variables mentioned previously (Davies et al., 2013). However, 
instances of application to public health questions also include a natural 
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experiment in neighbourhood violence reduction in Colombia (Cerda et al., 2012) 
and evaluations of changes in health care payment policies (Cheng et al., 2012, 
Stuart et al., 2014). 
The chief advantages of propensity score modelling, in addition to improved 
causal inference, are simplified management of multiple covariates (Guo and 
Fraser, 2010) and improved matching of treatment and controls (Craig et al., 
2011). As these methods are model-based rather than design-based, several 
caveats apply. The quality of the analysis depends crucially on adequate pretest 
measures of the covariates influencing the selection process and on sufficient 
overlap in propensity score values between treatment and control groups 
(Shadish and Steiner, 2010). Findings are mixed as to whether propensity score 
analyses produce accurate estimates of effect compared to randomised trials 
(Kuss et al., 2011, Peikes et al., 2008) and some studies have found that they 
produce no better estimates than standard regression modelling (Shadish and 
Steiner, 2010). A further caveat is that propensity score analyses are unable to 
address unmeasured confounding. 
2.4 Investigating the application of natural experi ments 
in public health through systematic reviews 
Although natural experiments and related methods have been promoted in the 
MRC guidance as potentially providing a desirable quality of evidence for public 
health, questions remain as to why these methods are not more widely used and 
to what extent they can fulfil the “epidemiologist’s dream” of unbiased causal 
inference from observational data. Systematic review is a method that can be 
used to determine the characteristics of the use of particular study designs in a 
given field and to promote new methodologies (Petticrew and Roberts, 2006). 
The MRC guidance states that systematic reviews of natural experimental studies 
in public health are important in order to identify interventions that could be 
further developed, to help with the interpretation of natural experimental 
evidence, and to synthesise available estimates of effectiveness (Craig et al., 
2011, p. 23). The guidance also recognises that such systematic reviews face 
difficult methodological challenges in needing to deal with multiple study 
designs, search a wide variety of sources, and address complex risks of bias (p. 
23). 
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This thesis proceeds in chapter 3 to use systematic review as a method to 
investigate the availability of natural experimental studies in public health by 
comprehensively identifying and describing RD studies of health outcomes. The 
thesis then demonstrates how systematic review methods can be used to 
incorporate RD studies into evidence synthesis (chapter 4) and to interrogate the 
quality of such studies (chapter 5). 
2.5 Chapter summary 
This chapter has described evidence-based public health as a context in which 
natural experimental studies are of interest as potentially providing the ‘best 
evidence’ needed to support public health decision-making, particularly when 
RCTs are not available or not feasible. Public health has been described as broad 
in scope and interdisciplinary in character, needing evidence from many 
research areas in order to address the wider determinants of health. Several 
natural experimental designs have been examined for their strengths, 
limitations, and application in public health research. The next chapter takes 
one of these designs which can provide strong support for causal inference, 
regression discontinuity, and asks how it has been used to provide evidence of 
relevance to public health decisions, i.e. to investigate the effects of 
interventions and exposures on health outcomes. 
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3 Regression discontinuity designs in the 
evaluation of health interventions, policies, and 
outcomes: a systematic review 
3.1 Chapter overview 
This chapter reports a comprehensive systematic review of the application of RD 
designs in research of the health effects of any interventions or exposures, 
including social, medical, and public health interventions, environmental 
exposures, and public policy. Based on a published protocol and a search of 32 
databases and grey literature sources, the review identifies 181 studies that 
apply an RD design in health-related research, more than five times the number 
of studies identified by a previous review of RD studies that searched only one 
database (PubMed). A thematic analysis of the underlying natural experimental 
designs shows that a relatively small number of different types of forcing 
variables and threshold rules has produced applications across a wide spectrum 
of research questions relevant to public health and policy, with little replication 
of the same design to answer similar questions in different settings. Therefore, 
the review concludes that RD has the potential to be more widely applied in the 
evaluation of social and public health interventions and policy. 
3.2 Aims 
This chapter aims to conduct a comprehensive systematic review in order to 
determine how RD designs have been used in health research. The chapter aims 
to map the use of RD designs in settings and policy areas relevant to public 
health by answering the following research questions: 
1. How and in what areas of research have RD designs been applied to 
evaluate the health effects of interventions or exposures? 
2. What forcing variables and threshold rules have been used in RD studies of 
health-related outcomes? 
3. What is the quality of reporting in studies using RD designs to evaluate 
health-related outcomes? 
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3.3 Background 
The regression discontinuity (RD) design was first proposed by Thistlethwaite and 
Campbell (1960) based on the intuition that, given an eligibility rule based on a 
cut-off value for a continuous variable whose value cannot be precisely 
manipulated by participants or administrators, treatment assignment will be 
effectively random within a certain bandwidth on either side of the cut-off; 
therefore, the causal effect of the treatment can be estimated by comparing 
outcomes for groups just above and just below the cut-off, without any bias due 
to unobservables  (Imbens and Lemieux, 2008, Thistlethwaite and Campbell, 
1960). 
An illustrative example of the implementation of the RD design can be found in a 
study of the effect of receiving a diagnosis of hypertension on health behaviour 
(Zhao, Konishi, and Glewwe, 2013). A nationally representative longitudinal 
survey, The China Health and Nutrition Survey, collected data on individuals’ 
dietary patterns, socioeconomic characteristics, and health status. Trained 
investigators measured (among other biomarkers) the participants’ blood 
pressure; participants with systolic blood pressure above the diagnostic 
threshold of 140 mmHg were informed that they had hypertension. Zhao, 
Konishi, and Glewwe recognised in this situation a natural experiment that could 
be analysed with an RD design in which systolic blood pressure is the forcing 
variable. As the authors explain, “Since individuals cannot precisely control their 
blood pressure, among those with blood pressure readings near the cutoff, some 
randomly are above it while others randomly fall below it, which can be 
regarded as a random assignment of hypertension status. Because the 
consumption patterns and other behaviors are likely to be almost identical for 
the samples right below and right above the cutoff, the difference in the 
outcomes between these two groups may be used to estimate the treatment 
effect – i.e. the effect of being informed that one has hypertension” (p. 368). 
The study authors addressed the potential for bias in their study in several ways. 
First, they checked the assumption that participants could not manipulate their 
value of the forcing variable, observing that people cannot precisely control 
their systolic blood pressure. Next, they checked the distribution of the forcing 
variable in the sample, presenting the data graphically and demonstrating that 
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there is no evidence of ‘heaping’ near the cut-off, which might suggest 
manipulation by the survey investigators. They also checked the distribution of 
other observed variables in the diagnosed and undiagnosed groups, to see if any 
systematic differences at baseline might contribute to explaining any difference 
observed in the outcome of interest. They considered and addressed the 
potential for attrition bias (loss to follow-up within the original survey). In 
estimating regressions, they investigated whether the results were sensitive to 
model specification. Finally, they performed a type of falsification test by 
checking whether their models detected a false ‘treatment’ effect at other, 
non-threshold values of systolic blood pressure (120, 130, etc.); no statistically 
significant effects were detected at any of the ‘placebo’ cut-off values. The 
study concluded that receiving a hypertension diagnosis led to changed dietary 
behaviour in the form of reduced fat intake. 
RD is attractive because it allows the evaluation of causal effects of 
interventions or exposures using non-experimental data; furthermore, the 
method requires relatively weak assumptions that can be empirically tested. By 
using administrative data, existing surveys, or government statistics as well as 
real-world treatment assignment rules, RD can be implemented efficiently and 
can avoid the criticism of limited external validity sometimes directed at 
randomised controlled trials. The main limitation of the design noted in the 
literature is the need for larger sample sizes than in randomised experiments 
(Lee and Lemieux, 2010). 
Following its initial presentation in educational research in the 1960s, uptake of 
the design was limited, partly due to a belief that few situations existed in 
which it could be applied, until its use became common among economists 
(Cook, 2008). Lee and Lemieux (2010) reviewed the use of RD in the economic 
literature with the aim of identifying in what topic areas RD had been applied 
and where cut-off rules could be found. They identified 60 studies, half of which 
related to education or labour economics, with the remainder spanning diverse 
topics in political economy, health, crime, the environment, and other subjects. 
Lee and Lemieux described cut-off rules as emanating from four types of 
situations: necessary or intentional discretisation (in the allocation of a limited 
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resource), and nonrandomised discontinuities based on age or geographic 
boundaries. 
Moscoe, Bor, and Barnighausen (2015) argued that RD is likely to be useful in 
health research because the use of cut-off rules for treatment assignment is 
common. Their review, based on a search of one database (PubMed), identified 
32 studies from medicine, epidemiology, or public health that used an RD 
design, of which two involved interventions to improve physical health. 
Accordingly, they argued that RD is likely underutilised in these fields. They 
evaluated studies on a scale of 0-5 based on the presence of key elements of 
“good RD practice” and found that a histogram of the assignment variable was 
the most commonly omitted element. 
Most recently, a review in the BMJ (Venkataramani, Bor, and Jena, 2016) 
presented 13 studies as examples of RD in healthcare. These examples were 
used to illustrate the application of time, age, programme eligibility, geography, 
and therapeutic assignment rules in the design and to support an assertion that 
the design could be applied usefully and widely in clinical medicine and health 
policy. The review did not use systematic methods. 
3.4 Methods 
The review protocol was published in the PROSPERO international prospective 
register of systematic reviews (reference number CRD42015025117). The 
protocol is reproduced in Appendix 1.  
3.4.1 Inclusion criteria 
Primary, empirical studies were included from any field of research that (1) used 
a regression discontinuity design and (2) had an outcome that measured any 
aspect of physical or mental health or wellbeing. 
3.4.2 Search strategy 
The search encompassed 32 electronic databases for publications containing the 
phrase “regression discontinuity” or “regression-discontinuity” in title, abstract, 
keyword, or (where available as a search option) publication full text. No index 
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terms were identified that corresponded to RD. The date range covered was 1 
January 1960 (year of first publication describing RD methods) to 15 March 2015. 
No language restrictions were applied. The databases were selected in 
consultation with expert librarians experienced in systematic review in public 
health and the social sciences to ensure broad coverage of disciplines relevant to 
social determinants of health and to public policy, particularly those such as 
educational research and economics in which RD designs are more commonly 
used than in health. This approach also reflects previous findings that health 
databases are not sufficient for comprehensive searches on the health effects of 
social interventions (Ogilvie et al., 2005). The list of 32 sources searched 
appears in Table 3.1. 
Table 3.1. Databases searched for the systematic re view of regression 
discontinuity studies, by subject area 
Health: CINAHL, Cochrane Library, Embase, HMIC, King’s Fund Publications, MEDLINE, NICE 
Evidence Search, POPLINE, PsycINFO, TRIP 
Social Sciences: ASSIA, Business Source Premier, EBSCO Professional Development Collection, 
EconLit, ERIC, International Bibliography of the Social Sciences, Social Care Online, Social 
Services Abstracts, SocINDEX, Sociological Abstracts 
Full Text: Google Scholar, Scopus, Web of Science  
Grey Literature: EThOS (British Library Electronic Theses Online Service), Idox Information 
Service, NTIS, Open Grey, ProQuest Dissertations and Theses, EconPapers (RePeC), US 
Environmental Protection Agency document repository, WHO Institutional Repository, World 
Bank Documents and Reports 
 
Reference lists of included studies, review articles, and textbook chapters on 
regression discontinuity design were hand-searched to identify additional 
studies. 
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3.4.3 Study selection 
Retrieved references were compiled in an EndNote X7 library and duplicates 
were manually removed. A random 10% sample (random number sequence 
generated in Stata version 13) was screened by two reviewers independently for 
eligibility based on the record title and abstract. Results were compared and 
disagreements were discussed to clarify the application of the inclusion criteria. 
After discussion, agreement was 100%. Following this piloting of the study 
selection process, all references were screened by one author and reasons for 
exclusion were recorded in EndNote. 
3.4.4 Data extraction 
The aim of extracting data about publication characteristics was to identify 
discipline-related patterns in study design, quality, and publication trends. A 
coding framework was designed to record information extracted from the full 
text of each included study about the publication, research topic, study design, 
and outcomes. Each study was given a unique identification number derived 
from the first author’s surname, year of publication, and publication type. Year 
of publication and publication type were coded as separate fields, with 
publication type categorised as journal article, working paper, thesis, report, 
conference paper, or conference abstract. For journal articles, the academic 
discipline of the journal was additionally described in a method derived from 
Stuckler et al. (2014), who used the Web of Science category assigned to the 
journal in order to analyse citation patterns by discipline. In fact, Web of 
Science typically assigns two or more categories to each journal in its database, 
without distinguishing a primary classification. Accordingly, all categories 
assigned to each journal were recorded and then seven groupings were created 
as follows: 
• Health economics: any journal indexed under both an economics category 
and a health category (including public health) 
• Public health: any journal indexed as “Public, Environmental & 
Occupational Health” and not under an economics category 
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• Economics: any journal indexed under an economics category, but not a 
health category 
• Psychiatry and psychology: any journal indexed as “Psychiatry” or under 
any psychology category 
• Medical: any journal indexed under any medical specialty (Surgery, 
Endocrinology, Medicine General and Internal) and none of the above 
categories 
• Other health sciences: any health category not covered by the above 
(Health Policy and Services, Healthcare Sciences and Services, Nutrition 
and Dietetics) 
• Other social sciences: any category not covered by the above (Political 
Sciences, Public Administration, Demography, Multidisciplinary Sciences). 
The study design was described as sharp or fuzzy RD and any additional designs 
(such as difference-in-difference or instrumental variable) used in the paper 
were noted. The country of authorship was recorded as the country of the 
institution to which the first author belonged at the time of publication. The 
country of origin of the study data was also recorded. The implementation of RD 
in the study was described in terms of the forcing variable used, the intervention 
or exposure under investigation, the health-related outcome(s) measured, 
whether a primary outcome was specified, and whether a study protocol was 
reported. Coding was performed by one reviewer. 
3.4.5 Quality assessment 
The purpose of quality assessment in this review was to describe the strengths 
and limitations of the literature and thereby enable users, producers, and 
funders of RD studies in health to understand, recognise, and address quality of 
conduct and reporting RD. The purpose was not to exclude studies, to identify 
risk of bias, or to inform meta-analysis of effect estimates. Accordingly, an 
appraisal tool was sought that was specific to RD and allowed detailed 
investigation of the methodology of RD studies. 
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What Works Clearinghouse (WWC) is an online resource centre funded by the 
United States Department of Education to support reviews of the effectiveness 
of educational policies and interventions. At the time of conducting this review, 
the WWC standards were the only publicly available quality assessment tool 
specific to the design and reporting of regression discontinuity studies (Schochet 
et al., 2010) (see section 5.4.1). The WWC tool offers detailed criteria and has 
three additional strengths: it is relatively short and simple to use; it was 
developed by experts in RD methodology; and it has screening questions that 
ensure the study correctly employs the RD design. 
The WWC tool allows users to determine whether a study meets an overall 
standard of quality. Accordingly, each of the four standards in the RD tool 
involves judgments to determine whether the standard has been met, not met, 
or met with reservations based on whether a combination of various criteria are 
satisfied. The tool was piloted on 15 studies with two appraisers (MHB and MC) 
evaluating each study independently. The tool was easy to use, there was little 
disagreement between appraisers, and the few items of disagreement were 
easily resolved upon discussion. However, all of the studies ‘failed’ the overall 
quality standard because of failing to meet standard 2 (attrition). Both 
appraisers agreed that most studies based on population or administrative data 
would ‘fail’ in this way and that such judgments would not be helpful in meeting 
our aims of describing quality. Therefore, the WWC tool was adapted by only 
looking at whether the various criteria were satisfied and not whether the 
standards were met, not met, or met with reservations. For all included studies, 
answers of yes/no/unclear were recorded for the three screening questions and 
yes/no for the seven quality criteria extracted from the tool. These questions 
and criteria were not used to exclude studies from the analysis. Following the 
pilot, a 10% sample was appraised by two reviewers and, with satisfactory 
agreement on interpretation of the criteria obtained following discussion, the 
remainder of the studies were evaluated by a single reviewer. This process of 
adapting and developing the critical appraisal method for RD is described in 
more detail in chapter 5. 
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3.4.6 Synthesis methods 
The synthesis methods reflect the aims of the review, namely to map and 
describe the implementation of RD designs in the investigation of health 
outcomes. As the review was not designed to identify studies that answer a 
particular question of effectiveness, no meta-analysis was planned. Instead, a 
narrative synthesis was undertaken that aimed to identify and describe patterns 
and commonalities across studies. The main method of narrative synthesis used 
was thematic summary, in which a descriptive coding framework is developed to 
allow the grouping of studies in order to compare their characteristics (Gough, 
Thomas, and Oliver, 2012). Extracted data were presented in tables organised by 
research topic themes. Additional themes were developed to describe 
commonalities among the RD designs in terms of forcing variables and cut-off 
rules. Numbers of publications by year, by topic, and by academic discipline 
were tallied to enable identification of trends in the use of RD.  
3.5 Results 
3.5.1 Characteristics of included studies 
The searches of 32 databases resulted in 3832 records retrieved, of which 2033 
were duplicate records and 196 were working paper versions of studies 
subsequently published as journal articles. The titles and abstracts of the 
remaining 1603 unique records were examined for evidence of RD design and 
relevance to health outcomes, of which 1179 did not meet the inclusion criteria. 
The full text of the remaining 424 studies was obtained and assessed against the 
inclusion criteria, resulting in the exclusion of a further 259 papers. The 
reference lists of the included studies were checked for additional references, 
as were the reference lists of review articles on RD. Sixteen additional studies 
were identified in this way. Figure 3.1 shows the study selection process as a 
flowchart. In total, 181 studies were included in this review. 
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Figure 3.1. PRISMA flowchart for systematic review of regression 
discontinuity studies 
 
The use of RD designs in health research is increasing over time, with the 
greatest increase in output taking place in the past five years. The number of 
studies published by year (Figure 3.2) shows that initially, in the decades 
following Campbell’s first publication describing the design, few studies used RD 
to investigate health outcomes. The earliest publication relating to health 
appeared in 1990, with only 28 studies published before 2009. In that year, ten 
publications appeared and interest increased each year for the subsequent five 
years, reaching a high of 42 publications in 2014. Results for 2015 are limited to 
the first quarter only. 
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Figure 3.2. Histogram of regression discontinuity p ublications by year  
Data for 2015 is limited to January-March only. 
 
 
More than two thirds (124/181; 68.5%) of the RD publications identified 
appeared in peer-reviewed journals. Approximately one third were identified 
from grey literature sources. Almost half (80/181; 44.2%) of publications 
appeared in journals indexed in Web of Science as economics or health 
economics journals (Figure 3.3). Journals indexed as “Public, Environmental & 
Occupational Health” were the source of 14 (7.7%) of included studies. 
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Figure 3.3. Frequency of publications using regress ion discontinuity 
designs by academic discipline 
 
 
Of the included studies, nearly one third (57/181) investigated public health 
policy-related questions and nearly one fifth (33/181) evaluated health 
insurance schemes in either developed or low and middle income countries 
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Figure 3.4. Regression discontinuity studies of hea lth outcomes by topic 
area  
The topic areas were identified through thematic analysis of the interventions or 
exposures and settings investigated. 
 
 
The remaining studies considered questions of clinical effectiveness, 
epidemiological cause and effect, and the health effects of insurance schemes, 
social programmes, and education. A large number of studies (n=17) evaluated 
the impact of minimum legal drinking age (MLDA) legislation. The MLDA studies 
represent the largest number of RD studies on the same policy issue. Further 
























RD studies of health outcomes by topic area
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Figure 3.5. Regression discontinuity studies invest igating specific public 
health policy topics 
The topic areas were identified through thematic analysis of the interventions or 
exposures under study. 
 
 
Tables describing the detailed characteristics of all included studies along with 
references to all the studies appear in Appendix 2, organised by the topic 
headings that appear in Figures 3.4 and 3.5 above.  
A fundamental requirement of a regression discontinuity design is the presence 
of a forcing variable. Thematic analysis of the forcing variables used in the 
included studies suggested that six types of forcing variables are used in studies 
of health outcomes. These types can be summarised as: age; social measures 
such as poverty indices, literacy rates, or income; clinical measures that act as a 
threshold for intervention; environmental measures; geographical boundaries; 
and dates of events that trigger a change in exposure status, such as policy 



































RD studies of public health interventions, 
by policy area 
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Table 3.2. Thematic analysis of forcing variables u sed in RD studies of 
health outcomes 
 




Measurement used Threshold rule 
Age 65 Age in days, months, weeks, or 
years 
Age threshold for:  
• Starting school 
• Leaving school 
• Legal drinking age 
• Insurance eligibility 
• Retirement age 
Date 56 Calendar date, month, or year Dates of: 
• Implementation of policy/ 
legislation 
• Repeal of policy/ 
legislation 
• Disaster or major incident 





39 • Company payroll total 
• Dropout risk score 
• Family income 
• Household acreage 
• Investment cost 
• Poverty or literacy rate 
• Poverty or welfare index 
• Predicted probability of 
borrowing microcredit 
• Programme quality score 
• Vote share or margin 
 
• Benefit or programme 
eligibility 
• Election outcome 
• Legislated threshold 
Clinical measure 10 • Addiction severity measure 
• Birthweight 
• Cardiovascular risk 
• CD4 count 
• Down syndrome risk  
• Exeter Alcohol Scale 
• Positive Symptoms Scale 
• PTSD Reaction Index 
• Systolic blood pressure 
• Time of birth 
• Weeks of gestation 
 
• Risk threshold for 
intervention 
• Guideline threshold for 
intervention 




5 • Ozone forecasts 
• Air pollution levels 
• Policy threshold for action 




4 • Political boundary 
• Distance from boundary 
• Latitude and longitude 
 
• Programme eligibility 
Other 3 • Class size 
• Number of schools 
• Draft lottery number  
• Policy threshold for 
intervention/exposure 
• Programme eligibility 
 
 
For a regression discontinuity design to be used, the forcing variable must be 
implemented in the context of the application of a threshold rule to assign 
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people or study units into treatment and control groups. Recognition of 
threshold rules is therefore essential to the use of RD to analyse natural 
experiments. Thematic analysis suggested that four sources of threshold rules 
are common to the included studies: programme eligibility rules for social 
programmes and other complex interventions; clinical decision-making rules or 
guidelines; thresholds imposed by legislation to restrict or limit activities that 
affect health; and dates of the implementation of changes to these rules. Table 
3.2 provides examples. 
3.5.2 Quality assessment 
Study quality was assessed against ten appraisal criteria developed for this 
review (see chapter 5). The ten quality appraisal criteria were fully met by only 
5% (9/181) of the studies. Common issues in study quality included lack of 
information about study attrition, failure to assess baseline equivalence on 
covariates, lack of density tests and falsification tests, and failure to establish 
that the forcing variable was unconfounded (Figure 3.6). Only 8% (15/181) of 
studies reported a pre-specified primary outcome or study protocol. 
Figure 3.6. Summary of quality assessments of regre ssion discontinuity 
studies of health outcomes  
Each horizontal bar shows the number of studies (total=181) judged as yes, no, or 
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Almost all studies (179/181; 98.9%) clearly reported the forcing variable used 
(criterion 1) and most (162/181; 89.5%) reported the use of at least four discrete 
values of the forcing variable on either side of the cut-off value (criterion 2). In 
the included studies, 93/181 (51.4%) provided enough information to support a 
conclusion that the forcing variable was not confounded, 9/181 (5%) used a cut-
off that was clearly used to assign people to additional treatments other than 
the one under investigation, and 79/181 (43.6%) used a forcing variable that 
could conceivably be confounded without reporting clear evidence to the 
contrary (criterion 3).  
Of the included studies, 160/181 (88.4%) provided some account of scoring and 
treatment assignment (criterion 4), and 74/181 (40.9%) reported a density test 
or histogram of the forcing variable (criterion 5). 
Reporting of study attrition was the area of poorest quality in these studies, with 
57/181 (31.5%) reporting any information on attrition (criterion 6). Just over two 
thirds of studies (123/181; 68%) examined whether treatment and control groups 
showed baseline equivalence on any covariates (criterion 7), but less than half 
(74/181; 40.9%) conducted falsification tests (criterion 8). 
Finally, regarding the quality of the statistical analysis, the model was adjusted 
for the forcing variable (criterion 9) in most, but not all, studies (153/181; 
84.5%). Robustness checks of the model were reported in nearly three quarters 
(133/181; 73.5%) of studies (criterion 10). 
3.6 Discussion  
This review has identified 181 studies that apply the RD design to investigate 
health-related research questions, approximately six times the number of 
studies identified by Moscoe et al. in their 2015 review of RD despite using the 
same inclusion and exclusion criteria. Furthermore, the included studies cover a 
wide range of health and social interventions, exposures, and policy topics. 
Thus, this review demonstrates that RD has been applied more often and for a 
greater diversity of health-related research questions than was previously 
appreciated. The findings confirm and lend weight to the arguments of previous 
authors that RD is a suitable design for consideration in the evaluation of health 
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interventions and health policy. This review also provides some evidence against 
the criticism that RD and natural experiments depend upon contrived research 
questions that fit the available data rather than addressing genuine and 
meaningful evaluation problems (Dunning, 2012).  
The difference in findings between the present and previous reviews indicates 
the importance of searching multiple databases for any systematic review, but 
particularly for review questions that are interdisciplinary in nature (Petticrew 
and Roberts, 2006). The sizeable numbers of included studies found in 
economics journals and grey literature suggest that systematic reviews of public 
health policy topics would be more comprehensive if databases such as Econlit 
and RePeC were included in search strategies.  
This review offers two important contributions to the literature concerning 
policy evaluation and natural experiments. First, it offers a comprehensive view 
of where to look in health policy and practice for the threshold rules and forcing 
variables that can be exploited for analysis using regression discontinuity 
designs. Second, it shows the strengths and weaknesses of the existing literature 
in terms of study quality. Users of this review who intend to design or fund RD 
studies should note the variation in study quality and use the results to learn 
from examples of good practice and the potential pitfalls of misapplication of 
the design. Studies such as the evaluation of Head Start (Ludwig and Miller, 
2007), for example, provide a full account of the choice of forcing variable and 
how it was implemented in the context of the programme; explore the 
sensitivity of their results to bandwidth choice; apply both parametric and non-
parametric methods; and investigate and rule out rival hypotheses. Other studies 
demonstrate that the mere existence of a cut-off score does not necessarily 
make the application of RD feasible or logical. Indeed, it was apparent that 
some studies have misapplied the RD design in ways that violate its assumptions 
and potentially do not support the aims of the evaluation or the conclusions of 
the study.  
In conducting this review, some limitations of the regression discontinuity design 
became evident. Previously the chief limitation of the design was recognised as 
the need for large sample sizes to achieve adequate statistical power. Many of 
the RD studies examined in this review used very large datasets and thus sample 
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size was less of a concern. However, in exploring functional form and conducting 
robustness checks in the absence of a study protocol or primary outcome, many 
studies inadvertently created problems for both interpretation and synthesis. RD 
studies frequently present the results of multiple analyses, including different 
stratification of data (for example, by gender or age), different choices of 
bandwidth around the forcing variable, and different statistical methods. Many 
studies have multiple outcomes without being powered for a particular primary 
outcome and have dozens of datapoints that could be extracted. The critical 
appraisal tool did not help to distinguish between studies that perform multiple 
analyses in a design-driven manner according to a protocol developed a priori 
versus apparent data dredging in which results are reported at multiple levels of 
significance testing, few results are statistically significant (but those that are 
statistically significant are cherry-picked for emphasis), and no adjustment has 
been made for multiple comparisons. As a result, extracting outcome data from 
the studies was problematic. It would also be difficult to accurately and 
meaningfully summarise the conclusions of such studies for decision-makers. 
This review joins a small number of other systematic reviews that have 
investigated the application of innovative non-randomised study designs and 
methods to medicine, epidemiology, and public health. Compared to the findings 
of a systematic review of instrumental variables in epidemiology and medicine 
(Davies et al., 2013), more examples of RD than of instrumental variables can be 
identified, suggesting that, although good instruments may be hard to find, good 
forcing variables may be less so. These findings also support the conclusion of 
Moscoe et al. (2015) that RD is probably underutilised in health research: 
although numerous relevant applications of the design can be identified, few 
have been replicated or extended to other contexts, and the results suggest that 
the potential to do so exists. Also, RD is not yet as commonly applied as, for 
example, propensity score matching has been in medicine; a systematic review 
on that topic identified 296 studies published in a six-month period in PubMed 
alone (Ali et al., 2015). Finally, this review found variation and weaknesses in 
the quality of RD studies; the reviews of instrumental variables and propensity 
score matching similarly found important weaknesses and gaps in the reporting 
of those study types, suggesting that researchers using these methods, relatively 
new in medicine, epidemiology, and public health, would benefit from tools and 
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educational opportunities designed to promote the rigorous design, analysis, and 
reporting of natural experiments and other non-randomised studies. 
The limitations of the review include the double-sifting of a sample rather than 
the full set of initial search results; however, the sample was randomly chosen 
and reviewer agreement was 100% after discussion. Similarly, although the 
critical appraisal method was piloted with two reviewers and a 10% sample of 
the full results was also appraised by two reviewers, with 100% agreement after 
discussion, the bulk of the critical appraisal results reflect assessments by a 
single reviewer. In both of these cases, the unexpectedly large number of 
included studies and limitations of time and resource prevented the involvement 
of two reviewers at all steps. 
3.7 Chapter summary 
This review contributes to the literature by identifying 181 RD studies, 
describing their findings, critically appraising their quality, and grouping them 
by policy area or clinical topic in order to facilitate either replication or the 
identification of opportunities for new and original research. The key strength of 
the review is its exhaustive search of 32 databases from multiple disciplines, 
including education, economics, environmental science, and sociology as well as 
health, as well as grey literature sources and handsearching of included papers, 
to provide the most systematic and comprehensive review to date of the use of 
regression discontinuity designs in public health, epidemiology, medicine, 
healthcare, and related policy areas. 
The next chapter performs a further synthesis of the largest subset of RD studies 
on a single intervention or policy topic identified in chapter 3, namely 17 studies 
of minimum legal drinking age (MLDA) legislation. This further synthesis was 
anticipated as part of the published protocol for the RD review. Examining this 
subset of studies allows more detailed exploration of how a natural experimental 
design can be applied to answer questions of policy effectiveness, how the 
resulting data can be synthesised, and what challenges natural experimental 
studies and designs may present for systematic reviews. 
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4 Effectiveness of minimum legal drinking age 
(MLDA) laws in preventing alcohol-related 
harms: a systematic review 
4.1 Chapter overview 
Minimum legal drinking age (MLDA) laws constitute a natural experiment that is 
suitable for RD analysis because the drinking age threshold creates a sharp 
difference in alcohol availability between two groups. This chapter reports a 
systematic review of RD studies of MLDA, conducted within the wider review of 
RD studies reported in chapter 3. This chapter first places MLDA within the 
broader context of alcohol control policies and demonstrates the importance of 
these policies to public health. Then the characteristics and quality of the 
included studies are described. A narrative synthesis is conducted and the 
results visualised using an effect direction plot. Finally, the implications of the 
review for alcohol policy, systematic review methods, and reporting of RD 
studies are discussed. 
4.2 Aims 
By analysing and synthesising MLDA studies identified within the systematic 
review of RD designs in public health reported in the previous chapter, this 
chapter aims to investigate the following research questions: 
1. How have RD designs been implemented in research on the health effects 
of MLDA legislation? 
2. What is the evidence from RD studies on the effectiveness of MLDA 
legislation in reducing alcohol-related harms in young people? 
3. What is the quality of RD studies on MLDA and what are the strengths and 
limitations of this evidence? 
4. What issues do RD studies present for data extraction and synthesis in 
systematic reviews and how might these issues be resolved? 
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4.3 Background 
4.3.1 Prevention of alcohol-related harms 
Alcohol is a serious public health problem, causing an estimated 2.5 million 
deaths per year worldwide; alcohol use is a leading risk factor for premature 
death and disability and one of the top four modifiable risk factors for non-
communicable diseases (World Health Organization, 2010). Alcohol has a causal 
role in breast, liver, colon, oral, and oesophageal cancers (The Lancet, 2017). 
The global burden of disease due to alcohol in 2004 amounted to 3.8% of all 
global deaths, 4.6% of the total global disease and injury burden, and 36.4% of 
all neuropsychiatric disability-adjusted life years (DALYs) (Rehm et al., 2009). In 
addition to physical and psychological harms, the social harms attributable to 
alcohol consumption are considerable, including domestic violence, child abuse 
and neglect, negative impacts on work and education, public disorder and safety 
issues, and crime, amounting to social costs estimated between 1 and 3 % of 
gross domestic product in Europe (Klingemann, 2001). 
Europeans consume the most alcohol and have the highest burden of associated 
cancers (The Lancet, 2017).  In the UK, some ten million adults exceed the 
recommended maximum intake of 14 units per week (Williams et al., 2018); in 
Scotland, the equivalent of 19.6 units of alcohol per adult were sold per week in 
2017 (NHS Health Scotland, 2018). Alcohol-related hospital admissions exceeded 
24,000 in 2016-17 and demonstrated pronounced inequalities, with rates of stay 
more than eight times higher in the most deprived compared to the least 
deprived areas in Scotland (NHS Health Scotland, 2018).  
The multifaceted disease and societal burden associated with alcohol combined 
with the scope and magnitude of harmful alcohol consumption suggests that 
policy action is imperative; however, both the WHO (Casswell and Thamarangsi, 
2009) and the United Kingdom (Williams et al., 2018) have been criticised for 
inadequate policy responses. Like smoking, alcohol consumption is a complex 
social behaviour which involves vested economic interests and which can 
potentially be addressed through a variety of programmes, policies, and 
legislation at the individual, health service, and population levels. The World 
Health Organization Global Strategy to Reduce the Harmful Use of Alcohol (2010) 
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grouped policy responses into ten recommended target areas, which included 
leadership, community, and health service responses; policies to target drink-
driving, alcohol availability, pricing, and marketing; harm reduction; addressing 
illicit alcohol production; and monitoring and surveillance.  
In Scotland, an alliance of organisations led by Alcohol Focus Scotland produced 
a series of recommendations to inform the next iteration of the Scottish 
Government’s alcohol strategy (Alcohol Advocacy Coalition, 2017). The 
recommendations included: a Health in All Policies approach; pricing and 
taxation reforms; restricting availability through licensing and enforcement; 
changes to marketing and labelling; health promotion actions; and improvements 
to healthcare and social services. Given the importance of the problem to public 
health and the variety of policy options available, there is arguably an ongoing 
need for evidence synthesis to inform policy decisions.  
An abundance of systematic review evidence exists to support decisions in 
alcohol policy. Previous systematic reviews have addressed the effectiveness of 
different alcohol policy approaches and interventions, including pricing, 
taxation, licensing, labelling, and marketing restrictions. A systematic overview 
and synthesis of these reviews is beyond the scope of this chapter. The following 
section will summarise a selection of systematic reviews that set the scene for 
the present work by providing a global overview of policy effectiveness, 
specifically considering the contribution of natural experiments, and more 
closely examining policy effectiveness in the UK context. The focus then shifts to 
reviews that address minimum legal drinking age legislation.  
Two overviews of systematic reviews have demonstrated that most alcohol 
policy interventions are supported by evidence of effectiveness and meet 
thresholds of cost-effectiveness. Anderson, Chisholm, and Fuhr (2009) conducted 
an overview of systematic reviews and meta-analyses of policies to reduce 
alcohol-related harms. They noted that the conceptual framework and 
theoretical basis of such policies (such as deterrence and cost increases) is well 
understood and generally applicable across societies. Their narrative synthesis 
was structured according to the target areas of the WHO Global Strategy and 
identified evidence to support policy effectiveness in all areas apart from 
education, community programmes, harm reduction in bars, and illicit alcohol 
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production. They also considered cost-effectiveness and determined that, in 
Europe, population policy approaches (drink-driving legislation and enforcement, 
reduced retail access, advertising ban, and pricing policies) were more cost-
effective than health sector interventions, ranging from I$ 335 to 961 
(international dollars) per DALY saved (the cost per DALY for brief clinical 
interventions for heavy drinkers, by comparison, was I$2671) (Anderson, 
Chisholm, and Fuhr, 2009).  
In 2013, a similar but more methodologically rigorous overview of systematic 
reviews was reported by Martineau et al., who produced a narrative synthesis of 
52 reviews, 12 of which were high-quality (Martineau et al., 2013). Their findings 
on effectiveness mirror those of Anderson et al. (2009): consistent evidence that 
taxation, drink-driving policies, policies to restrict sales availability, and mass 
media campaigns were effective, mixed or weak evidence to support 
interventions in family, educational or workplace settings, and a lack of 
evidence on harm reduction in bars, illicit alcohol interventions, and community 
interventions.  
The broadly positive picture of evidence for the effectiveness of alcohol policy 
interventions may be somewhat different if study selection criteria are changed. 
Nelson and McNall conducted a systematic review of pricing and tax policies 
evaluated as natural experiments (Nelson and McNall, 2016, Nelson and McNall, 
2017). They argued that natural experiments should be of particular use in 
evaluating the causal effects of policies, but noted these study types have been 
neglected in previous systematic reviews. They identified 45 studies that 
assessed the effects of policy changes on alcohol-related harms in nine countries 
(2016). Contrary to Anderson et al., they found a mixture of positive, null, and 
negative effects. They found a similar mixture of effect directions when 
considering alcohol consumption and drinking patterns as outcomes (2017). For 
these outcomes, 29 papers from five countries were identified and almost all 
used survey data to construct regression models to evaluate policy effects. 
Nelson and McNall concluded that the evidence base was inconsistent and 
insufficiently robust to inform policy development.  
An additional review has systematically examined and synthesised evidence on 
these same alcohol control policies, but with specific reference to implications 
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for policy and public health professionals in the UK. Commissioned by the 
Department of Health, Burton et al. conducted a rapid review of studies 
published between 2000 and 2016, organising alcohol control policies into seven 
areas broadly similar to other reviews, although they also included brief 
interventions and treatment in healthcare, workplace, and criminal justice 
settings as an alcohol control policy area (Burton et al., 2017). This review was 
innovative in applying GRADE methodology, modified so that the hierarchy of 
evidence included natural experiments and modelling studies, to assign a 
strength of evidence rating to each policy intervention. This review also differed 
from others discussed above by including minimum unit pricing (MUP), citing UK 
modelling studies and natural experiments from Canada as evidence. The review 
concluded that policies that reduce the affordability of alcohol are the most 
effective and cost-effective, and that there is strong evidence to support 
regulation of marketing. Although the evidence to support drink-driving 
legislation was graded ‘high’ and found to be both effective and cost-effective, 
the review concluded that in England such legislative measures “are estimated 
to lead to minimal public health gains compared with policies such as taxation. 
Nonetheless, reducing drink-driving is an intrinsically desirable societal goal” (p. 
1574). The review did not include minimum legal drinking age among the alcohol 
control policies investigated. 
Mapped against the range of policy interventions investigated in these 
systematic reviews, current areas of alcohol policy development in the UK may 
seem relatively limited. In Scotland, the introduction of a minimum unit price of 
50p per unit of alcohol has been an important policy action to address alcohol-
related harm through a population-level intervention, the expected 
effectiveness of which has been supported by the findings of a systematic review 
(Boniface et al., 2017). In England, the 2010-2015 Coalition Government 
consulted on a new alcohol strategy in 2012 and in 2013 published its response to 
the consultation (Home Office, 2013). Then-Home Secretary Theresa May argued 
that MUP should be delayed until “conclusive evidence” of effectiveness was 
available and to prioritise engagement with the alcohol industry instead of using 
“the sledgehammer of national legislation, which often misses its target” (Home 
Office, 2013, p.7). The effectiveness of interventions incorporated into the 
resulting Public Health Responsibility Deal was subsequently examined in an 
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overview of systematic reviews (Knai et al., 2015), which concluded that the 
Responsibility Deal was largely based on information and communication 
interventions that are probably ineffective at changing behaviour. 
Although comprehensive overviews of evidence are not lacking, comprehensive 
policy is more difficult to find. The Responsibility Deal ceased in 2015 with the 
change of Government but has not to date been replaced with a coherent 
framework or strategy for alcohol policy in England. Similarly in Scotland, the 
last comprehensive alcohol strategy, the Alcohol Framework for Action, was 
published in 2009 and a “refresh” of the framework, promised for early 2018, 
has at the time of writing (September 2018) not yet materialised (Scottish 
Government, 2018). 
4.3.2 Minimum legal drinking age legislation 
Policies to prevent alcohol-related harm may operate universally, by reducing 
risks at a population level (for example, advertising bans), and/or selectively, by 
targeting groups who are disproportionately at risk of alcohol-related harms (for 
example, minimum unit pricing, which aims to reduce consumption in heavy 
drinkers). Young people face a particular risk of harm due to alcohol’s 
neurotoxicity, which can adversely affect brain development (Scottish Health 
Action on Alcohol Problems, 2014, Spoth et al., 2008). Adolescent drivers are 
also at heightened risk of motor vehicle accidents (MVA), which are the leading 
cause of death for people aged 16-19 in the United States, and drinking any 
amount of alcohol increases the risk of MVA in this age group compared to older 
drivers (Centers for Disease Control and Prevention, 2017). Policy interventions 
to prevent harm in this group include driver licence restrictions (such as 
graduated licence programmes) and age restrictions on alcohol sales and 
consumption. The most well-studied of such policy interventions is the minimum 
legal drinking age (MLDA) (Wechsler and Nelson, 2010). 
MLDA laws have been in place in the United States since at least 1933 and, after 
states that lowered their MLDA to 18 years old were found to have higher MVA 
rates, an MLDA of 21 years old was in place across the country by 1988 (Wechsler 
and Nelson, 2010). At least two comprehensive systematic reviews of MLDA in 
the United States have concluded that these laws are effective in reducing 
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alcohol-related harms. In 2002 Wagenaar and Toomey comprehensively reviewed 
132 studies that evaluated the MLDA from 1960 to 1999 (Wagenaar and Toomey, 
2002), a work that has been described as “definitive” (DeJong and Blanchette, 
2014). They evaluated the quality of these studies according to three criteria of 
sampling design (probability sampling or census data = higher quality), study 
design (pre-post, longitudinal, and time series higher quality compared to cross-
sectional), and presence of a comparison group. They coded study results 
according to their direction of effect and statistical significance. They argued 
that the preponderance of evidence, particularly of higher-quality studies with 
statistically significant effect estimates, showed that a higher MLDA reduced 
alcohol consumption and MVA; that evidence on other outcomes such as suicide 
and vandalism was inconsistent; and that lack of enforcement was a mediating 
factor in effectiveness (Wagenaar and Toomey, 2002). Their review was well 
reported, with transparent and reproducible methods, only lacking detail in how 
final judgments were made from a complex synthesis, which appeared to rely on 
vote-counting of statistically significant effects. 
At the same time the Task Force of Community Preventive Services was 
undertaking a related systematic review on behalf of the CDC and National 
Highway Traffic Safety Administration (Shults et al., 2001). They evaluated the 
effectiveness of five policy interventions to reduce alcohol-related MVA. For 
MLDA they included 33 studies that investigated the effects of changing the 
MLDA in the USA, Canada, and Australia. They included only time series or 
controlled before and after designs. They concluded there is “strong evidence” 
that MLDA laws are effective in preventing alcohol-related MVA and related 
injuries (p. 75). 
Despite this evidence base and apparent consensus, the MLDA became a subject 
of renewed debate in America with the launch of the Amethyst Initiative, a 
campaign to lower the MLDA organised by some university and college presidents 
and chancellors as their observations of underage drinking on campuses led them 
to believe existing legislation was not effective in regulating behaviour 
(Amethyst Initiative) (n.d.). This campaign came as a “surprise” in public health 
and road safety circles “given an extensive research literature showing that the 
age 21 MLDA reduces injuries and saves lives” (DeJong and Blanchette, 2014) and 
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led to renewed interest in research on MLDA and the underlying evidence base. 
In a commentary in the American Journal of Public Health, Wechsler and Nelson 
argued that public health professionals needed familiarity with the evidence 
base on MLDA in order to “advocate effective public policy” (2010, p. 988). They 
note that debate has centred on two questions: whether the MLDA actually had a 
causal effect, and whether lowering the MLDA from 21 to 18 would actually 
change the behaviour of 18-20 year olds (2010, p. 989). 
Both questions can be addressed by identifying and analysing the many natural 
experiments that have arisen as MLDA legislation has been introduced and 
revised in different jurisdictions over time. RD is well suited for such analyses 
because two types of thresholds can arise that sharply divide people into 
exposed and unexposed groups without any opportunity for them to interfere 
with their allocation. One such threshold is the date on which legislation is 
enacted. The other is the drinking age limit itself. People who age past that 
threshold gain legal access to alcohol and thus experience what is effectively a 
price decrease in the total cost of obtaining alcohol to the individual. People 
just above the age limit can be compared to those just below. Given the 
assumption that all other characteristics that could affect alcohol-related 
outcomes are smoothly distributed across the threshold, any differences in 
outcomes between the groups can be causally attributed to legal access to 
alcohol. Carpenter and Dobkin (2009, 2011) were the first to identify MLDA as a 
natural experiment that could be analysed using RD. In an introduction to 
econometric methods, Angrist and Pischke cite Carpenter and Dobkin’s MLDA 
work as a paradigmatic example of the design, remarking that their studies 
“appear to have been written in RD heaven” (Angrist and Pischke, 2015, p. 164). 
The insensitivity of the results to specification or bandwidth, they argue, 
“suggests the findings generated by an RD analysis of the MLDA capture real 
causal effects” (p. 164). 
4.4 Methods 
4.4.1 Identification and appraisal of studies 
The RD MLDA studies were identified within the larger systematic review of RD 
studies in health described in chapter 3, where the methods are reported in full. 
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In brief, the search encompassed 32 databases, using “regression discontinuity” 
or “regression-discontinuity” as search terms in title, abstract, or full text (when 
available), as well as the reference lists of included papers. Studies published 
between 1960 and March 2015 in any language were included that used a 
regression discontinuity design to investigate any physical or mental health 
outcome for any intervention or exposure. No search filters were used as none 
have been developed for RD studies. 
The citations retrieved were downloaded into an EndNote database. Titles and 
abstracts were screened by one reviewer (myself); a 10% random sample was 
screened by a second reviewer (HT) and the results compared. Full text papers 
were then screened for relevance by one reviewer (myself); a 10% random 
sample was screened by a second reviewer (HT) and the results compared. 
Disagreements were resolved through discussion and involvement of a third 
reviewer when required. 
The RD studies thus retrieved were then categorised by topic area. The review 
protocol stated that a topic area in which several studies were identified would 
be the subject of more detailed analysis. Seventeen studies used an RD design to 
evaluate the health effects of MLDA legislation, the highest number of studies on 
a single topic. These studies were therefore chosen as the subject of further 
investigation for critical appraisal, narrative synthesis, and possible meta-
analysis.  
At the time of this review, no critical appraisal tools for the quality assessment 
of RD studies had been published in the health research literature or by evidence 
synthesis organisations such as the Cochrane Collaboration. The only quality 
assessment tool identified through the literature search was a set of standards 
for the evaluation of RD studies to be used as evidence in education policy and 
planning decisions. This tool, the What Works Clearinghouse Standards for RD, is 
described in detail in chapter 5. Two reviewers (myself and MC) independently 
assessed each included study, recorded the assessments, and met to discuss and 
agree a final assessment for each study. 
Chapter 4 Page 62 
 
4.4.2 Data extraction 
Data were extracted to describe each study in terms of the country and time 
period represented, the natural experiment under investigation, the forcing 
variable used, number and summary characteristics of participants, outcomes 
examined, primary outcome if stated, data sources used. 
In order to consider the validity of the RD approach, data were extracted on any 
other approaches used to analyse the same natural experiment within the study 
(for example, panel data, time series, or IV) and any efforts at falsification of 
the RD approach. 
In order to investigate the nature of the information provided within RD studies 
and the potential challenges presented for systematic reviews, data were also 
extracted that described the characteristics of the statistical analyses presented 
in these studies. The extracted data included: whether the analysis was based 
on a pre-established protocol, the number of models reported, variables 
included in models, subgroup analyses performed, the model selection method, 
whether this selection was made a priori, a description of the preferred model, 
and the number of observations in the preferred model compared to the full 
sample. 
Finally, outcome data were extracted (where available) for mortality (all cause, 
motor vehicle related, and suicide), alcohol-related hospital admissions, and 
motor vehicle accidents. These outcomes were selected because of their 
relevance to public health policy given their direct and high costs to both 
individuals and society, and because they can be interpreted (within the context 
of the RD design) as a direct measure of the effects of MLDA on health. 
4.4.3 Synthesis methods 
The design and methods used in the included studies to analyse MLDA are 
presented as a narrative synthesis (Popay et al., 2006). Aspects of study context 
and details of statistical approaches are presented in tables.  
If event rate data were available from two or more studies for a given outcome, 
the protocol specified that a meta-analysis would be performed. Meta-analysis 
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was considered for two outcomes, change in rates of all-cause mortality and 
change in rates of mortality due to motor vehicle accidents, which were 
reported in a comparable statistical manner in two studies (Carpenter and 
Dobkin, 2011; Carpenter, Dobkin, and Warman, 2014). These studies reported 
data for these outcomes as a rate difference with standard error, but without 
the numbers of events observed on either side of the threshold nor the 
denominators used, meaning that any recalculation of the outcome was not 
possible. Accordingly meta-analysis could not be undertaken.  
As the meta-analysis was not possible, and at best could only have incorporated 
two of the 17 studies, a third synthesis approach was applied to make the best 
use of the available evidence. Estimates of the effect of MLDA on mortality, 
hospital admissions, and MVA were synthesised in the form of effect direction 
plots (Thomson, 2013, Thomson and Thomas, 2013). Effect direction plots 
provide a visual summary of a body of evidence for a given systematic review, 
showing the included studies and relevant outcomes in a grid along with symbols 
for the direction (increased or decreased effect or risk) and statistical 
significance of each effect estimate from each study. This visual summary 
complements a detailed and complex narrative review, from which it may be 
difficult to get an overall sense of the evidence or to draw conclusions.  
Some modifications have been made to the effect direction plot. The example 
plot shown in the original methods papers (Thomson and Thomas, 2013; 
Thomson, 2013) is taken from a Cochrane review on housing improvement 
interventions and included columns for study design, time since intervention, 
and intervention integrity. These columns have been omitted as they are not 
necessary to describe the results of the present review. Study quality has also 
been omitted as current methods do not support summarising the quality 
appraisal of RD studies in a single letter or symbol. Numbers in sample has been 
omitted as it is an area of incomplete reporting in these studies and the relative 
sample size of the studies can be represented graphically.  
The most important modification relates to synthesis of multiple outcomes. The 
effect direction plot was originally conceived to support the merging of 
heterogeneous yet conceptually related outcomes into a single outcome 
category. For example, diverse measures such as cough frequency, cough 
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severity, wheeze incidence, wheeze duration, and asthma exacerbations could 
be represented under one category, “Respiratory”, and effects synthesised 
despite heterogeneity. This approach allows the end user to form a judgment as 
to whether the intervention improves conceptually related outcomes and is 
useful when the judgment does not depend upon a point estimate or effect size 
for a precisely defined clinical endpoint. The approach provides a solution when 
a body of studies evaluate a similar intervention but use diverse outcome 
measures. 
In the MLDA RD studies, the chief difficulty in synthesis is not so much a diversity 
of outcome measures as a diversity of modelling specifications, which results in 
multiple effect estimates for each outcome measure (as reported in section 
4.5.4 below). Accordingly, for the effect direction plot to be useful for RD 
studies, it must allow not only for synthesis of multiple outcomes but also for 
synthesis of multiple specifications. To this end, the original methodology has 
been adapted to provide synthesis rules to account for situations in which 
direction of effect and statistical significance vary across model specifications. 
The original methodology specified decision rules based on the percentage of 
outcomes in the study reporting a consistent direction or statistical significance 
of effect (60% or 70%, depending on the rule). The number of model 
specifications to be synthesised per outcome ranged from 1-9 in the present 
review with a median of 6. A pragmatic decision was made to change the 
decision threshold to 2/3 of specifications as it was better suited to the data at 
hand. Furthermore, studies reporting only one specification and only one 
outcome were to be flagged with an asterisk (*) to indicate that they were not 
subject to the synthesis decision rules. Otherwise, the effect direction plot 
could be incorrectly interpreted such that consistency of effects in these studies 
could be overestimated. 
4.5 Results 
4.5.1 Included studies 
Of the 181 RD studies identified in the systematic review, 17 investigated the 
health effects of minimum legal drinking age legislation. MLDA was the most 
frequently assessed intervention or exposure among RD studies of health 
Chapter 4 Page 65 
 
outcomes. Table 4.1 reports the study characteristics in terms of the setting, 
dates, and natural experiment analysed. One study examined the MLDA in 
Australia (Lindo et al., 2014), two in New Zealand (Boes and Stillman, 2013, 
Conover and Scrimgeour, 2013), five in Canada (Callaghan et al., 2014b, 
Callaghan et al., 2013a, Callaghan et al., 2013b, Callaghan et al., 2014a, 
Carpenter et al., 2014), and nine in America (Carpenter and Dobkin, 2009, 
Carpenter and Dobkin, 2011, Carpenter and Dobkin, 2015b, Crost and Guerrero, 
2012, Crost and Rees, 2013, Deza, 2013, Ertan Yoruk and Yoruk, 2015, Ertan 
Yörük and Yörük, 2012, Yörük and Yörük, 2011).  
Table 4.1. Characteristics of regression discontinu ity studies of the health 
effects of minimum legal drinking age legislation 
Study Country Dates 
Represented  
in Data 
Natural Experiment Forcing Variable 





1996-2007 Policy change 
(SLAA1999) which 
lowered the MLDA to 
18 








1996-2007 MLDA of 20 (pre-law 
change) or 18 (post-
law change) 
Age (in quarters) 
Callaghan et al. 
2013a 
Canada April 1997- 
March 2007 
MLDA of 18 or 19 
(province/territory 
dependent) 
Age in months 
(range 72 except 
MVA which is 48) 
Callaghan et al. 
2013b 
Canada April 2002- 
March 2007 
MLDA of 19 Age in months, 
range 16-22 (72 
months) 
Callaghan et al. 
2014a 
Canada 1980-2009 MLDA of 18 or 19 
(province/territory 
dependent) 
Age in months, 
range 48 months 
Callaghan et al. 
2014b 
Canada 2000-2012 MLDA of 18 
(Québec) 









MLDA of 21 Age in 30-day 
blocks (range 19-
23 years old) 
Carpenter and 
Dobkin 2011 
USA 1997-2003 MLDA of 21 Age in months, 





Canada 1980-2008 MLDA of 18 or 19 
(province/territory 
dependent) 
Age in days 








MLDA of 21 Age in months, 







1993-2006 Policy change 
(SLAA1999) which 
Date of policy 
change 
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Study Country Dates 
Represented  
in Data 
Natural Experiment Forcing Variable 









1993-2006 MLDA of 20 (pre-law 
change) or 18 (post-
law change) 





USA 2002-2007 MLDA of 21 "Each observation 
is the average of 
substance use 
over a month-of-
age cell" (Tables 
2 and 3) 
Crost and Rees 
2013 
USA 2000-2006 MLDA of 21 Age in months, 
range 19-22 (48 
months) 
Deza 2015 USA 1997-2009 MLDA of 21 Age in months, 
range 19-23 years 
Ertan Yoruk and 
Yoruk 2012 
USA 2000-2006 MLDA of 21 Age in days 
(MLDA ±732 
days; range ages 
19-22) 
Ertan Yoruk and 
Yoruk 2015 
USA 2000-2006 MLDA of 21 Age in days 
(MLDA ±732 





Australia 2000 or 2001 
to 2010 or 
2011 
MLDA of 18 (NSW) Age in days 
(MLDA ±22 mos) 
Yoruk and Ertan 
Yoruk 2011 




Note: Boes and Stillman (2013) and Conover and Scrimgeour (2013) each report 
two different RD analyses, corresponding to the two different MLDA natural 
experiments that can be identified in New Zealand. 
 
All of the identified studies were retrospective RD designs which used data 
obtained from national administrative databases or nationally representative 
longitudinal surveys. Each study included multiple years of data from these 
sources, with a mean of 11.2 calendar years (range 6 to 30) represented in the 
study data. In terms of the currency of the data used, the decade 1997-2007 is 
covered in all studies (range of dates from 1980 to 2012).  
The approach to investigating the effects of MLDA was broadly similar across 
studies. All studies used age (in days, weeks, months, or quarters) as a forcing 
variable to examine an outcome in people aged just above or below the 
treatment threshold, i.e. the age at which they can legally purchase and 
consume alcohol. In the sole Australian study, this age threshold (in New South 
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Wales) was 18. The American studies used the age threshold of 21 which has 
been in place in all states since the 1980s. In Canada, the MLDA varies by 
province (18 in Alberta and Québec, 19 elsewhere). In New Zealand, the MLDA 
was lowered from 20 to 18 in 1999, creating two natural experiments which 
were both exploited by the two included studies. Boes and Stillman (2013) and 
Conover and Scrimgeour (2013) analysed both age-based and date-based 
discontinuities. 
For the age-based RD designs, the natural experiment under investigation was 
the removal of legal restrictions on alcohol purchase and consumption that 
occurs when individuals cross the age-based threshold. In economic terms, this 
situation represents a discontinuous ‘price decrease’ for alcohol in terms of the 
full personal and social costs an individual may incur for consuming alcohol 
(Carpenter, Dobkin and Warman, 2014, p.11). This situation allowed 
investigation of the effects of legal access to alcohol versus age-restricted 
prohibition on alcohol consumption and its proximal sequelae, including motor 
vehicle accidents, attendance at A&E, hospital admissions, and mortality risk. 
Some authors additionally identified within this natural experiment the 
opportunity to investigate whether alcohol is a complement or substitute for 
marijuana and other drugs by comparing age-based discontinuities in the 
consumption of these substances (Crost and Guerrero 2012; Crost and Rees 2013; 
Deza 2015; Yoruk and Ertan Yoruk 2011). 
Additionally, Boes (2013) and Conover and Scrimgeour (2013) investigated the 
natural experiment represented by the New Zealand Sale of Liquor Amendment 
Act (SLAA) 1999. The enactment of this legislation created a date-based 
discontinuity which the studies analysed using monthly data, with date as a 
forcing variable and December 1999 (when the legislation was passed) as the 
cut-off. This design assumes that no other changes took place at the same cut-
off that would affect the outcomes. Both sets of authors acknowledge and 
address this issue. Boes and Stillman state their belief the assumption holds 
because they know of no other policy changes that occurred at that time; 
Conover and Scrimgeour test the assumption by implementing a difference-in-
discontinuities estimator. Both acknowledge, however, that SLAA 1999 was a 
legislative package that involved not only lowering the MLDA but also changes to 
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where and how alcohol could be sold, accompanied by changes in enforcement 
of these laws. Therefore, any discontinuities must be seen as effects of SLAA 
1999 as a whole and not exclusively of the MLDA component of the package. 
The age-based RD studies would similarly be at risk of confounding and 
invalidation if other factors which contribute to the outcome also change at the 
same age cut-off. The studies address these concerns through design, analysis, 
narrative argument, or a combination of these approaches. Some studies 
examined whether a discontinuity occurred at the cut-off in an outcome that 
could not plausibly be caused by MLDA; such a discontinuity would serve as 
evidence of another factor that could be causing discontinuity in the outcomes 
of interest, whereas absence of a discontinuity would support the validity of the 
RD design. For example, Callaghan et al. (2013b), investigating whether hospital 
admissions in Ontario were discontinuous at the MLDA, demonstrated that rates 
of admission for appendicitis (which should not be affected by increased alcohol 
consumption) were not discontinuous at the cut-off. Less commonly, some 
studies provided an argument as to the plausibility of other changes at the same 
cut-off affecting the outcomes. In a different approach to testing RD 
assumptions, Lindo et al. (2014) acknowledged that the age-18 cut-off in 
Australia corresponds to the ‘age of majority’ at which young people are 
considered to become adults and this could confound the RD design. They 
addressed this issue by testing for and ruling out discontinuous changes in 
demographic characteristics that could serve as ‘coming of age’ markers, such as 
living at home or being employed.  
4.5.2 Quality of studies 
Detailed critical appraisal results for each study are presented in Appendix 3. A 
summary of the quality of the included studies is presented in chapter 5, figure 
5.1. All studies met the three qualifying questions of the WWC Standards for RD, 
with the New Zealand studies deemed to meet question 3 (unconfounded forcing 
variable) on the basis that the studies acknowledge they are assessing the 
effects of SLAA 1999 as a package. All studies met the standard for integrity of 
the forcing variable as neither data subjects nor the researchers would have had 
the opportunity to alter the birth records in the datasets used. Probably because 
the data sources and retrospective nature of the studies precluded such 
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manipulation of the forcing variable, most studies did not report conducting 
tests of the smoothness of the forcing variable at the threshold, which led both 
reviewers to agree to assign a judgment of ‘not applicable’ to these studies for 
criterion 1B. However, four studies did present graphs of number of observations 
by age in order to present visual evidence of the smoothness of the forcing 
variable across the threshold, which is sufficient to meet the criterion. 
Only one of the 17 studies (Deza 2015) provided any information about attrition, 
an area of very poor reporting in RD. Although data on attrition may not be 
available or may not be considered an important source of risk of bias when 
using comprehensive government datasets, as many of these studies do, over 
half (9/17) used survey data for which information on attrition rates is relevant 
and available. The WWC Standards require RD studies to meet the same standard 
for reporting attrition as randomised trials. Moreover, failure to meet the 
attrition standard leads to failure to meet the overall quality standard. The 
second reviewer and I agreed that this was not helpful for describing the quality 
of the studies and decided to add a judgment of ‘not applicable’ for 
retrospective RD studies.  
A majority (10/17; 58.8%) of studies failed to meet the third WWC quality 
standard, which requires studies to verify that there are no discontinuities at the 
cut-off in covariates other than the forcing variable that are correlated with the 
outcome (criterion 3A) or in the outcome at values of the forcing variable other 
than the cut-off (criterion 3B). Failure to meet this standard meant that the 
overall judgment for that study would be ‘met with reservations’.  
The studies generally performed well against standard 4, which assesses the 
quality of the statistical modelling and reporting. Fifteen (88.2%) of the studies 
met all applicable criteria, while one study (Lindo et al. 2014) met with 
reservations because it (by not presenting graphs with fitted curves) did not 
meet the full criterion for graphical analysis and another (Callaghan et al. 
2013a) met with reservations because it did not report results separately by 
province when it could have. These were minor quality issues compared with 
criteria 4A and 4C, which address model specification and robustness; failure 
against these criteria would reflect serious risk of bias in the study results, but 
all studies met these two key criteria. 
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Overall six of 17 studies (35.3%) fully met the WWC standards (modified to allow 
omission of density tests, on the assumption that the forcing variable could not 
be manipulated, and omission of reporting of attrition, on the basis that it was 
not reasonable to expect retrospective, population-level studies to investigate 
attrition to the same standard as an RCT). The remaining 11 studies (64.7%) met 
the WWC standards with reservations: ten because they did not conduct 
falsification tests of the cut-off, and one because of failure to report results 
separately by province. In summary, approximately one-third of the studies are 
at low risk of bias and two-thirds might be said to be at a moderate risk of bias 
because of insufficient assessment of the smoothness condition. 
4.5.3 Reporting of RD analyses 
Table 4.2 provides information on study reporting in relation to 
participants/population and outcomes. Four of 17 studies (24%) reported the 
exact number of participants or records analysed in the study (Carpenter and 
Dobkin, 2015; Crost and Benjamin, 2013; Deza, 2015; Lindo, 2014). Four studies 
(Carpenter 2014, Crost 2012, Ertan 2012, and Yoruk 2011) reported an 
‘approximate’ sample size in thousands and four studies provided numbers of 
observed events which varied across outcomes and subgroups (Boes and Stillman, 
2013; Callaghan et al., 2013b; Conover and Scrimgeour, 2013; Ertan 2015). Only 
one study (Boes and Stillman, 2013) specifically named one outcome measure as 
the primary outcome of the study. 
 
Table 4.2 Reported number of participants, outcomes , and data sources 
used in RD studies of MLDA 
Study Number of  
Participants 




Not reported Alcohol-related hospital 
admission rates per 10,000 
population; alcohol-related 
MVA 
NZ Ministry of Health hospital 
episode database; NZ Ministry 
of Transport data on MVA; 
population estimates from 





Not reported Alcohol-related MVA NZ Ministry of Transport data 
Callaghan et 
al. (2013a) 
Not reported Alcohol-related hospital 
admission rates per 1,000 
population 
CIHI Hospital Morbidity 
Database 
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Study Number of  
Participants 
Outcomes Data Sources 
Callaghan et 
al. 2013b 
Not reported Morbidity (alcohol-related 
inpatient and emergency 
admissions) 
Rates per 1000 hospital 
events: CIHI Hospital Morbidity 
Database and National 




Not reported Mortality: All-cause, external 
causes, internal causes (+/- 
MVA), MVA. Mortality counts 
within each age-in-month, 
NOT rates 
Statistics Canada VICES (Vital 
Integration Capture and Edit 








Not reported Alcohol consumption, mortality 
(internal and external causes: 
alcohol, homicide, suicide, 
MVA, drugs, external other): 
rates per 100,000 
NHIS (consumption); National 




Not reported Mortality (age-specific 
mortality rate, estimated) 
alcohol consumption 
Mortality due to all causes, 
MVA, alcohol overdose, or 
suicide: estimated using 
National Vital Statistics records 






Approx. 36,000 Alcohol consumption, mortality 
(internal and external causes: 
alcohol, internal, external, 
MVA, injuries): rates per 
100,000 
Statistics Canada (mortality), 
National Population Health 




N records = 
3770267  
Alcohol-related ED visits and 
hospital admissions per 
10,000 person-years 
Healthcare Cost and Utilization 
Project (HCUP) State Inpatient 















but tables 5 
and 6 give very 



























28,089 Marijuana use NLSY97 longitudinal survey 
Deza 2015 8984 Alcohol and hard drugs 
consumption 




Approx. 9000 20-point psychological 
wellbeing index based on 
Mental Health Inventory (self-
NLSY97 longitudinal survey 
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Study Number of  
Participants 












Alcohol consumption and 8 
sexual behaviour outcomes 













Alcohol consumption, MVA, 
hospital admissions (inpatient 
episodes involving alcohol 
intoxication or poisoning, 
MVA, motorcycle accidents, 
other external causes) 
National household survey 
(HILDA), NSW Centre for Road 





Approx. 9000 Alcohol, cigarette, and 
marijuana consumption 
NLSY97 longitudinal survey 
 
The estimation of the effect of an intervention (or exposure) on an outcome 
within an RD design is achieved through regression analysis, for which the 
underlying functional form is typically unknown, making the estimate sensitive 
to model specification. There is no single or simple approach to identifying the 
best estimate or eliminating inappropriate specifications, so testing and 
reporting multiple specifications is standard practice in RD; relying only on one 
specification is not recommended.(Lee and Lemieux, 2010) Table 4.3 reports 
findings on how the studies conducted and reported modelling of the 
relationship between the forcing variable and outcomes. No studies reported the 
existence of a protocol or a priori method of model specification and selection.  
Table 4.3. Characteristics of statistical analyses presented in RD studies of 
MLDA legislation 
Study No.  models 
reported 












6 1/6 models adjusted for 
gender, ethnicity 
(admissions) or vehicle 
type (MVA), month of 
year, day of week, 



















6 1/6 models adjusted for 
gender, month of birth, 
vehicle type (MVA), 
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Study No.  models 
reported 










month of year, day of 
week, time of day, 















































1 Birthday month, age Gender (M, 
F)/MLDA 
18 or 19 
Polynomials 













1 Birthday week, age Gender 
(M,F) 
Polynomials 













4 1/4 models adjusted for 
birthday effect 






































8  Age, birthday 
celebration effect. 
Appendix 9 additionally 
reports results for 
alcohol consumption 
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Study No.  models 
reported 





























5 Day of week and New 

































1 Age (donut approach to 









of 3 years 
Crost and 
Rees 2013 
8 Age (donut approach to 




status, gender, race, 
student/employment 
status 

























includes birthday month 
effect, gender, race, 
educational enrolment, 
current or prior military 
service. Third spec 
includes fixed effects 
for time-invariant 
omitted variables 






























status, gender, race, 
student/employment 
status 





















Age; 3/6 models 












Not reported None 
chosen; 
emphasis 
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Study No.  models 
reported 
























1 (with range 
of different 
bandwidths) 
Age (donut approach to 























status, gender, race, 
student/employment 
status 














Reported model specifications varied across studies. Of the 17 studies, six 
reported only one specification (Callaghan 2014a and 2014b; Carpenter and 
Dobkin 2011 and 2015; Crost and Guerrero 2012; and Lindo et al. 2014), although 
one of these studies (Lindo et al. 2014) also reported results for a range of 
different bandwidths, and two of the studies (Callaghan et al. 2014 a and 2014b) 
tested other specifications but reported only a linear model after polynomials 
were tested and found not statistically significant. The other eleven studies 
reported between 3 and 9 specifications (median 6). Roughly half of the studies 
(9/17; 52.9%) additionally reported subgroup analyses by gender. All studies 
reported models that were adjusted for the forcing variable and for a ‘birthday 
celebration effect’, following Carpenter and Dobkin’s original MLDA RD study 
(2009) which identified an immediate and short-term increase in mortality on 
the date of, or the day after, the 21st birthday. 
Reporting of model selection methods and of preferred effect estimates varied 
considerably across studies. Of the eleven studies that reported estimates from 
more than one specification, one (Conover and Scrimgeour, 2013) reported using 
the Bayesian Information Criterion to select a preferred model for the age-based 
RD, although it was unclear which of the five models presented was selected and 
thereby represented the preferred estimate. Three studies (Callaghan 2013a and 
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2013b; Carpenter and Dobkin 2009) reported using statistical significance of the 
polynomial term for age as the rationale for model selection. One study 
(Carpenter 2014) identified a preferred specification but offered no rationale for 
the choice. The remaining six studies did not report any model selection method 
and did not report a preferred estimate, reporting instead a range of estimates 
and an approximation (Boes and Stillman, 2013), a lack of statistically significant 
estimates (Ertan Yoruk and Yoruk, 2012), or comments on the consistency of 
results across specifications (Conover and Scrimgeour, 2013; Crost and Rees 
2013; Deza 2015; Yoruk and Ertan Yoruk, 2011). 
4.5.4 Estimates of effects of MLDA 
4.5.4.1 Mortality 
Four studies reported estimates of the effect of reaching the MLDA on mortality. 
These studies used government death records from Canada (Callaghan et al. 
2014a; Carpenter et al. 2014) or the United States (Carpenter and Dobkin 2009 
and 2011). Estimates of effects on mortality due to all causes, MVA, and suicide 
were extracted and are reported in Table 4.4. 
Table 4.4 Estimates of effect of minimum legal drin king age legislation on 
mortality 
Study All-cause mortality MVA mortality Suicide mortality 
Callaghan et 
al. 2014a 
Male MLDA 19 25.79 [SD 
8.24] additional deaths or 
7.2% increase, p=0.003; 
female MLDA 19 -0.21 [5.24] 
or -0.2% decrease, p=0.968 
Male MLDA 19 22.05 [SD 
5.50] additional deaths or 
15.3% increase, p<0.001; 
male MLDA 18 12.7% 
increase, p<0.05. 
Female MLDA 19 2.09 [2.98] 
or 4.8% increase, p>0.05; 
female MLDA 18 13.6%, 










8.06 [SE 2.17] additional 
deaths per 100,000 person-
years or an 8.7% increase, 
p<0.01; analysis by gender 
finds statistically significant 
effect for men only 
3.65 [SE 1.25] additional 
deaths per 100,000 person-
years or a 12.2% increase, 
p<0.01 
2.37 [SE 0.76] 
additional deaths 
per 100,000 





4.10 [SE 2.76] additional 
deaths per 100,000 person-
years or a 5.8% increase, 
p>0.05; 
4.78 [SE 1.56] additional 
deaths per 100,000 person-
years or a 17% increase, 
p<0.05; higher for males 
(7.32) than for females (2.12) 
NA 
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higher for males (6.91) than 
females (1.14) but neither 
increase is statistically 
significant, nor in the 
difference in effect by gender 
 
Also reported in Appendix 27: 
Provincial MLDA 19 0.25 [SE 
2.73] increase in mortality 
rates; provincial MLDA 18 
10.41 [SE 4.02] increase in 
mortality rates 
and only statistically 
significant for men. 
 
Also reported in Appendix 27: 
Provincial MLDA 19 5.28 [SE 
1.83] increase in mortality 
rates (19.8% relative increase, 
calculated); provincial MLDA 
18 3.97 [SE 2.25] increase in 
mortality rates (12.8% relative 
increase, calculated) 
 
The two Canadian studies both found an increase in all-cause mortality for 
males; in Callaghan et al. (2014a) this relative increase of 7.2% in provinces with 
an MLDA of 19 (p=0.003) and 14.2% in provinces with an MLDA of 18 (p=0.002) 
was statistically significant, but in Carpenter et al. (2014) the increase (of 6.91 
additional deaths per 100,000 person-years) was not statistically significant. 
Neither study found a statistically significant change in mortality for females. 
Both studies used Statistics Canada mortality data, although Carpenter et al. 
analysed the period 1980-2008 and Callaghan et al. analysed 1980-2009. 
Carpenter et al. analysed average mortality rates for each age-in-months, 
whereas Callaghan et al. analysed mortality counts for each age-in-months 
category. Carpenter et al. defined the birthday celebration effect as the 
birthday or week immediately after, whereas Callaghan et al. defined it as the 
birthday month. Both studies include individuals within two years of either side 
of the MLDA cutoff (48 age-in-month periods). Callaghan et al.’s model is linear 
whereas Carpenter et al. used a second order polynomial; both models are 
adjusted for interaction with the MLDA. A final difference between the studies is 
that Callaghan et al. conduct separate analyses for provinces with MLDAs of 18 
and 19, respectively, while also stratifying by gender; Carpenter et al. combine 
all provinces in a single analysis, arguing that “separate analyses by provincial 
MLDA are not informative because the vast majority of the Canadian population 
resides in provinces with an MLDA of 19” (p. 4). (A footnote (p. 23) points to the 
presentation of further results in Appendix 27, where Carpenter et al. present 
mortality estimates stratified by provincial MLDA. Unfortunately, these are not 
stratified by gender. 
The results of the two Canadian studies showed greater similarity when 
evaluating MVA mortality. Both found statistically significant increases in MVA 
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mortality at the MLDA for males, but not for females. The point estimates of the 
increase are similar when comparing the results for males in both provincial 
MLDA categories in Callaghan et al. with the results stratified by province (but 
not gender) in Carpenter et al. (see column 3 of table 4). 
The two studies of American data, both by Carpenter and Dobkin (2009 and 
2011), report the same statistically significant (p<0.01) estimated increase in all-
cause mortality of 8.7%, although when stratified by gender the increase is 
statistically significant for males but not for females (web appendix O, 2009). 
The two papers give different estimates for effects on mortality from MVA or 
suicide but all estimates are increases and range from 12.2% to 20.3%. It is 
unclear why the estimates differ between the two papers when they use very 
similar analytical approaches and data (with one extra year of observations used 
for the 2009 paper). 
4.5.4.2 Hospitalisation 
Seven RD analyses in six studies examined changes in hospital admissions at the 
MLDA (Boes and Stillman, 2013; Callaghan et al, 2013a and 2013b; Carpenter and 
Dobkin, 2015; Conover and Scrimgeour, 2013, both age- and date-based RD 
designs; and Lindo et al., 2014). These studies cover all four countries 
represented in this review. All six studies used large administrative datasets and 
ICD-9 or ICD-10 codes to identify admissions related to alcohol, injury, or MVA, 
although the specific codes used and the composite outcomes created vary 
across studies. Table 4.5 presents the estimates of effect and definition used for 
alcohol-related hospital admissions. 
Table 4.5 Estimates of effect of minimum legal drin king age legislation on 
alcohol-related hospital admissions 
Study Alcohol-related hospital admissions ARHA definition 
Boes and Stillman 
2013 (date-based) 
Lowering of MLDA from 20 to 18 in 1999 led 
to small absolute increases in ARHA for 15-
21 year olds (24 point estimates presented 
“which range from about 0.3 to 0.4 additional 
admissions per 10,000 
population for the 15-19 year-olds (significant 
at the 1% level) and 0.2 additional 
admissions per 10,000 population for the 20-
21 year-olds (significant at the 5% level)”. In 
relative terms ARHA “almost” doubled.  
Admissions for alcohol 
use disorder, alcohol 
intoxication, and alcohol 
dependence as per ICD-9 
codes 
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Callaghan et al. 
(2013a) 
At MLDA there are statistically significant 
increases in admissions for alcohol use 
disorders/poisoning (M and F), self-inflicted 
injuries (total), MVA (M), and external injuries 
(M), but not assault and not for F other than 





assault, MVA, and 
external injuries as per 
ICD-9 or 10 
Callaghan et al. 
2013b 
(Looking at best-fit models only) No 
significant effect on suicide broadly defined, 
alcohol-use disorders in females, MVA; 
significant increase in alcohol-use disorders 
(male and all), assaults, alcohol-related 
suicide (female and all, but total events =11), 
male external injuries 
Alcohol use disorders, 
suicides related to 
alcohol, suicides broadly 
defined, assault, MVA, 




At MLDA there are statistically significant 
increases in all ED visits (71.3 per 10,000 
person-years) and hospital admissions (8.4 
per 10,000 person-years). These are the 
highest estimates of effect for any of the 
outcomes/subgroups. If look only at E/D or 
hospital admission for alcohol intoxication, 
effects are much smaller (but still statistically 
significant) 
All admissions/visits 
excluding pregnancy and 
for the following causes: 
alcohol intoxication, 
alcohol or injury 
(composite), accidental 
injury, self-inflicted injury, 





Following policy change (MLDA lowered to 
18) there was an increase in hospitalizations 
of 53.663% (SE 24.605, p<0.05) for males 
and 4.673% (SE 14.153; NS) for females 
(linear estimate using one year's data) 
Admissions coded with 





At MLDA hospitalizations increase by 
19.395% (SE 8.452) for males (p<0.05) and 
decrease for females by -1.959% (SE 6.374) 
(linear estimate using one year's data) 
Admissions coded with 
ICD-9 or -10 with mention 
of alcohol 
Lindo, Siminski and 
Yerokhin 2014 
At MLDA there is a statistically significant 
increase in hospital admissions for alcohol 
intoxication or poisoning of approximately 4 
episodes per 10,000 person years or a 30% 
relative increase (similar magnitude for 
males and females), and approximately 7 
episodes per 10,000 person years for assault 
(greater for males than females – 
approximately double). No evidence of 
discontinuity in admission for drivers injured 
in MVAs. 
Alcohol intoxication or 
poisoning (ICD-10 alcohol 
use disorder or toxic 
effect of alcohol), 
assaults, transport 
accidents 
Despite these similarities among studies, relatively clear definitions of 
outcomes, and use of large national datasets, it was challenging to extract data 
and summarise the findings of these studies. Table 5 reports the results. Boes 
and Stillman (2013), Callaghan et al. (2013 a and b), and Conover and 
Scrimgeour (2013) all report estimates from multiple model specifications; 
Callaghan et al. and Conover and Scrimgeour provide estimates only by gender. 
Estimates of effect were expressed as number of additional admissions per 
10,000 population (Boes and Stillman, 2013), rates per 1,000 hospital events 
(Callaghan et al., 2013b), admissions per 10,000 person-years observed 
(Carpenter and Dobkin, 2015; Lindo et al., 2014), or relative increases in 
admissions (Conover and Scrimgeour, 2013; Lindo et al., 2014). Although 
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absolute numbers of events observed were sometimes reported, denominators 
generally were not. Denominators frequently were estimates based on 
government census data. 
4.5.4.3 Motor vehicle accidents 
Four RD analyses in three studies examined changes in MVAs at the MLDA (Boes 
and Stillman, 2013, both age- and date-based RD designs; Callaghan et al., 
2014b; and Lindo et al., 2014), using data from three of the four countries 
represented in this review. All three studies used government data on MVAs. 
The inconsistent findings among these analyses are described in table 6. Despite 
conducting numerous analyses using different subgroups of MVAs, Lindo et al. 
found no evidence of any discontinuity at the MLDA. Boes and Stillman identified 
a significant effect in their age-based approach, but not in their date-based RD 
analysis. Callaghan et al. found statistically significant increases in all MVA types 
and for almost all subgroup analyses, despite the fact that the study 
hypothesised that any effect of MLDA would only be seen in nighttime and 
single-vehicle nighttime crashes (their proxy outcomes for MVA involving 
alcohol). Table 4.6 presents the estimates of effect and definition used for 
alcohol-related hospital admissions. 
Table 4.6 Estimates of effect of minimum legal drin king age legislation on 
motor vehicle accidents 




(date-based discontinuity) "Overall…the reduction in the MLDA had no 




(age-based discontinuity) "Taken at face value, these results indicate that 




Statistically significant increases in total MVAs (all, daytime, nighttime, single-
vehicle nighttime) and MVAs for men (all types except single-vehicle nighttime), 
but not for women (although all MVAs just reached statistical significance, 
p=0.473) (tables 1 and 2. Estimates of the increase ranged from 4.2% (women, 




“Consistently, we found no evidence of discontinuities” (p. 18) 
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Boes and Stillman (2013) provide a unique insight by analysing the same data 
using the discontinuities created by two different natural experiments, the age 
threshold and the date that the age threshold was lowered in New Zealand. 
Unlike the data used in the other two studies, the New Zealand data did record 
whether the accidents were deemed by the police to be alcohol-related (p. 13). 
The date-based RD found that alcohol-related MVA did not increase following the 
change in MLDA legislation and the authors further confirm this finding through 
sensitivity checks and by estimating a difference-in-difference model (p. 14). An 
age-based RD of MVA during the period before the change in legislation, when 
the MLDA was 20, also found “little evidence” of a discontinuity. However, 
repeating the age-based RD for the period post-legislative change, Boes and 
Stillman found an increase of approximately 0.08 alcohol-related MVA per 10,000 
population at the threshold (p. 17) or an approximate relative increase of 25%. 
Boes and Stillman offer a three-pronged explanation of this inconsistency. First, 
they argue that the RD design is a LATE estimator which only identifies an effect 
on individuals whose behaviour is changed by the MLDA, meaning that those 
ageing past the threshold will be inexperienced drinkers more likely to 
experience a negative impact of increased access to alcohol. Second, they note 
that the distribution of MVA by age is an inverse U-shape and it is this nonlinear 
distribution that affects the RD estimate for the younger age group. Third, they 
offer contextual information suggesting that enforcement of MLDA legislation 
was lax prior to 1999 but increased following the law change. They conclude 
that their results “provide strong evidence that an age-based RDD is likely to 
give misleading evidence on the average impact of changing a MLDA, which is 
the policy relevant question” (p. 18). 
4.5.4.4 Effect direction plot 
The effect direction plot for this review (Figure 4.1) was designed to summarise 
the findings for all of the above outcomes in one table with graphical 
representation of effect estimates. Studies have been grouped by country of 
MLDA to aid comprehension of the body of evidence and judgment of any 
similarities and differences in effects. The outcome groupings ‘drugs 
consumption’ and ‘psychosocial outcomes’ have been added so that findings 
from all included studies can be represented in the plot. Drugs consumption 
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includes marijuana (Crost and Guerrero 2012; Crost and Rees 2013; Yoruk 2011) 
and ‘hard’ drugs such as cocaine (Deza 2015). Psychosocial outcomes include 
various psychological wellbeing measures (Ertan Yoruk 2012) and sexual 




Figure 4.1. Effect direction plot for age-based reg ression discontinuity studies of minimum legal drin king age legislation 


































Lindo 2014 Australia 
      ↔ □   
Callaghan 2013a Canada 
      ∆    
Callaghan 2013b Canada 
      ∆    
Callaghan 2014a Canada 
 ▲ v  ▲ ∆     
Callaghan 2014b Canada        ∆   
Carpenter 2014 Canada ∆ ∆ ∆ ▲ ▲ ∆     
Boes 2013 NZ        ↔   
Conover 2013 NZ 
      ∆    
Carpenter 2009 USA 
▲ ▲ ∆ ▲       
Carpenter 2011 USA 
▲   ▲       
Carpenter 2015 USA 
      ▲    
Crost 2012 USA         ▼  
Crost 2013 USA         ∆  
Deza 2015 USA         ▼  
Ertan Yoruk 2012 USA          v 
Ertan Yoruk 2015 USA          v 
Yoruk 2011 USA         ↔  
            
Symbol key 
Effect direction: upward arrow = negative health impact of legal access to alcohol (increased risk of negative outcome for observations above the cut-off, 
i.e. ageing past the MLDA) ▲▲▲∆∆∆ 
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 downward arrow = positive health impact of legal access to alcohol (decreased risk of negative outcome for observations above the cut-
off, i.e. ageing past the MLDA) ▼▼▼vvv 
 sideways arrow=mixed effects or conflicting findings ↔  
 
square: consistent evidence of no effect, i.e. no discontinuity, i.e. zero health impact □□□ 




Black arrow p<0.05; white arrow p>0.05 
  
Synthesis of multiple model specifications within same outcome category 
1. Where multiple specifications all report effect in same direction and with same level of statistical significance, report accordingly. 
2. Where direction of effect varies across specifications, report direction of effect and statistical significance where at least 2/3 of specifications report same 
direction and similar statistical significance. 
If less than 2/3 of specifications report same direction of effect, then report no clear effect / conflicting findings (sideways arrow) 
3. Where direction of effect is similar across specifications but statistical significance varies: 
 If direction of effect is similar in at least 2/3 of model specifications AND at least 2/3 of specifications are statistically significant, report as 
statistically significant (black arrow). 
 If direction of effect is similar in at least 2/3 of model specifications AND less than 2/3 of specifications are statistically significant, report 
as not statistically significant (gray arrow). 
 
 
Assumptions: Boes and Stillman: large sample size based on 2001 New Zealand census (n=270,456 people aged 15-19). Source: Statistics 
New Zealand. Age Group and Sex, for the Census Night Population Count, 1991, 1996 and 2001. Available from: 
https://www.stats.govt.nz/tools/nz-dot-stat [accessed 19 June 2018]. Callaghan 2013b: large sample size based on reported number of 
hospital admissions per month (approximately 40,000) for five years of data. Callaghan et al. 2014b: medium sample size based on 
reported number of MVA involving at least one 18-year-old driver (n=70,585). Carpenter and Dobkin 2009 and 2011: large sample size 
representing all deaths in United States over an eight-year period (number not reported). 
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Reading down each column, the effect direction plot can be interpreted as 
follows: 
• Evidence from four studies conducted in Canada and the United States 
suggests that mortality (from all causes and from MVA) increases at the 
MLDA and that this effect is statistically significant in males but not 
females. 
• Evidence from five studies conducted in Australia, Canada, New Zealand, 
and the United States suggests that alcohol-related hospital admissions 
increase at the MLDA, but that this effect is probably not statistically 
significant and is not consistent across settings. 
• Evidence is inconsistent from three studies conducted in Australia, 
Canada, and New Zealand on the effect on MVA at the MLDA. 
• Evidence is inconsistent from four studies conducted in the United States 
on drugs consumption. However, the two larger (and higher-quality) 
studies suggest a positive health effect, i.e. reduced drugs consumption. 
• Evidence from two small studies conducted in the United States suggests a 
positive but not statistically significant effect on psychosocial outcomes 
at the MLDA. 
4.6  Discussion 
This chapter has examined a subset of studies from a systematic review of RD in 
health (chapter 3), as per the review protocol which specified that further 
analyses would be undertaken if multiple studies were identified on the same 
topic. Seventeen studies investigated the health effects of MLDA legislation. This 
chapter reported the characteristics of those studies, quality assessments of the 
studies based on the WWC RD standards, and a synthesis of findings on the 
effects of MLDA legislation (or more precisely, the effect of ageing past the 
threshold for legal drinking) on mortality, hospital admissions, MVA, drugs 
consumption, and psychosocial outcomes. 
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4.6.1 Interpretation of results: evidence on effect iveness of MLDA 
This review shows that RD studies of the MLDA provide consistent evidence that 
mortality, fatal MVA, and alcohol-related hospital admissions increase when 
people age past the MLDA threshold, i.e. when age-based restrictions on alcohol 
are removed. This evidence suggests that MLDA legislation is effective in 
preventing alcohol-related harms in people younger than the age cut-off. The 
policy implication is that lowering (or removing) the age limit would expose 
people to these risks of harm at an earlier age and thereby increase social costs 
(through more life-years lost or through earlier onset of disabling conditions). 
These findings are consistent with previous systematic reviews that did not 
include RD studies (Shults et al., 2001, Wagenaar and Toomey, 2002). 
The effectiveness of MLDA was not consistent across all outcomes (although it 
must be kept in mind that the number of studies for each outcome is low). 
Contrary to previous reviews, the narrative synthesis and effect direction plot in 
this review suggest that there is inconsistent evidence on the effect of the MLDA 
on MVA. Lindo et al. (2013) found no evidence of a change in MVA at the 
threshold and argue that this finding reflects the “relative seriousness” with 
which New South Wales enforces and penalises drink-driving (p. 21), such that 
MLDA does not perceptibly change driver behaviour. Callaghan et al. (2014b), 
although emphasising statistically significant findings, especially in men, in fact 
reported a mixture of positive and negative findings with wide confidence 
intervals, and found a statistically significant increase in daylight MVA, an 
outcome which they suggested should not be predominantly affected by alcohol.  
Although the number of RD studies of this outcome is small, it is worth giving 
some consideration to possible reasons for differences between the findings of 
these studies and previous MLDA reviews, such as Shults et al. who found strong 
evidence for the effectiveness of MLDA in reducing alcohol-related MVA. 
Granted, these RD studies were conducted in countries other than the United 
States, and although MLDA operates on principles that are cross-cultural, factors 
such as enforcement and social norms may lead to different effects of MLDA in 
different countries. However, the impact of different study designs should also 
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be considered. Is it possible that previous reviews of observational studies 
mistook association for causation (McCartt et al., 2010)? Or could RD studies 
provide inaccurate and misleading results? 
To explore these questions, it is helpful to look closely at an example from New 
Zealand. Boes and Stillman (2013) also reported mixed findings on MVA, with 
implications not just for the effectiveness of MLDA but also for the 
interpretation of age-based versus date-based RD. Their date-based RD found 
that after the lowering of the MLDA December 1999, MVA decreased for all four 
age groups examined in the majority of model specifications; in the 18-19 year 
old age group which newly had legal access to alcohol in this situation, all 
specifications found a decrease in MVA, although only two of six estimates were 
statistically significant. Perhaps because the majority of estimates for all age 
groups were not statistically significant, they concluded that the 1999 reduction 
in the MLDA “had no immediate impact” on MVA (p. 14). 
Their age-based RD, on the other hand, found a small but statistically significant 
increase in MVA at the age threshold of 18 in the period 2000-2007, i.e. for 
drivers with newly-acquired legal access to alcohol. This increase was consistent 
in direction and significance across six specifications. The point estimate of the 
increase ranges between 0.065 to 0.099 alcohol-related MVA per 10,000 
population. Boes and Stillman interpret the disagreement between age-based 
and date-based RD as follows: 
“given that the results in the previous section, which identify the 
impact of the MLDA using the policy change itself, show no impact of 
moving the MLDA to 18, we believe the results here provide strong 
evidence that an age-based RDD is likely to give misleading evidence 
on the average impact of changing a MLDA, which is the policy 
relevant question.” (p. 18) 
Before accepting that the age-based RD design is misleading and inaccurate 
compared to a date-based design, it is necessary to closely consider the natural 
experiment being assessed in each design. Boes and Stillman interpret the age-
based RD to estimate the effect of the change of legislation. However, using age 
as the forcing variable means that the RD design is estimating the effect of 
reaching the age threshold and thereby gaining legal access to alcohol – not the 
effect of introducing new legislation. The date-based RD investigates that 
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change, but it also assumes that no other significant changes occur at that date. 
In fact, the 1999 SLA included several changes affecting access to alcohol in 
addition to the MLDA change. Thus, it is entirely plausible that different effects 
could be produced by the two different RDDs, because they are evaluating two 
different exposures and two different natural experiments. 
That stated, it is also worth considering the evidence from controlled before-
and-after studies of the effect on MVA of lowering the MLDA from 20 to 18 in 
New Zealand. These studies found statistically significant increases in MVA in the 
under-20 age group following the law change (Huckle and Parker, 2014, Kypri et 
al., 2017, Kypri et al., 2006). Perhaps it is the date-based RD rather than the 
age-based design that produces misleading evidence on the effects of the 
legislative change. How estimates of effect may vary according to the study 
design of natural experiments with date- or time-based cutoffs would appear to 
warrant further investigation. 
4.6.2 Implications for alcohol policy 
The evidence from RD studies on mortality and alcohol-related hospital 
admissions supports the place of MLDA in alcohol policy as a public health 
intervention that reduces a range of alcohol-related harms and societal costs. 
The findings support the WHO Global Strategy recommendation to establish a 
minimum age for purchase and consumption as an effective policy option for 
reducing availability of alcohol (World Health Organization, 2010). The 
inconsistent evidence on MVA may be interpreted to mean that other policy 
options should be explored if reduction of MVA is the policy objective. The 
protective effect of MLDA appears to be larger, and the supporting evidence 
stronger, for men compared to women. Policymakers should note gender 
differences in the evidence base for reduction of alcohol-related harms and 
ensure that related policy frameworks and strategies include a mixture of 
interventions that will, in toto, be effective for both groups so as not to 
inadvertently increase gender inequality.  
Despite, or perhaps because of, the apparent lack of interest in MLDA as an 
alcohol policy option in the UK, policymakers in this country should seriously 
consider the potential reductions in alcohol-related harms and related societal 
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costs that could be achieved by setting, and enforcing, an appropriate legal 
drinking age. It seems shocking to have to say, given the evidence of binge 
drinking, alcohol-related hospital admissions, and related violent offending 
among UK adolescents (Healey et al., 2014), that the age of five should no 
longer be considered an appropriate MLDA in this country (Gerard, 2007). 
4.6.3 Implications for research 
This section discusses the implications of the findings for future research in 
relation to three topics. First, areas for development of systematic review 
methods are considered. Second, implications for the design and reporting of RD 
studies are discussed. Finally, some possibilities for further research into MLDA 
are described, including extension of the present review and further potential 
applications of RD to evaluate MLDA in different settings. 
4.6.3.1 Methods for systematic review of natural ex periments 
This review demonstrates the potential for RD studies to be incorporated into 
evidence syntheses and to inform public health policy. Systematic review 
methods require some adaptation to achieve this end. The PICO (Population, 
Intervention, Comparison, Outcome) model may be a loose fit for natural 
experiments; studies of MLDA legislation actually represented two different 
natural experiments, effects of ageing past the threshold (removal of age-based 
restriction) and effects of changing the legislation. Critical appraisal tools and 
synthesis methods may require adaptation to fit the different study design and 
different conventions of reporting in disciplines other than health. There is a 
need to develop methods for synthesising effect estimates from multiple models; 
the effect direction plot is helpful, but requires further testing and application. 
Poor statistical reporting means that meta-analysis of such studies is likely to 
require author contact, which takes up time and resources. Reviews of natural 
experiments also would likely benefit from synthesising information about the 
context and implementation of the intervention, not just the results. This would 
also require additional time and resources, as well as considerations at the 
protocol and data extraction stages. 
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The reporting of data in these studies represented a significant challenge for the 
review. No studies clearly reported the number of events and observations 
(numerators and denominators) involved in each analysis. Most of the studies 
presented multiple model specifications, sensitivity analyses, and estimates of 
effect, with no clear rationale for choosing among them. All but one study 
lacked a primary outcome. Confidence intervals were generally absent. One 
study (Lindo et al. 2014) presented all of its RD estimates as a series of visual 
plots without any tabular presentation of data. Essential data sometimes 
appeared in footnotes or online appendices. These challenges were exacerbated 
by different conventions in reporting in economics compared to health research; 
however, these challenges were encountered consistently in the included 
studies, regardless of whether they were published in economics, health 
economics, or health research journals.  
Given the data issues, the potential for meta-analysis was severely limited. The 
effect direction plot represented a useful method of visualising the results. In 
this review, construction of the effect direction plot was rendered more difficult 
by non-reporting of included numbers in each study. I solved this problem by 
creating categories that reflected the relative size of the included studies, 
which were based on large surveys, larger administrative datasets, and very 
large datasets such as census data. However, I had not anticipated this during 
initial data extraction, which meant that it was necessary to revisit all the 
studies in order to ‘code’ them for the effect direction plot.  
The effect direction plot was designed to produce a synthesis that combined 
multiple related outcome measures into a single domain, which simplified 
reporting and aided interpretation. It solved a problem of interpreting study 
findings when results may vary across multiple related outcomes. This situation 
applied to many MLDA studies, which used multiple measures of mortality, 
hospital admissions, or MVA. However, an even bigger challenge was interpreting 
the results across multiple model specifications, so I decided to extend the 
principle to the synthesis of findings across outcomes and specifications. This, 
too, necessitated extracting additional data and sometimes needing 2X2 tables 
to apply the decision rules about direction and statistical significance in order to 
code the outcome for the plot. This process would become easier with greater 
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familiarity, and easier still if anticipated earlier in the review and incorporated 
into the data extraction and synthesis plan. Overall, the effect direction plot is a 
good tool for summarising and visualising the results of natural experimental 
studies that involve multiple models and multiple outcomes. 
4.6.3.2 Design and reporting of natural experiments  using RD 
The critical appraisal and data extraction performed in this review point to 
several areas for improvement in the conduct and reporting of RD studies. Many 
studies lacked basic details such as numbers included in analyses, information 
about attrition, and uncertainty of effect estimates. No studies were protocol-
driven, only one specified a primary outcome, and model selection methods 
were often unclear. A standard for reporting could help to improve RD studies, 
as CONSORT did for RCTs, which would have the additional benefit of making 
systematic reviews of such studies both easier to perform and more informative. 
Contextual information about the natural experiment under investigation is 
necessary in order to understand the hypothesis being tested and to assess the 
validity of the RD design. Most of the MLDA studies provided little narrative 
justification for the validity of the RD design and little or no statistical 
investigation of related assumptions, perhaps because the legislation seemed 
relatively straightforward and the assumption that age cannot be manipulated 
seemed reasonable, or perhaps too obvious to mention. However, contextual 
information is important for understanding differences between studies and 
explaining inconsistent results. Moreover, study quality is improved and the 
strength of the overall evidence base may be increased if design assumptions, 
such as smoothness of the forcing variable, are investigated. Improving the 
standard of design and reporting is important if natural experimental studies are 
to fulfil their potential to contribute to the public health evidence base. 
4.6.3.3 Further MLDA research 
The present review could usefully be expanded in at least three ways. First, 
alcohol consumption could be included as an outcome and a meta-analysis might 
be possible. Second, it would be informative to investigate the context of MLDA 
in these studies, obtaining information from the study reports and from 
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additional sources in order to better understand the natural experiments. 
Conclusions could then be drawn about reasons for differences between settings 
and what information would be useful to include in reports of natural 
experiments. Third, in order to better understand the place of RD in a larger 
body of evidence and to understand the sensitivity of results to study design, it 
would be useful to conduct a larger review of MLDA including study designs such 
as controlled before and after, difference-in-differences, and interrupted time 
series as well as RD. A review of MLDA evidence of such scope has not been 
reported since 2002. In addition to providing an updated synthesis, such a review 
would afford an opportunity to investigate and better understand whether and 
how different natural experimental designs differ in their estimates of effect. 
This review has demonstrated the potential for Carpenter and Dobkin’s original 
RD design to be replicated in different settings and to investigate various 
outcomes. With only 17 studies identified in four countries, there is potential to 
repeat the design in other countries that have an MLDA with appropriate 
enforcement and which is not confounded by other changes at the same age 
threshold, i.e., the cut-off has meaning and plausibly creates a discrete change 
in access to alcohol. One European candidate country for evaluation would be 
Iceland, with its MLDA of 20, strict drink-driving laws, and low perceived 
availability of alcohol to underage drinkers (The European School Survey Project 
on Alcohol and Other Drugs, 2015).  
Further applications in new settings could also investigate extensions of the RD 
design. One possibility would be to investigate whether this design could 
evaluate policies like those in the UK and Germany, where different access to 
alcohol (types of alcohol and settings of purchase/consumption) becomes 
available at several different age thresholds, for example using the multiple cut-
off RD design (Cattaneo et al., 2016). It would also be possible to use 
geographical boundaries as cut-offs to investigate the comparative effectiveness 
of different MLDAs where these vary between neighbouring countries. For 
example, Paraguay has an MLDA of 20 whereas all of its neighbours have an 
MLDA of 18.  
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4.6.3.4 Strengths and limitations   
The outcomes selected for detailed data extraction (mortality, hospital 
admissions, and MVA) have undoubted policy relevance and are among the most 
costly of alcohol-related harms affecting young adults. Restricting the 
systematic review to health outcomes meant that other policy-relevant 
outcomes with high social costs, such as crime, have not been included. RD 
studies on this topic (published after the search cut-off date) exist (Callaghan et 
al., 2016a, Callaghan et al., 2016b, Carpenter and Dobkin, 2015a) and it can be 
argued that crime, particularly violent crime, is an outcome of interest to public 
health. 
Alcohol consumption was an outcome measured by most of the seventeen 
studies. I did not include this outcome in data extraction or synthesis for two 
reasons. First, an increase in consumption of any desirable and plentiful 
commodity following a price decrease (removal of age restriction) can hardly 
come as a surprise (although a lack of discontinuity would be informative 
regarding compliance with and enforcement of MLDA laws). Second, in terms of 
causality I considered alcohol consumption an intermediary outcome whose 
sequelae, such as hospitalisation and mortality, were of greater policy 
relevance. For this reason I focused on outcomes that were further downstream. 
The design and conduct of this systematic review has several strengths. With 
reference to AMSTAR-2 criteria for the quality of systematic reviews (Shea et al., 
2017), the review has been well conducted as it was based on a pre-published 
protocol with explicit inclusion criteria and had a robust and reproducible 
literature search. Characteristics of included studies were described in detail, 
duplicate study selection was performed on a sample of studies, risk of bias was 
assessed independently by two reviewers, and implications of risk of bias were 
considered and discussed.  
The AMSTAR-2 criteria also point to several limitations of the review. Duplicate 
extraction of data was not performed owing to resource limitations. This may be 
of particular concern given the complexity of these studies and their reporting. 
However, the data extraction in this review was exploratory, being a novel 
application of systematic review methods to this study type. As such, duplicate 
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extraction may have added another layer of difficulty and complexity, of 
unknown utility, to this activity, which furthermore might have hindered the 
production of any synthesis. Further extension, development, and validation of 
the methods tested here, from one reviewer to a review team and from one 
natural experiment design to others, could be pursued in future research. 
The investigation of heterogeneity in this review was limited, partly by the non-
quantitative nature of the synthesis, but also by the focus of the review on 
methods rather than study contexts. Some attention has been paid to 
heterogeneity created by study setting and by type of forcing variable, but 
further consideration could be given to other factors that might have influenced 
the varying findings. The statistical reporting of outcomes in these studies would 
not lend itself to meta-regression, however. What would be most useful would 
be a consideration of the details of the natural experiment itself: the contexts 
and mechanisms of MLDA. Extraction of such information from the studies, and 
collation of supporting information from external sources, was beyond the scope 
of this review. 
An AMSTAR-2 appraisal would also point out that the review failed to consider 
the funding sources of these studies and to investigate publication bias. Study 
funding is potentially important as it would be in the interest of the alcohol 
industry to fund research that supported lowering the MLDA or that reported low 
risks of alcohol-related harms. Current methods of assessing publication bias 
would need to be adapted as they rely on consistent reporting of effect sizes 
across studies, which cannot at present be observed in the RD literature. 
However, in the present sample of studies both positive and negative as well as 
conflicting findings were identified within and across studies, grey literature was 
searched, and numerous unpublished studies were identified, all of which 
suggest that this review is at low of risk of bias in these domains. 
A final limitation relates to the currency of the review. The last date searched 
was March 2015 and at least two new RD studies of MLDA and health outcomes 
have been published since then.(Callaghan et al., 2016c, Koppa, 2018) Callaghan 
et al. extend their study on Quebec (2014b) to six other provinces and the 
Northwest Territories of Canada, reporting effects above the MLDA on alcohol-
related motor vehicle collisions and night-time motor vehicles collisions. Each 
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outcome is reported (where data are available) for males, females, and total 
population separately by province/territory, resulting in a mixture of positive 
and negative effects of varying statistical significance. Koppa (2018) examines 
data from California to investigate whether there is an increase in cases of 
gonorrhoea at the MLDA threshold and finds no evidence of an increase. Both of 
these studies would be useful to add to the effect direction plot, particularly 
given the small number of studies investigating MVAs and psychosocial outcomes 
(including sexual behaviours), but would not change the conclusions of the 
review or the implications for policy. 
4.6.4 Contribution of this systematic review 
This chapter presents the first systematic review of an intervention or policy 
effectiveness question restricted to RD studies; the first application of the effect 
direction plot to RD; and the first systematic synthesis of RD evidence on MLDA 
legislation. As such it represents a proof of concept for several points relevant to 
encouraging the creation and uptake of evidence from natural experiments, 
showing that it is possible to replicate a natural experiment design in different 
contexts with different data, synthesise such evidence, and thereby reduce the 
uncertainty associated with the findings of single studies. Furthermore, it 
demonstrates that policy-relevant conclusions can be drawn even though 
randomised trials are lacking, the reporting of RD studies poses challenges, and 
synthesis is complex. 
The key contributions of this chapter are methodological, specifically knowledge 
about the application of RD designs and the incorporation of these studies in 
systematic reviews. Although Angrist and Pischke (2015) claimed that Carpenter 
and Dobkin’s original MLDA study design was “made in RD heaven”, this review 
has demonstrated some limitations in the MLDA studies when compared to 
standards for RD. Close examination of these studies also shows that careful 
consideration of the setup of the natural experiment and the implementation 
context of the legislation are necessary to determine exactly what hypothesis is 
being tested; studies that appear to have essentially the same RD design may in 
fact be answering quite different research questions. Data extraction for this 
systematic review further demonstrated that an apparently straightforward and 
intuitive design in fact poses considerable challenges for systematic review, 
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which could constitute a barrier for uptake of this evidence and for further 
implementation of the RD design. However, ultimately these challenges could be 
overcome with only minor adaptations of existing synthesis methods. This 
chapter, then, serves as a positive example of the potential for natural 
experiments generally and RD designs in particular to be incorporated into 
systematic reviews and to usefully inform the public health evidence base. 
Although this systematic review was designed to contribute to methodological 
knowledge, the relevance to alcohol policy adds some further value to this work. 
As randomised trials of age-restricted access to alcohol or other unhealthy 
commodities are not likely to be feasible or acceptable to legislators, regression 
discontinuity designs are likely to represent the best available evidence on the 
effects of such legislative interventions. Despite the challenges posed by the 
evidence, it was possible, through narrative synthesis, to make clear statements 
on the evidence of effectiveness and the areas of uncertainty. This review 
supports conclusions about the effects of MLDA legislation on important and 
policy-relevant outcomes (mortality, MVA, alcohol-related hospital admissions, 
and drug use) which could be used to inform public health decision making and 
policy intended to prevent alcohol-related harms in young people. In particular, 
it shows that existing MLDA laws probably have an overall protective health 
effect on young people who are prevented legal access to alcohol, but that the 
marked reduction in MVA shown in earlier observational studies of MLDA is no 
longer evident. Three possible explanations present themselves. The effect of 
MLDA on MVA may have been confounded in the earlier observational studies, it 
may have been caused by intervention components or implementation factors 
other than the age-based purchase restriction, or it may have been an effect 
subject to fade-out over time. 
4.7 Chapter summary 
This chapter has reported a systematic review of 17 RD studies of minimum legal 
drinking age (MLDA) legislation in four countries. The review provides updated 
evidence of the effects of MLDA on policy-relevant outcomes including mortality, 
hospital admissions, and motor vehicle accidents. It is innovative in applying a 
visual synthesis method, the effect direction plot, to RD studies. Poor reporting 
in these studies was evidenced through the results of critical appraisal and 
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through difficulties and gaps in data extraction. In response to Angrist and 
Pischke’s view that MLDA is a natural experiment “made in RD heaven”, this 
review suggests that although there is good reason to hope, heaven on earth has 
yet to be attained. 
The next chapter completes the reporting of the systematic review of RD studies 
in health that began in chapter 3 and continued in chapter 4. Chapter 5 
describes how an approach to quality assessment of RD studies was developed 
for this thesis. Both the adaptation of the effect direction plot (reported in 
chapter 4) and the development of a critical appraisal checklist for RD (reported 
in chapter 5) constitute contributions made by this thesis to systematic review 
methodology. 
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5 Critical appraisal of regression discontinuity 
studies 
5.1 Chapter overview 
Critical appraisal is an essential component of systematic review. In the absence 
of tools to support the appraisal of natural experimental studies, the 
development of critical appraisal methods is necessary if systematic reviews are 
to make greater use of evidence using these designs and the value of natural 
experiments as evidence is to be appreciated. This chapter reports research 
undertaken to identify, test, and develop methods for the critical appraisal of 
regression discontinuity (RD) studies. A literature search identified one design-
specific quality assessment tool, the What Works Clearinghouse Standards for 
RD. As this tool was developed to assess evidence for educational interventions 
prior to their implementation in schools, I tested its face validity and 
applicability on a sample of 17 RD studies in health incorporating assessments 
conducted by a second independent reviewer. Based on these results, I modified 
the standards to produce a 10-item checklist, RD-10. I then tested the usability 
and applicability of RD-10 on a sample of 13 RD studies. This assessment 
incorporated assessments conducted by three independent reviewers. Finally the 
checklist was applied in the systematic review of 181 RD studies reported in 
chapter 3. On the basis of these experiences, I suggest further refinements of 
the tool.  
5.2 Aims  
This chapter aims to: 
1. test a published quality assessment tool for RD, the US Department of 
Education What Works Clearinghouse Standards for RD (WWC), using a 
sample of studies that evaluate a public health intervention (minimum 
legal drinking age legislation) 
2. develop a critical appraisal checklist for RD that is applicable to health 
research and useable in systematic reviews 
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3. test the checklist on a further sample of studies before applying the 
checklist in a comprehensive review of RD studies in health. 
5.3 Background 
5.3.1 Introduction 
Systematic review is an important method within the evidence-based paradigm 
because it can produce a trustworthy and comprehensive representation of 
available evidence, which then can be accessed in a single publication. By 
increasing the accessibility of the evidence and presenting conclusions based on 
its totality, systematic reviews can act as a facilitator of evidence-based 
decision-making (Petticrew and Roberts, 2006, pp. 11-12). However, given that 
reviews synthesise information from multiple individual studies, with inevitable 
loss of detail from the individual study reports, there is the potential for 
information from studies that have been poorly designed and conducted and/or 
studies at high risk of bias to be reproduced uncritically. A review could then 
unintentionally increase the dissemination of biased results and even lend 
credence to them, which could ultimately result in decisions being made based 
on flawed or erroneous conclusions, with potentially harmful effects.  
In order to avoid such unintended consequences, textbooks, handbooks, the 
PRISMA standard, and the AMSTAR-2 checklist for systematic reviews all agree on 
the need for reviews to critically appraise included studies, report the appraisal 
findings in the results, and take risk of bias (RoB) into consideration in drawing 
conclusions (Egger, Smith, and Altman, 2001; Higgins and Green, 2011; Petticrew 
and Roberts, 2006; Shea et al., 2017). However, there is a lack of critical 
appraisal tools specific to natural experimental designs. 
This section will provide the necessary context for the work I conducted to test 
and develop methods of critical appraisal of RD studies. The section covers the 
principles of critical appraisal including definitions of study quality; principles 
for evaluation and selection of tools; the availability of existing critical appraisal 
tools; and the rationale for testing and developing a new tool. 
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5.3.2 Principles of critical appraisal 
The Dictionary of Epidemiology defines critical appraisal as “Application of rules 
of evidence to a study to assess the validity of the data, completeness of 
reporting, methods and procedures, significance of results, conclusions, 
compliance with ethical standards, etc.” (Porta, 2014), a potentially broad field 
of enquiry. The object of critical appraisal is sometimes more simply described 
as ‘study quality’, but in defining this term it quickly becomes apparent why 
critical appraisal is subjective. Deeks et al. (2003) in their review of critical 
appraisal tools for NRS note that study quality is “a rather subjective concept, 
open to different interpretations depending on the reader” (p. 23) and cite the 
definition used by Moher et al. (1995) in their review of RCT appraisal tools: 
“the confidence that the trial design, conduct and analysis has minimised or 
avoided biases in its treatment comparisons”. The Cochrane Handbook notes 
that assessment of study quality “suggests an investigation of the extent to 
which study authors conducted their research to the highest possible standards” 
(section 8.2.2) and sets out its reasons for focusing instead on internal validity 
and assessment of risk of bias within critical appraisal, not least of which is that 
a study conducted to the highest possible standards might still be at a very high 
risk of bias. Bias has the advantage of a less contentious definition than quality: 
“a systematic error, or deviation from the truth, in results or inferences” 
(section 8.2.1); yet the concepts of both ‘truth’ and ‘risk’ return us to an 
epistemological situation in which subjective opinion is highly operative. 
Critical appraisal tools can help to reduce the influence of subjective opinion, 
assist the reviewer in investigating the many different aspects of a study in 
which risk of bias may operate, structure discussions between reviewers, and 
organise information about risk of bias for presentation in the findings of the 
review. The tools may be presented as scales, checklists, or domain-based 
evaluations (Higgins and Green, 2011). Scales assign points according to the 
presence or absence of study characteristics, resulting in a total score for 
quality. This approach is specifically discouraged in the Cochrane Handbook. 
Checklists aid in the identification and recording of relevant information. 
Domain-based risk of bias evaluation with ‘signalling questions’ is the approach 
taken by the Cochrane Risk of Bias tool for RCTs and the ROBINS-I tool for NRS. 
Deeks et al. (2003) note that the content of appraisal tools can be identified 
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through two approaches, ‘threats to validity’ as identified by Cook and Campbell 
in their work on quasi-experimental designs (Shadish, Cook and Campbell, 2002) 
or ‘methods-description’ in which the characteristics of the reported method are 
recorded.  
The publication of the Cochrane RoB tool for RCTs laid out seven principles for 
assessing risk of bias which have been influential in shaping subsequent 
methodological research practice. Higgins et al. (2011) advised against quality 
scales in favour of a focus on internal validity, which should be assessed on the 
basis of the trial results and not quality of reporting or other aspects of trial 
conduct such as ethical approval or statistical power. They accepted that critical 
appraisal requires judgment while at the same time arguing that it should be 
based on the assessment of domains chosen for a combination of theoretical and 
empirical reasons. They asserted that judgments of high or low risk of bias need 
to be specific to the data and outcomes as represented in the review, which may 
differ from the risk of bias in the overall report of each individual study.  
5.3.3 Evaluation and selection of critical appraisa l tools 
Somewhat surprisingly given the importance of critical appraisal within 
systematic review, there is no quality standard for critical appraisal tools. 
Perhaps the most relevant information comes from Viswanathan et al. (2017), 
who convened a working group to update AHRQ methodological guidance and 
produced 18 recommendations covering the planning and conduct of risk of bias 
assessment in systematic reviews. Given the plethora of tools available and 
noting the lack of any suitable universal tool, Viswanathan et al. provided 
principles for selection, arguing that reviewers should choose tools that: 
• were specifically developed for use in systematic reviews 
• are specific to each study design being assessed 
• address domains of bias through specific items 
• are at least based on theory, and preferably on empirical evidence of 
bias, or “have reasonable face validity” 
• avoid numeric scores. 
 
Further relevant considerations can be extracted from the criticisms Deeks et al. 
noted that are commonly made of critical appraisal tools: failure to provide a 
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rationale for appraisal criteria, inclusion of criteria of uncertain relevance to 
study quality, and neglect of the methods of scale development (p. 36). These 
methods should follow four steps: “preliminary conceptual decisions; item 
generation and assessment of face validity; field trials to assess frequency of 
endorsement, consistency and construct validity; and generation of a refined 
instrument” (Deeks et al., 2003, p. 36). 
5.3.4 Availability of critical appraisal tools 
The development of systematic review methods over time has seen a 
proliferation of critical appraisal tools. Systematic reviews of critical appraisal 
tools have identified 34 different tools for the appraisal of RCTs (Moher et al., 
1995), 40 for clinical practice guidelines (Siering et al, 2013), and 194 for non-
randomised studies (Deeks et al., 2003). The tools vary in content and 
complexity; the number of items in the tools identified by Moher et al. ranged 
from 3 to 57, for example, while in Deeks et al. the number of items was 
between 3 and 103 (2003, Appendix 3).  
Critical appraisal of non-randomised studies remains an active area of 
methodological development. The Cochrane Risk of Bias Methods Group and 
Statistical Methods Group have recently produced the ROBINS-I (“Risk Of Bias In 
Non-randomised Studies – of Interventions”) tool (Sterne et al., 2016), 
incorporating the domain-based approach familiar to users of the RoB tool for 
RCTs while also providing specific evaluation criteria (or “signalling questions”) 
for cohort and case-control study designs. The tool has three sections: one for 
review protocol considerations such as the PICO of interest, one which asks the 
user to specify a “target trial” or hypothetical RCT that would answer the review 
question, and one that focuses on risk of bias of NRS. The seven RoB domains 
investigated are confounding, selection of participants into the study, 
classification of interventions, deviation from intended interventions, missing 
data, outcome measurement, and selective outcome reporting. ROBINS-I was 
developed through informal expert consensus and repeated rounds of revision. 
User feedback was obtained through telephone interviews and training 
workshops (number of participants not reported). The first training workshop 
involved application of the tool to six NRS.  
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Thomson et al. (2018) tested the applicability of ROBINS-I for the assessment of 
risk of bias in public health natural experiments. Although the tool was helpful 
in articulating risk of bias, many elements of the tool were difficult to apply to 
natural experimental studies, the tool required a high level of epidemiological 
expertise to interpret, the accompanying guidance did not address issues that 
arose relating to applicability to natural experiments, and agreement among 
reviewers was poor. While these experiences demonstrated that reporting 
quality of natural experiments needs to improve, the authors also concluded 
that revisions to ROBINS-I would be helpful to address the level of difficulty for 
users and problems with applicability to natural experiments in public health. 
5.3.5 Rationale for testing and developing a tool f or RD 
As described in chapter 2, the study designs and methods for analysing natural 
experiments have largely been developed in disciplines other than health. As 
natural experimental methods remain less familiar to health researchers than 
randomised studies or the designs commonly used in epidemiology, critical 
appraisal tools for natural experiments are lacking in the evidence-based toolkit 
and no comprehensive effort has yet been reported to identify domains or 
criteria for risk of bias across natural experimental designs. Within the Cochrane 
Collaboration, work is underway to expand the ROBINS-I approach to encompass 
regression discontinuity designs and interrupted time series (personal 
communication). Until these tools are published and performance-tested, health 
researchers conducting systematic reviews that include natural experiments 
have the options of applying generic non-randomised study assessment tools, 
borrowing design-specific tools from other disciplines, adapting tools, or 
developing new tools. Indeed, even as the ROBINS-I approach expands, there 
may be an ongoing unmet need for tools that are more straightforward to use 
and that do not require a high level of specialist knowledge to apply, 
particularly given the added technical difficulties of appraisal of NRS and the 
increased level of subjective judgment required (Thomson et al., 2018; 
Waddington et al., 2017). 
In keeping with the principles of evaluation and selection of tools described in 
section 5.3.3, I sought a design-specific critical appraisal tool with detailed 
criteria for investigating the internal validity of RD designs. This tool needed to 
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be applicable to RD studies in public health, which may be retrospective and 
based on population-level data, and suitable for use in a systematic review. 
5.4 Methods 
This section describes the methods used to develop and implement a design-
specific approach to the critical appraisal of RD. The development involved four 
steps:  
1. A literature search was undertaken to identify any existing appraisal tools. 
2. A tool identified by the search, the What Works Clearinghouse Standards for 
RD (WWC), was tested on a sample of 17 papers (the MLDA studies reviewed in 
chapter 4). 
3. A ten-item checklist was adapted from WWC and tested on a purposive sample 
of 13 papers.  
4. The ten-item checklist was applied to all studies identified in the systematic 
review of RD in health (reported in chapter 3). Each of these steps is described 
in the sections below. 
5.4.1 Literature search for existing tools 
The systematic review of RD studies of health outcomes involved a 
comprehensive literature search using the terms “regression discontinuity” and 
“regression-discontinuity” as keywords or free text terms. This search (reported 
in section 3.3.2) was broad enough to capture any quality standards or appraisal 
tools available from the resources covered. I supplemented the electronic 
searches by hand-searching textbooks, methodological papers, and the websites 
of systematic review and guideline development organisations for potential 
quality assessment tools. Box 5.1 lists the resources that were hand-searched. 
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Box 5.1 Handsearching for RD critical appraisal tools 
 
Textbooks and Handbooks: 
Cochrane Handbook 
Dunning, Natural Experiments in the Social Sciences 
Shadish, Cook, and Campbell, Experimental and Quasi-Experimental Studies 
Petticrew and Roberts, Systematic Reviews in the Social Sciences 
Angrist and Pischke, Mostly Harmless Econometrics 
 
Methodological Papers: 
Deeks et al. 2003 
Imbens and Lemieux 2007 






Critical Appraisal Skills Programme (CASP) 
AHRQ Effective Health Care Program 
Cochrane Effective Practice and Organisation of Care (EPOC) 
 
 
The only tool identified in the search was WWC (Schochet et al., 2010). This 
finding was confirmed by a recent review of appraisal tools for quasi-
experimental designs; of the 14 tools identified in that review, only WWC 
addressed both study design and methods of analysis in RD (Waddington et al., 
2017). That review concluded that current appraisal tools are inadequate for 
consistent and “appropriate” evaluation of quasi-experimental designs (p. 50). 
5.4.2 Pilot of WWC Standards 
As critical appraisal should be conducted by two reviewers, I worked with a 
second reviewer to pilot the only published RD-specific appraisal tool (WWC) on 
a sample of RD studies. Both reviewers had more than ten years of experience in 
conducting systematic reviews involving non-randomised studies. The purpose of 
the pilot was (1) to determine whether the selected (health-related, non-
educational) studies reported the information necessary to make a judgment 
against the criteria, (2) to decide whether the criteria had face validity or 
apparent usefulness in investigating the quality of health studies, (3) to assess 
the feasibility of using the tool in terms of time requirements and difficulty of 
application, and (4) to determine informally whether interrater agreement was 
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satisfactory or whether extensive disagreement might indicate additional 
problems with feasibility and face validity. 
The sample of RD studies assessed in the pilot consisted of 17 studies of 
minimum legal drinking age (MLDA) legislation. This sample was selected 
because it was the largest number of studies that evaluated the same natural 
experiment. The RD review protocol specified that more detailed analysis of 
subsets of studies would be conducted if multiple studies were identified that 
evaluated the same intervention or that investigated sufficiently similar policy 
questions. The rationale for the sample selection involved two additional 
considerations. First, it would be easier for a reviewer unfamiliar with RD to 
appraise multiple studies of the same intervention as each study was likely to 
have a numerous elements of design and reporting in common. Second, as 
systematic reviews commonly evaluate the evidence on a single intervention (or 
group of similar interventions), this sample was more likely to reflect a real-life 
implementation of a review tool as compared to a random sample of studies on 
diverse topics.  
The steps of the pilot were as follows. Both reviewers ensured familiarity with 
RD methodology by reading two methodological review articles (Lee and 
Lemieux, 2010; O’Keeffe et al., 2014) and the WWC standards document. We 
held an initial meeting to read through the standards together and clarify our 
understanding of the criteria, instructions for implementation, and the test 
methodology. We then independently appraised one study (Carpenter and Dobkin 
2011) and met to compare our answers. The purpose of this initial appraisal was 
to clarify any further issues of understanding or interpretation of the tool and to 
ensure a consistent approach to its application. We then independently 
appraised the remaining 16 MLDA and met a final time to compare our 
assessments and discuss our experiences of using the standards. I recorded our 
individual assessments, reasons for any initial disagreements, and our consensus 
on final assessments. 
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5.4.3 Adaptation of WWC Standards and Development o f RD-10 
Checklist 
Based on the findings of the pilot, I decided to adapt the WWC standards into a 
checklist. The rationale for doing so involved the following considerations: 
usability; consistency with the design approach of other critical appraisal tools in 
common use in public health systematic reviews; potential ability to 
differentiate between higher and lower quality RD studies; and potential ability 
to identify specific elements of high, low, or uncertain quality in RD studies.  
I worked with two additional reviewers to test the usability of the checklist and 
to investigate how subjective the interpretation of criteria and of study quality 
might be. Both reviewers were highly experienced in the systematic review of 
non-randomised studies; in addition, one reviewer had expertise in natural 
experiments and prior knowledge of RD designs. 
As the intention was to use the adapted checklist to assess the quality of RD 
studies across a wide range of topics in public health, a purposive sample of 13 
RD studies was selected in order to include examples of different types of 
forcing variables (age, date, clinical measurements, and social measures), 
different interventions or exposures, and different academic disciplines 
(economics, education, and health). Following an initial meeting to review and 
discuss the criteria, the reviewers independently appraised the papers, recorded 
their assessments, and made notes of any queries or problems. When the 
appraisals were completed, we met to discuss and compare the results. 
Measurement of interrater agreement using kappa statistics was considered and 
rejected for two reasons. First, the checklist was at too early a stage of 
development; usability and face validity were felt to be sufficient considerations 
at this stage. Second, almost all of the interrater disagreements stemmed from 
difficulty in finding the relevant evidence in the paper (particularly lengthy 
economics papers, whose reporting structure is unfamiliar in public health), 
meaning that kappa would reflect similarities in ability to find information in the 
papers rather than similarities in interpreting checklist criteria or similarities in 
‘correctly’ answering questions. 
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5.5 Results 
5.5.1 Tools and quality criteria 
The literature search did not identify any critical appraisal tools designed for the 
assessment of RD studies in health. However, the search did identify one 
published critical appraisal tool designed to assess RD studies in education.  
The What Works Clearinghouse (WWC) standards were, at the time of this 
review, the only published critical appraisal tool for RD. The standards were 
developed for use in systematic reviews of educational interventions and is 
published by the US Department of Education. The complete standard involves 
the application of three criteria to determine whether the study qualifies as a 
regression discontinuity design followed by ten further criteria to determine 
whether the study meets four standards. The user then determines whether the 
resulting combinations of standards mean that the overall WWC standard of 
evidence for the effects of educational interventions has been met, met with 
reservations, or not met.  
WWC has several strengths. It was developed by a panel that included 
recognised experts in regression discontinuity designs from the fields of 
education, economics, and statistics. It is supported by a comprehensive 
document that explains how to use the standards, elaborates upon the criteria, 
and explains why they are important. Most of the criteria are specific to features 
of the RD design. However, WWC also has some limitations. The standards as 
published in 2010 were produced as a pilot and there is no evidence of user 
testing or validation. WWC is designed to evaluate studies of educational 
interventions with pre- and post-test data for individual participants and thus its 
applicability to public health and health economic studies, which may use 
administrative and population-level data and may be cross-sectional or 
retrospective, is unknown. Given the comparative strengths of the tool and the 
unknown applicability to public health, I decided to make WWC the subject of 
the pilot. 
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5.5.2 Pilot of WWC Standards 
After the reviewers independently completed the initial appraisal of one MLDA 
study (Carpenter and Dobkin, 2011), issues with more than half (7/13) of the 
WWC standards criteria required discussion prior to appraising the full sample of 
papers. These seven criteria included one of the three eligibility questions plus 
criteria from all four standards. Table 5.1 describes the criteria, issues 
encountered, and decisions made to address the issues. 
Table 5.1. Issues identified in the pilot of the Wh at Works Clearinghouse 
Standards for RD for appraisal of studies evaluatin g the health effects of 
minimum legal drinking age (MLDA) legislation  
Criterion  Issue  Decision  
Third qualifying question: 
Cutoff value must not be 
used to assign participants to 
other interventions 
The criterion is of critical 
importance because studies 
are disqualified if not met. 
The study did not address 
this criterion. The reviewers 
were not aware of other 
interventions that use age 21 
as a cut-off, but also had 
limited knowledge of 
American age restrictions or 
how these might vary 
between states. 
Consider the criterion to be 
met in the absence of any 
knowledge or reported 
information to the contrary. 
 
Furthermore, appraise all 
studies in the sample using 
all criteria, even if qualifying 
criteria or standards are not 
met, in keeping with the 
purpose of the review to 
describe study quality rather 
than to identify a reliable 
evidence base for an 
intervention. 
Standard 1, Criterion A: “an 
adequate description of the 
scoring and treatment 
assignment process…[which] 
must show that manipulation 
was unlikely because scorers 
had little opportunity or little 
incentive to change ‘true’ 
scores” 
The criterion contains seven 
different information 
components. The study did 
not address manipulation of 
the forcing variable, probably 
because it used US vital 
statistics from 1975-1993.  
Assume manipulation of age 
is unlikely and allow the 
criterion to be met even if 
manipulation of the forcing 
variable is not addressed. 
Standard 1, Criterion B: 
Statistical tests or graphical 
analysis should establish 
smoothness of the forcing 
variable around the cutoff 
There seemed to be no 
logical reason for the authors 
to do this as there would be 
no opportunity for data 
subjects or administrators to 
manipulate birthdates or age. 
Modify the standards to allow 
‘not applicable’ as a 
response. Agreement that 
the criterion was not met (in 
the absence of evidence), 
but that it was neither 
reasonable nor useful to 
expect authors to do this for 
application of the RD design 
in this situation. 
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Criterion Issue Decision 
Standard 2: attrition must be 
reported to the same 
standard as an RCT 
The study provided no 
information about attrition. 
The study was retrospective 
and reported estimated 
mortality rates based on 
death certificates from 1975-
1993. Studies that fail to 
meet this standard also fail 
the overall WWC standard of 
evidence. 
Modify the standards to allow 
‘not applicable’ as a 
response. 
Standard 3, Criterion A: 
“Baseline (or pre-baseline) 
equivalence on key 
covariates (as identified in 
the review protocol) should 
be demonstrated at the 
cutoff” 
The study design and data 
sources did not allow for 
investigation of covariates, 
and the review protocol did 
not specify any as it was not 
a review of effectiveness. 
Modify the standards to allow 
‘not applicable’ as a 
response. 
Standard 4, Criterion D: 
empirical support must be 
provided in the case of any 
constraints on the values of 
the forcing variable 
The standards document 
does not say how to judge 
this criterion if there are no 
such constraints, yet the 
standard is not met if the 
criterion is not satisfied. 
Modify the standards to allow 
‘not applicable’ as a 
response. 
Standard 4, Criterion E: 
specifies reporting of impacts 
across multiple sites 
The standards document 
does not say how to judge 
this criterion if it is not a 
multi-centre study, yet the 
standard cannot be met if the 
criterion is not satisfied. 
Modify the standards to allow 
‘not applicable’ as a 
response. 
 
Having agreed these modifications to the standards, the two reviewers 
independently appraised the remaining 16 MLDA studies. Agreement before 
discussion was very high, with only seven instances of disagreement. The initial 
disagreements stemmed from differing prior knowledge of the study context 
affecting judgment about the unconfoundedness of the forcing variable (n=3), 
unclear description of the data source in the study (n=1), uncertainty as to 
whether referencing another publication was acceptable evidence towards the 
standard (n=1), failing to spot relevant information in the paper (n=1), and 
erroneous application of the WWC guidance (n=1). Agreement was 100% after 
discussion. Figure 5.1 presents the appraisal of the MLDA studies after 
discussion. 
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Figure 5.1. Results of appraisal of 17 minimum lega l drinking age (MLDA) 
studies using the What Works Clearinghouse Standard s for RD 
 
 
The horizontal axis shows the number of studies falling into each category of 
judgment (met, not met, met with reservations, or not applicable). The vertical 
axis shows the qualifying questions (Q), criteria, and standards from the WWC 
document for which judgments were made.  
 
The pilot demonstrated that the tool could be used on studies in disciplines 
other than education research, but with modifications required to over half the 
criteria. Furthermore, the standards were time consuming to use and therefore 
not feasible to be applied in full to the large number of studies included in this 
systematic review. The formation of judgments as to whether a study met each 
standard statement (a combination of met/not met rules for several criteria, 
some of which had multiple components) and the overall evidence standard (a 
combination of met/not met rules for the standard statements) was time-
consuming and added complexity to the appraisal process without adding value, 
particularly as the review protocol specified that studies would not be excluded 
based on quality. More importantly, however, 16/17 studies failed to meet the 
overall quality standard because they did not report study attrition in the same 
manner as a randomised trial; all of the MLDA studies were retrospective. I 
concluded that many studies using population data would fail the standard, 
which then would not be useful to distinguish differing degrees of quality among 
studies. However, the individual WWC criteria were easy to apply, most were 
useful in identifying strengths and limitations of the studies, and interrater 
variability was low after the initial appraisal and discussion. 
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5.5.3 Development of RD-10 Checklist 
In order to retain these benefits of WWC while improving both useability and 
applicability to studies in public health and policy, I decided to use the content 
of the standards as a basis for developing a critical appraisal checklist for RD 
studies. The checklist approach to critical appraisal is familiar in health sciences 
and an adaptation would have the following benefits: 
• Retain elements of WWC that are applicable to RD studies in health and 
useful in distinguishing high and low quality studies 
• Modify or discard elements of WWC that were of limited applicability in 
health, caused difficulties of interpretation, or were excessively time-
consuming 
• Remove complex decision rules, taking a more descriptive than evaluative 
approach 
• Ensure each criterion assesses a single aspect of the study. 
 




Box 5.2. RD-10 checklist for critical appraisal of regression discontinuity (RD) 
studies. 
 
Answer ‘yes’ or ‘no’ to indicate whether the criterion accurately describes the 
study as it has been reported, taking into account any online supplements, 
appendices, and published protocols. ‘Inadequate information’ is additionally 
permitted as a response to criteria 2 and 3. 
 
1. A forcing variable with a threshold or cut-off value is used for treatment 
assignment 
2. The forcing variable is ordinal with at least four unique values on either side 
of the cut-off 
3. An argument is provided regarding the unconfoundedness of the forcing 
variable 
4. A description is provided of the scoring and treatment assignment process 
that makes the case for the integrity of the forcing variable 
5. Smoothness of the density of the forcing variable is established through 
graphical presentation or a McCrary density test 
6. Attrition is described such that it is possible to determine the numbers of 
participants or observations in the original sample, lost during key stages of 
analysis, and included in the final analysis 
7. The baseline values for key covariates are presented for treatment and 
control groups 
8. Falsification tests of the discontinuity at the cut-off are conducted, either 
by testing for discontinuities at values of the forcing variable other than the 
cut-off, or by testing for discontinuities at the cut-off in outcomes that should 
not be affected by the treatment 
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9. Robustness checks of the model specification are conducted, such as 
different functional form specifications or different bandwidths of the forcing 
variable 




Table 5.2 shows how the RD-10 criteria map to WWC. 
 
Table 5.2 Comparison of RD-10 to WWC Standards 
 
RD-10 Relationship to WWC standards 
1. A forcing variable with a threshold or cut-
off value is used for treatment assignment 
Based on first qualifying criterion (simplified 
wording) 
2. The forcing variable is ordinal with at least 
four unique values on either side of the cut-
off 
Based on second qualifying criterion (more 
precise wording) 
3. An argument is provided regarding the 
unconfoundedness of the forcing variable 
Based on third qualifying criterion, “There 
must be no factor confounded with the 
forcing variable” 
4. A description is provided of the scoring 
and treatment assignment process that 
makes the case for the integrity of the forcing 
variable 
Based on standard 1 criterion A, “The 
institutional integrity of the forcing variable 
should be established by an adequate 
description of the scoring and treatment 
assignment process” 
5. Smoothness of the density of the forcing 
variable is established through graphical 
presentation or a McCrary density test 
Based on standard 1 criterion B, “The 
statistical integrity of the forcing variable 
should be demonstrated by using statistical 
tests found in the literature or a graphical 
analysis to establish the smoothness of the 
density of the forcing variable right around 
the cutoff” 
6. Attrition is described such that it is 
possible to determine the numbers of 
participants or observations in the original 
sample, lost during key stages of analysis, 
and included in the final analysis 
Based on standard 2, which requires that an 
RD study meet the same standards for 
reporting of attrition as in a randomised 
controlled trial 
7. The baseline values for key covariates are 
presented for treatment and control groups 
Based on standard 3 criterion A (simplified 
wording and removal of requirement to 
demonstrate “equivalence”) 
8. Falsification tests of the discontinuity at the 
cut-off are conducted, either by testing for 
discontinuities at values of the forcing 
variable other than the cut-off, or by testing 
for discontinuities at the cut-off in outcomes 
that should not be affected by the treatment 
Based on standard 3 criterion B, which 
requires either graphical or statistical 
evidence of no unexplainable discontinuities 
at values other than the cut-off 
9. Robustness checks of the model 
specification are conducted, such as different 
functional form specifications or different 
bandwidths of the forcing variable 
Based on standard 4 (Functional Form and 
Bandwidth), which specifies these two issues 
as “the most critical aspects of the statistical 
modelling” but presents five criteria in total 
10. The statistical model controls for the 
forcing variable 
Based on standard 4 criterion A (simplified 
wording and reduction to a single criterion) 
 
Next, the checklist was tested by having two reviewers independently appraise 
the purposive sample of 13 studies and informally discuss their results. In 
appraising 13 papers against 10 criteria, 130 judgments could be compared. In 
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20 of the judgments one of the reviewers gave a response that expressed 
uncertainty rather than choosing from the permitted responses, and in 11 one of 
the reviewers gave no response, leaving 99 judgments (76.2%) that could be 
directly compared. Of these the pairs of reviewers initially agreed on 68/99 
(68.7%) of assessments against individual criteria and disagreed on 31/99 
(31.3%). These results are displayed graphically in figure 5.2. 
Figure 5.2. Agreement between independent reviewers  on appraisal of 13 
studies using RD-10 
 
The first question, on whether treatment assignment was based on a forcing 
variable, had the highest initial agreement (11/13, 84.6%), followed by the 
questions on number of unique values and density testing (8/13, 61.5%). 
Attrition had the lowest number of judgments showing initial agreement (3/13, 
23.1%); for seven of these judgments, one of the reviewers did not record any 
response. There was low initial agreement on the questions relating to the 
unconfoundedness and integrity of the forcing variable (5/13 and 7/13 
respectively) and on questions relating to statistical reporting.   
Agreement after discussion was 100%, but discussions were lengthy compared to 
the WWC pilot. The most common reason for disagreement was that one 
reviewer did not identify the evidence to support a ‘yes’ answer when it did 
exist (sometimes only in a footnote or appendix). The other source of 
disagreement was how to interpret the relevant evidence in the papers. 
ID RD1 RD2 RD3 RD4 RD5 RD6 RD7 RD8 RD9 RD10
Albouy 2009 Y N N
Bor 2014 Y I Y N
Chen 2013 Y N Y
Decker 2005 Y Y Y Y
Garrouste 2011 Y Y Y Y Y Y Y
Johnston 2009 Y Y Y N Y Y N
Jensen 2015 Y Y Y
Lindeboom 2009 Y Y Y Y N
Mezuk 2009 Y N N N
Olsho 2015 Y Y Y N N Y
Powdthavee 2010 Y Y Y N N N N Y
Urquieta 2009 Y Y N N
Ertan Yoruk 2012 Y Y Y Y N N Y N Y Y
Legend:
Initial independent agreement (Y=yes, N=no)
Disagreement due to one reviewer expressing uncertainty or no response
Initial independent disagreement
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Reviewers had questions about how to apply the criteria to different types of 
forcing variables and different types of RD studies (for example, exploratory or 
epidemiological studies versus evaluations of the effects of an intervention, as 
well as studies in which RD is not the main analysis and is reported only briefly). 
The reviewers also noted that some criteria involve more subjective decisions 
than others, particularly the assessment of unconfoundedness, the integrity of 
the forcing variable, and the reporting of attrition.  
The conclusion from this test of RD-10 was that it was possible to apply the tool 
to a range of studies from different disciplines involving different RD designs and 
forcing variables. The main barriers to implementation were the amount of time 
required to identify the relevant evidence from the papers being appraised and 
the amount of time required for discussion. Because of these considerations, it 
was not feasible to have two reviewers independently appraise all 181 studies in 
the systematic review of RD reported in chapter 3. Full appraisal results for all 
studies are available on request as an Excel spreadsheet. 
5.6 Discussion   
5.6.1 Implications of the findings 
This chapter makes a preliminary contribution to the methodological 
developments required for the critical appraisal of RD studies in health. The 
findings demonstrate that it is possible to apply a quality assessment tool (WWC) 
developed for prospective evaluation studies in education within a systematic 
review of a public health policy topic. However, given that the studies were 
population-based and retrospective, the quality assessment was largely 
negative, the standard was overly sensitive to the assessment of attrition, and 
the tool was not useful in discriminating between higher and lower quality 
studies. The attempt to adapt the WWC tool into a checklist involving the 
assessment of individual criteria rather than overall standards produced useful 
information about the quality of RD studies in health, but the checklist showed 
limitations in terms of interrater agreement and usability for reviewers less 
familiar with the technical details of RD design and reporting.  
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This exercise suggests that a need exists for a critical appraisal tool that is 
specific to the features of RD designs and describes the quality of these studies 
in adequate detail, while also being accessible to reviewers who may not have 
specialist knowledge of RD or familiarity with the reporting conventions of 
different disciplines, particularly econometrics. Such methodological 
development is necessary if the aim of incorporating the results of natural 
experiments in public health systematic reviews is to be realised. The same need 
and similar challenges may be anticipated for the critical appraisal of other 
types of natural experimental designs, such as instrumental variable studies. An 
inability to understand and evaluate such studies can only contribute to their 
continued exclusion from the public health evidence hierarchy, evidence 
syntheses, and guidelines. 
5.6.2 Reflections on methodology 
A strength of the work reported in this chapter is the detailed description of the 
methodology used, including the reasons for decisions taken at each step of 
testing. The methodology used broadly conforms to the process described by 
Deeks et al. (2003), namely preliminary conceptual decisions followed by 
assessment of face validity, ‘field trials’ or tests of applicability, and revision (p. 
36).  
Conformity to elements of good practice in critical appraisal adds further value 
to this work. RD-10 does not involve a score as this practice is specifically 
discouraged in the Cochrane handbook on the grounds that it has no empirical 
basis, produces unreliable assessments, and reduces transparency (Higgins and 
Green 2011, section 8.3.3). RD-10 also can be seen as an improvement on WWC 
because each criterion involves only a single question with clear wording. WWC 
criteria descriptions often involve several different statements and it is not clear 
how the user should make a judgment if some aspects of the description are met 
but not others. RD-10 meets the five criteria for tool selection described by 
Viswanathan et al. (2017), assuming that the expert opinion behind WWC and 
the applicability testing conducted are sufficient evidence of face validity. 
A final strength of this work is the testing of the criteria by using a relatively 
large sample for dual-reviewer appraisal, followed by application to a large 
Chapter 5 Page 117 
 
number of studies in a comprehensive review of RD studies in health. Whereas 
the applicability of ROBINS-I was tested on a sample of five studies (Sterne et 
al., 2016) and the Cochrane Handbook states that three to six papers might be a 
suitable sample for checking consistent application of risk of bias criteria in a 
review (Higgins and Green 2011, section 8.3.4), in the present work the first 
stage (testing WWC) involved a sample of 17 studies, the second (testing RD-10) 
a sample of 13 studies, and the final sample to which the tool was applied 
consisted of 181 studies. 
Poor interrater agreement would appear to be a serious limitation of the RD-10 
checklist. Some mitigation of the poor interrater agreement in the present work 
lies in two explanatory factors: the choice of a purposive sample of RD studies 
and the technical difficulty of the reports. A further consideration regarding this 
limitation is that low interrater reliability is a characteristic of critical appraisal 
tools generally, with studies having reported fair to poor interrater agreement 
for Cochrane RoB (Armijo-Olivo et al., 2014; Hartling, Hamm, et al., 2013), NOS 
(Hartling, Milne, et al., 2013), and ROBINS-I (Thomson 2018). This characteristic 
may be less a product of suboptimal tools or tool development and more an 
effect of poor reporting in the appraised studies as well as a reflection of the 
nature of critical appraisal itself. Judgments may differ according to the user’s 
experience with the tool, the study design, critical appraisal methods generally, 
and the topic under review.  
A final limitation of the methodology in this chapter is the absence of a formal 
consensus approach or more formalised methods of usability testing. The work 
reported here is therefore preliminary in nature. It could form the basis of 
further, more formalised development and evaluation of a revised version of RD-
10.  
5.6.3 Future Developments 
The experience of testing RD-10 with different reviewers points to several 
considerations that should be addressed in any further development of a critical 
appraisal tool for RD or other natural experimental designs. Lack of familiarity, 
not only with RD designs in the abstract, but with the reporting of RD studies, 
particularly from disciplines other than health, is a serious barrier to usability, 
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interrater agreement, and probably the uptake of any RD critical appraisal tool.  
A reviewer cannot appraise an RCT without understanding concepts such as 
sequence generation, allocation concealment, and blinding; knowing how to find 
the relevant information in a paper; and being able to interpret what is reported 
in the paper in terms of the appraisal criteria. Similarly, reviewers need 
knowledge of RD features such as treatment allocation by forcing variable and 
model specification, along with experience of how these are reported. 
Consideration is needed as to how to present these features in a way that is 
accessible to non-expert users, what supporting documentation and training may 
be required, and how to build capacity among systematic reviewers to conduct 
such appraisals. All of the initial disagreements between reviewers in the test of 
RD-10 can be related to inability to identify or locate the relevant information in 
the paper and/or uncertainty as to how the criterion should be interpreted in 
the context of the study under assessment. Arguably, then, problems with 
interrater reliability in critical appraisal are also problems of clarity and 
transparency of reporting in RD studies. If methods of critical appraisal need 
development, so too do standards of reporting for RD. 
It is also striking that the limited investigations of RD study quality to date have 
on the one hand focused to a large extent on the quality of statistical reporting, 
while on the other hand largely neglected more generic yet arguably more 
important domains of risk of bias, such as measurement bias and selective 
reporting. The quality of statistical reporting can be considered as distinct from 
study quality as defined in terms of risk of bias; statistical reporting quality is 
either absent from most critical appraisal tools in common use in health or 
restricted to very simple and readily identifiable issues such as the presence of 
confidence intervals. This exclusion of statistical reporting quality has the 
benefit of making these critical appraisal tools accessible to non-statisticians, 
usable within a multidisciplinary review team, and possible to implement with 
minimal training across a wide variety of fields and topics. The focus on 
statistical reporting may prove to be a factor limiting the incorporation of 
natural experimental studies in systematic reviews in health.  
Greater knowledge of the empirical relationship between RD design elements 
and biased estimates of effects would be useful for determining which aspects of 
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statistical reporting would be most important to include in a critical appraisal 
checklist and which could be eliminated. If this knowledge were also used to 
improve reporting by highlighting key aspects of study design in plain language, 
the result could be a simplified critical appraisal process that could be 
implemented more easily and more widely.  
Further research on this area is envisaged to develop RD-10 into a tool that could 
be used by systematic reviewers who are not experts in RD methodology, thus 
helping to realise the potential for natural experiments to be used more widely 
as evidence in public health. The development process could involve the 
following: 
1. Revision of risk of bias criteria based on experience acquired in the 
systematic review of RD (chapter 3) 
2. Consideration of additional, non-design-specific domains of bias such as 
selective reporting, including a literature review to identify empirical 
evidence of such biases with respect to RD studies 
3. Consensus-based research such as a Delphi activity involving experts in 
evidence synthesis, with and without specialist knowledge of RD, to 
investigate the face validity and acceptability of a revised checklist 
4. Development and evaluation of user guidance and training materials to 
ensure that users can appraise studies relatively quickly and consistently, 
without being experts in RD 
5. Usability testing to ensure criteria can be consistently interpreted and 
applied 
6. Measurement of interrater reliability in an appropriately selected sample 
of RD studies 
7. Field testing in systematic review and guideline development projects to 
evaluate implementation in terms of feasibility and acceptability 
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8. Extension of this process and application of learning to development of 
usable, design-specific appraisal tools for other natural experimental 
methods, such as instrumental variable, difference-in-difference, and 
synthetic control studies.  
An implementation study would additionally demonstrate real-world utility, 
further identify user needs and difficulties for revision of user guidance and 
training materials, and create examples of how appraisal results can be 
presented and incorporated into systematic reviews. 
5.7 Chapter summary 
This chapter has reported the testing and development of methods for the 
critical appraisal of RD studies. The What Works Clearinghouse Standards for RD 
were applied to 17 public health policy studies and showed limitations in the 
applicability of criteria to retrospective evaluative designs and in suitability for 
use in a systematic review. Accordingly relevant criteria from the standards 
were used as the basis for development of a ten-item checklist, RD-10. 
Compared to WWC, RD-10 produces a more detailed description of quality and is 
more applicable to the retrospective RD designs frequently seen in public health 
research. Issues relating to the reporting quality of RD studies, different 
conventions of reporting across academic disciplines, and difficulty identifying 
relevant information in study reports contributed to differences between 
reviewers in applying the tool.  
Chapters 3, 4, and 5 have reported findings from a systematic review of studies 
using one natural experimental design, namely RD. Chapter 6 will demonstrate a 
different approach to investigating the contribution of natural experiments to 
public health evidence by reporting an overview of systematic reviews relating 
to environmental causes of disease. As described in chapter 2, this is a topic to 
which natural experiments might reasonably be expected to form part of the 
evidence base.  
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6 Endocrine disrupting chemicals and breast 
cancer risk: A meta-review 
6.1 Chapter overview 
Whereas chapter 5 considered the application of natural experimental methods 
to the evaluation of an intervention, chapter 6 looks at the other type of health 
research question to which these methods may be applied, namely the 
investigation of the effects of environmental exposures. This chapter begins with 
a brief introduction to endocrine disrupting chemicals (EDCs), explaining why 
they are a public health concern, how they have become linked to breast 
cancer, and how natural experiments might contribute to understanding the 
environmental causes of disease. The chapter then investigates, via a protocol-
driven meta-review or overview of systematic reviews, what evidence has been 
assembled about EDCs and breast cancer risk and what contribution natural 
experiments have made to that evidence base. The systematic reviews are 
brought together in a narrative synthesis which describes in tables the reviews’ 
characteristics and conclusions. The quality of the reviews is assessed and 
described using the AMSTAR-2 appraisal tool. The findings of the meta-review 
are presented visually through (1) a diagram of overlap across reviews addressing 
one group of EDCs and (2) a map of evidence. The chapter concludes by 
discussing why natural experiments make a very limited contribution and what 
scope might exist to strengthen this evidence base. 
6.2 Aims 
By conducting and reporting a meta-review, this chapter aims to answer the 
following research questions: 
1. What is the evidence from systematic reviews that endocrine disrupting 
compounds (EDCs) cause breast cancer in humans? 
2. What is the contribution of natural experiments to the evidence base on 
the causal role of EDCs in breast cancer? 
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3. How have systematic reviews evaluated and presented evidence from 
different study designs, including natural experiments, in reaching their 
conclusions about EDCs? 
4. How do systematic reviews vary in their methodology with respect to 
inclusion criteria, appraisal methods, and synthesis methods, and how do 
these variations affect the inclusion and presentation of results from 
natural experiments? 
5. What have systematic reviews identified as the limitations and gaps 
relating to natural experiments within the evidence base on EDCs and 
breast cancer in humans? 
6.3 Background 
6.3.1 Breast cancer: epidemiology and the public he alth response 
Breast cancer is the most common cancer in women worldwide, the leading 
cause of cancer death among women in developing countries, and the second 
most common cause of cancer death (after lung cancer) among women in high-
income countries (International Agency for Research on Cancer, 2012). In 
Scotland the incidence of breast cancer has increased over the past two decades 
and the lifetime risk of breast cancer for women is 11.9%, or approximately 1 in 
8 women (Scottish Public Health Observatory, 2018). 
Breast cancer is a heterogeneous disease divided into subtypes according to 
hormone receptor status and HER-2 protein receptor status. The majority of 
breast tumours (approximately 70%) are oestrogen receptor positive (ER+), 
meaning that their growth appears to be stimulated by the presence of 
oestrogen (Macmillan Cancer Support, 2013). It is generally agreed that 
oestrogens and other hormones play an important role in the aetiology of breast 
cancer (Trichopoulos et al., 2008). Well-established risk factors for breast 
cancer include increasing age, reproductive history (age at menarche, age at 
first birth and parity, breastfeeding, age at menopause), family history, height, 
birthweight, high body mass index, postmenopausal weight gain, 
postmenopausal hormone therapy, alcohol intake, exposure to ionising radiation, 
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and mammographic density (Tamimi, Hankinson, and Lagiou, 2018). Other than 
weight and alcohol, most of these risk factors unfortunately are not modifiable. 
Public health messages relating to breast cancer prevention include minimising 
weight gain, avoiding alcohol, breastfeeding if possible, and physical activity 
(Tamimi et al., 2016). Increases in breast cancer survival have been achieved 
through screening programmes that lead to earlier detection and treatment and 
through healthcare improvement, including more effective treatment and better 
organisation and delivery of care (Scottish Public Health Observatory, 2018), 
rather than through prevention. 
6.3.2 Endocrine disrupting chemicals as suspected c auses of 
breast cancer 
The incidence of breast cancer has increased globally over the past century 
(Trichopoulos et al., 2008) but with nearly a five-fold difference in rates among 
countries (Tamimi et al., 2016) and higher risk in urban compared to rural areas 
(Trichopoulos et al., 2008). A four-fold difference in risk between women in 
North America and Europe compared to women in China and Japan is not 
explained by adult diet or reproductive factors (Trichopoulos et al., 2008). The 
unexplained global rise in incidence combined with unexplained geographical 
variation has led to questions about possible environmental causes of breast 
cancer (Tamimi, Hankinson, and Lagiou, 2018). 
Among the many environmental exposures that could contribute to breast cancer 
risk, endocrine disrupting chemicals (EDCs) have attracted particular interest 
due to the role of hormones in breast cancer aetiology (IOM, 2012). The World 
Health Organization defines an EDC as “an exogenous substance or mixture that 
alters function(s) of the endocrine system and consequently causes adverse 
health effects in an intact organism, or its progeny, or (sub)populations.” 
Common EDCs include dioxins, polychlorinated biphenyls (PCBs), organochlorine 
pesticides (OCPs) such as DDT, herbicides, fungicides, the industrial surfactant 
perfluorooctanoic acid (PFOA), and consumer product chemicals such as 
bisphenol A, phthalates, nonylphenols, and polybrominated diphenyl ethers 
(PBDEs, used as flame retardants) (Gore et al., 2015). Although production of 
many of these chemicals was eventually banned, they were produced in 
industrial quantities for decades and are now ubiquitous in the environment 
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(Gore et al., 2015). Others continue to be in common household and industrial 
use.  
Evidence for the endocrine system effects and any increased cancer risk 
associated with EDCs varies by chemical and is derived from laboratory, animal, 
and epidemiological studies (Rodgers et al., 2018). Uncertainty as to the 
applicability of laboratory and animal studies to human health, the potential for 
bias and inability to rule out confounding in cohort or case-control studies, and 
the difficulty of exposure assessment have contributed to controversy over EDCs 
as a cause of cancer (Brody et al., 2007, IOM, 2012). Additionally, the utility and 
health-protective effects of many of these chemicals in applications such as 
increasing crop yield, improving fire safety, and preventing insect-borne diseases 
must be weighed against the potential risks (Sadasivaiah, Tozan, and Breman, 
2007, Shaw et al., 2010). These uncertainties have contributed to conflicting 
public perspectives on EDCs. For example, Breast Cancer UK’s position on EDCs is 
that they should be regulated on the precautionary principle, recognised as 
preventable risk factors for breast cancer within national cancer plans, and 
classified as substances for which no safe exposure threshold can be determined 
(Breast Cancer UK, 2017). This position contrasts with that of Cancer Research 
UK, which has responded to public concerns about EDCs with advice that “the 
evidence linking these chemicals to cancer has generally been poor or 
inconsistent” (Cancer Research UK, 2016). 
6.3.3 Role of natural experiments in identifying en vironmental 
causes of diseases 
To address the question of how to understand and act upon environmental 
causes of disease, the Academy of Medical Sciences convened a working group 
chaired by Sir Michael Rutter (Academy of Medical Sciences, 2007). Their report 
found that, despite clear evidence of the important role environmental factors 
play in causing disease, specific knowledge of causal pathways was limited (p. 
7). Although RCTs provide the strongest evidence of a causal effect, in most 
situations random allocation to environmental exposures is neither feasible nor 
ethical, so the report recommended that researchers should use natural 
experiments “whenever possible” to assess the effects of environmental factors 
on disease (p. 13). Furthermore, in order to test causal inferences in different 
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populations and contexts, the report concluded that “The totality of evidence 
from all sources should be brought together in order to reach sound conclusions” 
(p. 8). 
The relationship between EDC exposure and breast cancer represents an area of 
current controversy in which natural experimental methods might be applied in 
order to support stronger causal inference, for example by leveraging situations 
such as accidental exposures or variation in geographical proximity to a source 
of exposure. Therefore, it may be expected that systematic reviews that have 
attempted to represent the evidence on EDCs and breast cancer will have 
needed to consider the designs of included studies, how the studies address 
unmeasured confounding, and how to assess and synthesise findings from studies 
of varying design. Accordingly, this chapter presents a meta-review on EDCs and 
breast cancer with a focus on the methods used in systematic reviews for 
identifying, assessing, and synthesising evidence on the health effects of 
environmental exposures, on the premise that these reviews will potentially 
include and synthesise results from natural experimental studies. 
6.4 Methods 
6.4.1 Protocol and deviations 
This meta-review was conducted according to a pre-specified protocol published 
in the PROSPERO registry. The protocol registration number is PROSPERO 2018 
CRD42018089344. Appendix 4 contains the protocol as published in the 
PROSPERO registry. Deviations from the protocol, with justifications, are 
reported in Table 6.1.  
Table 6.1. Deviations from protocol in the systemat ic review of endocrine 
disrupting chemicals and breast cancer risk 
Statement from protocol Deviation and justification 
IARC monographs will be searched 
 
IARC monographs are not systematic 
reviews and would not meet inclusion criteria, 
therefore the website was not searched. 
A data extraction form will be designed and 
piloted on two systematic reviews (one 
reviewer will pilot the data extraction form 
and a second will cross-check the extracted 
data for accuracy).  
A second reviewer was not available for data 
extraction piloting or checking.  
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Reviews that include a meta-analysis of risk 
of breast cancer in humans will additionally 
[in addition to AMSTAR2] be appraised using 
the MOOSE (Meta-analyses Of 
Observational Studies in Epidemiology) 
checklist. 
 
MOOSE is a reporting guideline, not a critical 
appraisal checklist. Only AMSTAR-2 has 
been used in this overview for critical 
appraisal. AMSTAR-2 has specific questions 
to assess the quality of meta-analyses and 
has been designed for reviews of both 
randomised and non-randomised studies. 
The primary qualitative outcome of the review 
is a map of evidence that demonstrates (1) 
the number and type of natural experimental 
studies included in the evidence base and (2) 
the amount of overlap of included studies 
among the systematic reviews. 
It was not possible to produce a map of 
evidence matching this description for two 
reasons. First, the included reviews did not 
specifically identify any studies as natural 
experiments. Second, overlap across 15 
reviews proved too complex to represent in a 
single diagram. Instead, the map of evidence 
demonstrates the number and quality of 
reviews for each subtopic, following 
Virendrakumar (2017). Overlap is 
investigated and described, but due to the 
number of reviews a diagram of overlap was 
created only for a subset of reviews as an 
illustration. 
Sensitivity analyses will be conducted by 
review characteristics, review quality, and 
inclusion of natural experiments. 
 
There were too few reviews on any EDC 
subgroup and too little differentiation in 
review quality to make sensitivity analysis 
meaningful. Also, no reviews specifically 
included natural experiments. The results 
section does identify some patterns of 




The primary qualitative outcome of the review specified in the protocol is a map 
of evidence.  
The primary quantitative outcome of the review specified in the protocol is the 
risk of breast cancer in humans, expressed as relative risk (RR), odds ratio (OR), 
or hazard ratio (HR), associated with a given exposure to an EDC or combination 
of EDC under a given set of circumstances, with 95% confidence intervals.  
6.4.2 Eligibility criteria 
The inclusion criteria for this overview were as follows. 
Study type 
This overview includes systematic reviews, defined as a study that (1) follows a 
specific, transparently reported method of retrieving and selecting studies in an 
effort to comprehensively address its research question and (2) presents the 
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characteristics and results of included papers in some form of synthesis 
(quantitative, qualitative, or narrative). This definition was derived from the 
PRISMA statement. Meta-analyses, rapid reviews, and scoping reviews could be 
included if they met the above definition of systematic review. Primary studies 
were not included.  
Date 
This review includes systematic reviews published on or after 1 January 2003 and 
whose cut-off date for searches is not earlier than 1 January 2002. The year 
2002 was chosen because it was the date of publication of the first Global 
Assessment of the State of the Science of Endocrine Disruptors (International 
Programme on Chemical Safety, 2002), at which time only very weak evidence 
was found to exist of a relationship between EDCs and human health.  
Language  
No language restrictions were imposed at the search stage. The protocol 
specified a plan for dealing with records in other languages; however, no 
documents without an English-language abstract were identified, and no 
abstracts selected for full-text screening were in languages other than English or 
French, so no translations were required. 
PICO 
Included reviews had to address the question of the effect of exposure to EDCs 
(any chemical or combination of chemicals, any dosage, any timeframe) on the 
risk of breast cancer in humans. Systematic reviews on a broader topic (such as 
environmental causes of breast cancer, or effect of EDC exposure on the risk of 
all cancers) were included if the other inclusion criteria were met and separate 
results on EDCs and breast cancer were presented. The specific PICO of interest 
was: 
Participants/population 
Humans exposed to endocrine disrupting chemicals. 
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Intervention(s), exposure(s) 
The exposure of interest is endocrine disrupting chemicals (see section 6.3.2 
above for definition). Environmental, household, and occupational exposures 
were included. Alcohol and benzene were included in the category of organic 
solvents as occupational exposures, but individual consumption (of alcoholic 
beverages or benzene as a component of tobacco smoke) as a route of exposure 
was excluded. Pharmaceuticals (e.g. hormone therapy) were excluded. 
Comparator(s)/control 
The comparators could be any variation in exposure (including non-exposure), 
degree, or timing. 
Outcome 
Risk of breast cancer. 
 
6.4.3 Search strategy 
I searched Medline, Embase, the Cochrane Database of Systematic Reviews 
(CDSR), Biosys Previews, Scopus, and Web of Science for records dated January 
2003 – April 2018. Additionally, Google and OpenGrey were searched for grey 
literature. The search strategies for the bibliographic databases combined 
keyword and subject index terms for endocrine disruptors and breast cancer 
with a filter to identify systematic reviews. The full search strategies are 
reported in Appendix 5. 
 
6.4.4 Study selection 
As per protocol, one reviewer (myself) screened at all stages. The protocol 
specified that any uncertainty over whether inclusion criteria were met would 
be discussed with a second reviewer. The only uncertainty that arose concerned 
reviews with very broad scope, for example with outcomes such as ‘any cancer’ 
or ‘human health’, which led to discussion with a second reviewer (HT). 
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However, the uncertainty was resolved by referring back to the inclusion criteria 
as detailed in the protocol. Decisions with reasons for exclusion were recorded 
in EndNote. 
6.4.5 Quality (risk of bias) appraisal 
Included systematic reviews were critically appraised using the AMSTAR 2 
checklist, which has been developed to allow for the appraisal of systematic 
reviews containing evidence from both randomised and non-randomised studies, 
with or without meta-analysis (Shea et al, 2017). Two reviewers appraised each 
study independently, compared results, and resolved disagreements through 
discussion. Each appraiser recorded their assessments on an individual Excel 
spreadsheet. 
6.4.6 Data extraction 
A data extraction spreadsheet was designed as described in the protocol. The 
data extracted from each included review were:  
Review characteristics: the citation, year of publication, objectives, search cut-
off date, databases searched, inclusion criteria, quality appraisal method, 
method(s) of synthesis  
Details of included studies: number of studies and population numbers included 
in the review, references of included studies (human populations only), number 
and date range of other included studies (animal and in vitro), designs of 
included studies in humans  
Details of review findings: EDCs covered, characteristics of EDC exposure 
covered (doses, timeframes, modifying factors), results of meta-analysis of risk 
of cancer in humans, numeric estimates of risk from included natural 
experiments in human populations, results of narrative synthesis, overall 
assessment of risk of bias and/or certainty of evidence, limitations or gaps noted 
in the evidence base. 
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6.4.7 Synthesis  
The characteristics of the included reviews were described in tables and grouped 
by the exposures of interest that they addressed. Information about the 
contribution of natural experiments and about limitations and gaps in the 
evidence base were summarised narratively and presented in an ‘overview of 
synthesis’ table. 
The primary quantitative outcome (risk of breast cancer) was presented in a 
table, with estimates of risk associated with different exposures presented 
separately. The primary qualitative outcome (map of evidence) was tabulated in 
a manner adapted from Sightsavers evidence gap maps (Virendrakumar et al., 
2017). These maps classify evidence as strong, weak, or inconclusive. Definitions 
of strong versus weak evidence vary widely and are arguably less clear-cut when 
the body of evidence does not include randomised studies. For the adaptation of 
the evidence map used in this review, I classified the strength of evidence based 
on characteristics that differed across the reviews and are commonly used as 
quality criteria, namely whether included studies were prospective or not, 
whether exposures were measured reliably, and whether the reviews assessed 
study quality. A judgment of inconclusive was determined when the review 
authors themselves came to this conclusion, or when insufficient information 
about study design and quality was provided to support a judgment of strong or 
weak. This classification is pragmatic but not overly dependent on subjective 
opinion, and serves as a thumbnail sketch to add some relevant detail to the 
evidence map.  
Overlap of primary studies among reviews (Lunny et al., 2017) was determined 
by cross-tabulating the reviews against a list of references that appeared at 
least once in each review as part of the evidence base for a similar question. 
The overlap was then presented graphically as a Venn diagram in a manner 
derived from McKenzie and Brennan (2017) and summarised in narrative form. 
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6.5 Results 
6.5.1 Literature search results  
The search retrieved 4745 records from citation databases and 36 additional 
records from internet searches. After I removed duplicates and records whose 
titles and abstracts did not meet the inclusion criteria, 118 full-text articles 
were retrieved and assessed. Of the full-text articles, 15 systematic reviews met 
the inclusion criteria; eleven of these reviews contained meta-analyses. Figure 
6.1 shows the PRISMA flow diagram for study selection. 
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Records identified through 
database searching 

























Additional records identified 
through other sources 
(n =  36 ) 
Records after duplicates removed 
(n =  4344 ) 
Records screened 
(n =  4344 ) 
Records excluded 
(n =  4226 ) 
Full-text articles assessed 
for eligibility 
(n =  118 ) 
Full-text articles excluded, 
with reasons 
(n = 103  ) 
59 not systematic reviews 
23 different PICO 
11 non-reproducible 
methods (incl. 1 
conference abstract) 
4 duplicate publications 
3 not retrievable 
2 updated versions 
available 
1 search pre-2002 
 
Reviews included in 
narrative synthesis 
(n = 15  ) 
Reviews that included 
quantitative synthesis 
(meta-analysis) 
(n = 11  ) 
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6.5.2 Excluded studies 
Of the 118 full-text articles that were assessed against the inclusion criteria, 103 
were excluded. Of the excluded papers, 59 did not meet even a relaxed 
definition of a systematic review, 23 did not meet the PICO inclusion criteria, 11 
were excluded based on a judgment that the review methods were neither 
comprehensive nor transparently reported and thus did not meet the definition 
of a systematic review set out in the protocol, and 10 papers were excluded for 
other reasons (duplicate publications, not retrievable, updated versions 
available, date of search outside of included range).  
6.5.3 Included systematic reviews 
The 15 included reviews were published between 2005 and 2018. Four of the 
reviews were broad in scope, encompassing a range of EDCs as well as other 
environmental exposures (Brody 2007, Gray 2017, Mouly 2016, Rodgers 2018). 
The eleven reviews that contained meta-analyses were more narrowly focused 
on a group of related chemicals or products. Of these meta-analyses, there were 
three on pesticides or DDT (Ingber 2013, Khanjani 2007,Park 2014), three on 
PCBs (Leng 2016, Zani 2013, Zhang 2015), and five on consumer products, 
including two on hair dyes (Gera 2018, Takkouche 2005), two on deodorants 
(Allam 2016, Hardefeldt 2013), and one on phthalates (Fu 2017). The four 
broader reviews also addressed all of these topics, with the exception of Brody 
2007, which did not address consumer products. Table 6.2 summarises the 




Table 6.2 Characteristics of included systematic re views 
 
 





source and COI 
ALLAM, M. F. 2016. 





journal of public 
health, 24, 245-247. 
Association between  
deodorant or 
antiperspirant use 
and breast cancer 
PubMed, PsycLIT,  
Current Contents, 
Best Evidence, cited 
references, contact 
with experts 
Index and keyword 
terms 
Actual search 
strategy not reported 
Date Database 





studies on breast 





studies, studies not 
comparing exposed 
and unexposed, 
unpublished studies  
None reported Funding source not 
stated. 
COI: none to declare 
BRODY, J. G., 
MOYSICH, K. B., 
HUMBLET, O., 
ATTFIELD, K. R., 
BEEHLER, G. P. & 
RUDEL, R. A. 2007. 
Environmental 









EDCs) and breast 
cancer 
Pubmed only 
Yes, table 1 











certain types of 
occupational studies, 
studies with five or 
fewer exposed 
women or studies of 
male breast cancer 







Funded by Susan G. 
Komen for the Cure; 
no statement of COI 
FU, Z., ZHAO, F., 
CHEN, K., XU, J., LI, 




metabolites and risk 





cohort studies and 
case-control studies 
in English with 
reported or 
Newcastle-Ottawa 
(scores reported; not 
discussed) 
Funding: Grants 
from Natural Science 
Foundation of 
Zhejiang Province 
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source and COI 
between urinary 
phthalate 
metabolites and risk 















Research Funds for 
the Central 
Universities  
COI: none to declare 
GERA, R., 
MOKBEL, R., IGOR, 
I. & MOKBEL, K. 
2018. Does the Use 
of Hair Dyes 
Increase the Risk of 
Developing Breast 
Cancer? A Meta-
analysis and Review 




personal hair dye 









studies with reported 
RR/OR and CI, 
baseline 
characteristics and 
selection criteria for 
cases and controls, 
and adequate 




None reported Funding: Breast 
Cancer Hope Charity 
No statement of COI 
GRAY, J. M., 
RASANAYAGAM, 
S., ENGEL, C. & 
RIZZO, J. 2017. 
State of the 
evidence 2017: an 
update on the 
connection between 
breast cancer and 
the environment. 
Environmental 
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source and COI 
Health: A Global 
Access Science 
Source, 16, 94. 
HARDEFELDT, P. 
J., EDIRIMANNE, S. 
& ESLICK, G. D. 
2013. Deodorant 




Effect of deodorant 










with internal control 
group, controls not 
diagnosed with 
breast disease, risk 
estimate given 
None reported No statement of 
funding or COI 
INGBER, S. Z., 
BUSER, M. C., 
POHL, H. R., 




2013. DDT/DDE and 






Effect of DDT 
exposure on risk of 
breast cancer 
PubMed and Web of 
Science plus cited 
references, 
keywords and MeSH 
index terms, 
unknown date 







and breast cancer 
risk, with data on 
both exposure and 
risk 
None reported Funding: CDC and 
Oak Ridge Institute 
for Science and 
Education 
COI: None declared 
KHANJANI, N., 
HOVING, J. L., 
FORBES, A. B. & 






and Ovid) 1966 to 
July 2006 and 





None reported No funding received 
COI: None declared 
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source and COI 
Systematic review 











Reviews, 25, 23-52. 
not provided, to July 
2006) plus reference 









LENG, L., LI, J., 
LUO, X. M., KIM, J. 
Y., LI, Y. M., GUO, 
X. M., CHEN, X., 
YANG, Q. Y., LI, G. 
& TANG, N. J. 2016. 
Polychlorinated 







Women exposed to 
any of 209 PCB 














which had to have 
“unequivocal 
evidence of 
exposure” to PCB 
congeners and 






of China and 
Ministry of 
Environmental 
Protection of China 
COI: none declared. 
MOULY, T. A. & 
TOMS, L. L. 2016. 
Breast cancer and 
persistent organic 










published in English 
with direct biological 
CASP checklists 




No statement of COI 
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source and COI 
pollutants (excluding 
DDT): a systematic 
literature review. 
Environmental 

















PARK, J. H., CHA, 
E. S., KO, Y., 
HWANG, M. S., 
HONG, J. H. & LEE, 
W. J. 2014. 
Exposure to 
Dichlorodiphenyltrich
loroethane and the 









DDT exposure and 




keywords and index 
terms; 
To August 2012 
Cohort or case-
control studies in 
English with OR/RR 
and CI or data for 
calculation  
 
None reported Funding: Ministry of 
Food and Drug 
Safety, Osong, 
Korea 
COI: None declared 
RODGERS, K. M., 
UDESKY, J. O., 
RUDEL, R. A. & 
BRODY, J. G. 2018. 
Environmental 
chemicals and 
breast cancer: An 
updated review of 
Human studies of 












human studies in 
English with risk 
estimate. Excluded: 




Assessed studies in 







Funded by Silent 
Spring Institute and 
Avon Foundation for 
Women 
Authors are 
employed by Silent 
Spring Institute 
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studies with five or 
fewer exposed 
women or studies of 
male breast cancer 
with <1 observed or 
expected case 
TAKKOUCHE, B., 
ETMINAN, M. & 
MONTES-
MARTINEZ, A. 
2005. Personal use 
of hair dyes and risk 
of cancer: a meta-
analysis. JAMA, 293, 
2516-25. 
Personal use of hair 







and keywords, no 
language 
restrictions,  
Inception to 2004 
(Medline to January 
2005) 
Published cohort or 
case-control studies 
with RR and CI or 
data for calculation 
Excluded: 
occupational 
exposure to hair 
dyes 
Assessed using a 
10-point scale 
adapted from an 
unrelated meta-
analysis; results not 
reported 
COI: none reported 
Funding: Canadian 






FILISETTI, B. & 








Health, Part C, 31, 
99-144. 
PCB exposure and 
risk of any cancer  
PubMed only 
Keywords 
“1970s” to end of 
2012 
Published, peer-
reviewed cohort and 
case-control studies 
of known direct 
exposure, 
occupational 
exposure, or with 
individual measures 
of exposure, with 
OR/RR/SMR or 





None reported No statement of 
funding source or 
COI 
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source and COI 
cross-sectional 
studies, cohort or 
case-control with 
indirect measure of 
exposure  
ZHANG, J., HUANG, 
Y., WANG, X., LIN, 








Studies. PLoS ONE, 
10, e0142513. 
Association between 
PCB exposure and 
breast cancer risk 
PubMed, EMBASE, 






















Funded by National 
Natural Science 
Foundation of China 
COI: none declared 
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The included reviews aimed to be comprehensive within their defined scope. All 
limited their inclusion criteria to studies in humans and the meta-analyses were 
additionally restricted to studies that quantified risk. Seven of the fifteen 
reviews restricted the included study types to cohort and case-control studies 
and three others included only ‘epidemiological’ studies. The searches generally 
were comprehensive, although three reviews (Brody, Rodgers, and Zani) 
searched only one database (PubMed) and five reviews (Fu, Gera, Gray, 
Hardefeldt, Mouly) reported using only keywords in the search strategy (as 
opposed to a combination of keyword and subject heading or index terms). 
Three reviews (Allam, Hardefeldt, and Zani) did not report a funding source and 
five (Brody, Gera, Hardefeldt, Mouly, and Zani) did not provide a declaration of 
conflicts of interest (COI).  
 
6.5.4 Quality of included systematic reviews 
Assessed against the AMSTAR-2 tool, the quality of the included systematic 
reviews was low (Leng, Takkouche) or critically low (the 13 other reviews). 
Rating overall confidence according to the number of critical flaws and other 
weaknesses, none of the reviews could be rated as high or moderate quality 
according to the AMSTAR-2 guidance, as both of these ratings require no critical 
flaws (a full ‘yes’ to each of 5 criteria for narrative reviews and 7 criteria for 
meta-analyses). No reviews mentioned a protocol, which is a critical flaw and 
immediately drops the overall confidence rating to ‘low’. Any additional critical 
flaw drops the overall confidence rating to ‘critically low’. Of the 13 reviews in 
this category, 10 reviews did not provide a list of excluded studies with 
justifications, 8 did not assess risk of bias, and 3 did not meet the quality 
criteria for literature searching. The overall AMSTAR-2 appraisal results for each 
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Table 6.3. Overall quality assessment of included s ystematic reviews on 
endocrine-disrupting chemicals and risk of breast c ancer 
 
Study Overall confidence Domains in which study shows critical 
flaws 
Allam 2016 Critically low Protocol, list of excluded studies, risk of 
bias assessment, publication bias 
assessment 
 
Brody 2007 Critically low Protocol, comprehensive search, list of 
excluded studies 
 
Fu 2017 Critically low Protocol, list of excluded studies 
 
Gera 2018 Critically low Protocol, risk of bias assessment 
 
Gray 2017 Critically low Protocol, list of excluded studies, risk of 
bias assessment 
 
Hardefeldt 2013 Critically low Protocol, comprehensive search, list of 
excluded studies, risk of bias assessment, 
appropriate meta-analysis, publication 
bias assessment 
 
Ingber 2013 Critically low Protocol, risk of bias assessment 
 
Khanjani 2007 Critically low Protocol, risk of bias assessment 
 
Leng 2016 Low Protocol 
 
Mouly 2016 Critically low Protocol, list of excluded studies 
 
Park 2014 Critically low Protocol, list of excluded studies, risk of 
bias assessment 
 
Rodgers 2018 Critically low Protocol, comprehensive search, list of 
excluded studies 
 
Takkouche 2005 Low Protocol 
 
Zani 2013 Critically low Protocol, comprehensive search, list of 
excluded studies, risk of bias assessment, 
publication bias assessment 
 




6.5.5 Overview of synthesis 
Data were extracted from included reviews as described in the protocol. Studies 
were grouped by synthesis type (narrative or meta-analysis) and then by the 
EDCs investigated. The narrative reviews took a broad approach to EDCs 
compared to the meta-analyses, each of which had a narrower focus, included 
more studies, and reported more specific conclusions regarding risks associated 
with the chemical(s) under review. Table 6.4 provides an overview of the 
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synthesis, including a summary of the evidence base presented in each review 
and extracts that summarise the review’s conclusions. 
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Brody 2007 152 epidemiological studies assessing a wide 
range of chemicals (not exclusively EDCs), 
including 5 studies in which exposure to OCPs 
was defined by proximity to treated crops, 1 
industrial accident (Seveso), 1 industrial 
contamination (Chapaevsk), 3 cohorts of herbicide 
workers exposed to TCDD contamination, and 1 
study of perchloroethylene-contaminated drinking 
water  
“The strength of evidence…supports an association 
between PCBs…and breast cancer risk in the 10% 
to 15% of women who carry certain genetic 
variants.” 
“Lack of evidence for an association between OCPs 
and breast cancer may be due to a true lack of 
association or to shared methodological weakness 
across a large number of studies.” 
“The evidence regarding dioxin and breast cancer is 
thus far inconclusive.” (p. 2706) 
Gray 2017 “Hundreds” of studies assessing a wide range of 
environmental exposures (not exclusively EDCs; 
studies not tabulated). Description of included 
studies was inconsistent but included the Seveso 
industrial accident cohort and two studies of a 
cohort of German factory workers exposed to high 
levels of TCDD (dioxin). 
“The growing literature on developmental exposures 
to EDCs and later development of breast cancer is 
especially strong.” 
“the breadth and strength of the evidence cited in 
this review, when taken as a whole, reinforce the 
conclusion that exposures to a wide variety of 
toxicants – many of which are found in common, 
everyday products and byproducts – can lead to 




151 epidemiological studies (published 2006-
2016) and 7 meta-analyses assessing a wide 
range of chemicals (update of Brody 2007), 
including continuing follow-up of Seveso and 
German factory cohorts. Several studies 
assessed exposure through geographic location 
(e.g. residence in a contaminated area, proximity 
to a factory), which may constitute natural 
experiments 
“New epidemiological studies add to evidence that 
EDCs and chemicals that are mammary carcinogens 
in animal models influence the risk of breast cancer.” 
(p. 175) 
“A precautionary approach is especially important 
because study methods are limited, short of a 50-
year study, to evaluate the life-long risks to humans 
from these chemicals” (p. 176) 
POPs excluding 
DDT 
Mouly 2016 14 case-control studies on PCBs, OCPs, PBDE, 
or perfluorinated compounds and 1 cohort on 
dioxin (Seveso) 
“Epidemiological studies published in the last 10 
years could neither prove nor rule out the 
association between breast cancer risk and 








Evidence base, including natural experiments Risk of breast cancer associated with exposure 








21 case-control studies investigating 10 different 
chemicals. No natural experiments (based on 
description of study recruitment methods) 
 
"Our meta-analysis did not show a significant 
association between any cyclodiene chemical and 
breast cancer except heptachlor, but that was based 
on only two studies" [ratio of geometric means 5.32 




      
Ingber 2013 37 case-control studies 
No description of study context or exposure 
mechanisms 
OR 1.04 (95% CI:0.94 to 1.15) 
I2 31.72, p=0.02, possibly due to inconsistent 
adjustment for confounding across studies 
"The results of our meta-analysis do not support an 
association between DDT and DDE exposure and 
the risk of breast cancer." 
 
Park 2014 37 case-control studies (11 nested, 15 hospital-
based, 11 population-based). No natural 
experiments (based on description of study design 
and recruitment) 
OR 1.03 (95% CI:0.95 to 1.12) 
I2 40.9, p=0.006, possibly due to confounding or 
effect modifiers 
"our meta-analysis found no evidence that there is 
an association between exposure to DDE and the 
risk of breast cancer" 
 
PCBs Leng 2016 16 case-control studies (5 nested). No natural 
experiments (based on description of study 
recruitment methods) 
The congener-specific meta-analysis found 
increased risk of breast cancer associated with three 
of the nine PCB congeners evaluated in two or more 
studies (eight congeners were only evaluated in 
single studies). Increased risk was associated with 
PCB 99 (OR: 1.36; 95% CI: 1.02 to 1.80), PCB 183 
(OR: 1.56; 95% CI: 1.25 to 1.95) and PCB 187 (OR: 
1.18; 95% CI: 1.01 to 1.39). 
Zani 2013 14 case-control and 9 cohort studies (12 and 6 in 
pooled analysis). One possible natural experiment 
(one study conducted in an area contaminated by 
PCB manufacturing) 
OR 1.15 (95% CI:0.92 to 1.43) 
I2 70.6%, p=0.000 
"The summary ORs …do not suggest a significant 
association of PCBs with breast cancer, although a 








Evidence base, including natural experiments Risk of breast cancer associated with exposure 
modest effect cannot be entirely excluded. 
…Overall, epidemiological research yields no 
evidence for an association between PCB exposure 
and breast cancer" (pp. 133-134) 
Zhang 2015 25 case-control studies (9 nested). No natural 
experiments (based on narrative synthesis) 
OR 1.09 (95% CI:0.97 to 1.22) 
I2 55.4%, p=0.000 
Breast cancer risk is associated with groups II and III 
PCBs but not group I or total PCB exposure (p. 11) 
Deodorant Allam 2016 2 case-control studies 
No natural experiments 
OR 0.40 (95% CI:0.35 to 0.46) 
Heterogeneity not assessed 
Antiperspirant use "could be a protective 





2 case-control studies 
No natural experiments 
OR 0.80 (95% CI:0.50 to 1.28) (different in figure, 
which includes 3 studies) 
Heterogeneity not assessed 
"We found no evidence from the combined published 
studies that deodorant promotes development of 
breast cancer” 
Hair dye Gera 2018 8 studies 
No natural experiments 
OR 1.1465 (95% CI:0.9962 to 1.3194) (random 
effect model, not weighted) 
I2=73.89 (reasons not explored) 
"the personal use of hair dyes may be associated 
with an increased risk of breast cancer. …Our 
findings do not represent evidence for the presence 
of a cause-effect relationship." 
Takkouche 
2005 
12 case-control and 2 cohort studies 
No natural experiments 
OR 1.06 (95% CI:0.95 to 1.18) (random effects) 
Q test <0.001, Ri 0.68 (moderate to large 
heterogeneity, disappears if Jordanian study 
excluded) 
"we did not find strong evidence of a marked 
increase in the risk of cancer among personal hair 
dye users" 
 








Evidence base, including natural experiments Risk of breast cancer associated with exposure 
Phthalates Fu 2017 3 case-control and 1 cohort study 
No natural experiments 
OR 0.96 (95% CI:0.80 to 1.14) 
I2=53.30%, p=0.001 (NS when Mexican study 
excluded) 
No significant association overall between urinary 
phthalate metabolites and risk of breast cancer 
(subgroup analyses associated risk or protective 
effect with specific metabolites) 
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This meta-review presents a substantial body of evidence from 15 systematic 
reviews to address the question of whether EDCs are associated with increased 
risk of breast cancer. All of the meta-analyses that considered total exposure to 
groups of related chemicals or consumer products did not find statistically 
significant increased risk associated with that group. However, some meta-
analyses that examined specific chemicals in subgroup analyses did find 
statistically significant increased risks associated with specific phthalate 
metabolites or types of PCBs. Also, two of the narrative reviews concluded that 
the strength of evidence was generally in favour of increased risk and two found 
that the evidence was inconclusive. The following section describes these 
findings in more detail by group of chemical or consumer product. 
 
6.5.6 Evidence from systematic reviews on endocrine  disrupting 
compounds (EDCs) and risk of breast cancer 
This section answers review question 1, what is the evidence from systematic 
reviews that endocrine disrupting compounds (EDCs) cause breast cancer in 
humans? 
6.5.6.1 Pesticides 
Three meta-analyses (Ingber, Park, and Khanjani) identified a total of 43 case-
control studies on pesticide exposure and breast cancer, with no one meta-
analysis including all the studies (see analysis of overlap, section 6.5.7). 
Although the pooled odds ratios were all slightly above 1, the confidence 
intervals all included 1 (no statistically significant difference in risk of breast 
cancer). Heterogeneity was statistically significant, which Ingber et al. and Park 
et al. both attributed to confounding. All three meta-analyses concluded that 
the evidence did not support an association between DDT exposure and breast 
cancer, a view shared by Mouly et al. after reviewing 14 of the DDT case-control 
studies in a broader narrative review on POPs. 
6.5.6.2 PCBs 
Three other meta-analyses (Leng, Zani, and Zheng) identified a total of 30 case-
control studies on PCB exposure and breast cancer, with no one meta-analysis 
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including all the studies (see analysis of overlap, section 6.5.7). In these 
reviews, the analysis of PCBs was undertaken in one or more of three different 
ways: total PCB exposure, exposure by PCB group (I, II, or III), or exposure by 
specific PCB congener. The conclusions about PCBs and breast cancer risk differ 
according to the type of analysis undertaken, with small, statistically significant 
increased risks associated with some groups and congeners, but not others. Zani 
and Zheng assessed total PCB exposure. The pooled odds ratios were 1.15 and 
1.09 respectively, but the confidence intervals included 1 (no statistically 
significant effect) and heterogeneity was high.  
6.5.6.3 Consumer products 
Five meta-analyses investigated exposure to various consumer product chemicals 
and did not find statistically significant increases in breast cancer risk. Two 
meta-analyses (Allam and Hardefeldt) pooled odds from the same two case-
control studies of deodorant use, yet arrived at different results, with Allam 
reporting pooled OR of 0.40 (95% CI 0.35 to 0.46) and Hardefeldt reporting 0.80 
(95% CI 0.50 to 1.28). Examining original study reports is outwith the scope of 
this overview, but in the absence of evidence to support the biological 
plausibility of a protective effect, Hardefeldt is more likely to be correct. In any 
event, both reviews concluded that there was no evidence of an association 
between deodorant use and increased risk of breast cancer. 
Other consumer product chemicals assessed by the included reviews were hair 
dyes and phthalates. Takkouche and Gera conducted meta-analyses of hair dye 
use 13 years apart. Both found slightly increased odds of breast cancer in their 
pooled analyses but these did not reach statistical significance and showed high 
heterogeneity. Finally, Fu et al. identified one cohort and three case-control 
studies that assessed urinary phthalate metabolites and breast cancer risk. 
Although an increased risk or a protective effect were seen with specific 
metabolites, for total phthalate exposure there was no statistically significant 
effect and the point estimate suggested a protective effect. 
Overall, the 11 included meta-analyses found little or no evidence of increased 
breast cancer risk associated with exposure to the EDCs studied except for some 
PCBs. However, the four narrative reviews were less willing to reject the null 
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hypothesis. Brody, Gray, and Rodgers all tended in their narrative synthesis to 
emphasise or cite studies that reported increased risks; Gray and Rodgers both 
stated in their conclusions that EDCs increase the risk of breast cancer, while 
Brody and Mouly were equivocal (see table 6.4 for quoted extracts).  
In comparing the findings of all 15 included reviews, it is important to note some 
sources of heterogeneity in this overview. The findings of the narrative reviews 
by Brody, Gray, and Rodgers are not strictly comparable to the other 12 reviews 
because, despite the stated inclusion criteria, these authors also integrated 
findings from selected in vitro and animal studies in what appears to be an ad 
hoc manner and incorporated these into their narrative of the body of evidence 
in humans. As the examination of overlap will show, these reviews were not as 
comprehensive as the meta-analyses of DDT or PCBs, missing a considerable 
number of relevant studies. Additionally, Brody, Gray, and Mouly were less 
systematic in their data extraction and in the organisation and presentation of 
their synthesis compared to Rodgers and to the better-quality meta-analyses. 
Finally, the type of synthesis method combined with the difference in scope 
appears to have created a fundamental divide between the included reviews, 
with none of the meta-analyses concluding that risk was increased except in 
subgroup analyses of specific congeners or metabolites. 
6.5.7 Analysis of overlap 
Because of the differences in scope of the various included reviews, an analysis 
of overlap across all 15 reviews would be neither feasible (because of the 
included number of reviews and cited studies) nor informative (as there is no 
reason to expect overlap between reviews that focus on mutually exclusive 
subgroups of EDCs). Two of the meta-analyses had nearly identical review 
questions and inclusion criteria (Ingber 2013 and Park 2014); therefore, these 
two reviews were selected to form the basis of an analysis of overlap relating to 
included studies on DDT/DDE exposure, including for comparison purposes two of 
the narrative reviews that also examined this exposure (Gray 2017 and Rodgers 
2018). (Venn diagrams are usually limited to two or three sets and become very 
complex to draw when more than four sets are involved.) The overlap is 
depicted in figure 6.2. 
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Figure 6.2. Overlap of primary studies included in systematic reviews of 
DDT/DDE exposure and risk of breast cancer 
 
The visualisation of overlap is informative about the comprehensiveness of each 
review and about the overall evidence base on DDT/DDE and breast cancer. The 
Ingber and Park meta-analyses identified the largest proportion of the available 
evidence; both included 37 studies in their respective meta-analyses, yet 
overlap in these two similar meta-analyses, published within a few months of 
one another, was not 100%. In fact, the two meta-analyses have 27 included 
studies in common. Park additionally identified four unique studies which do not 
appear in any of the other three reviews and Ingber identified three unique 
studies. Date of publication also contributes to a lack of overlap, with the two 
later reviews by Gray and Rodgers contributing a total of ten additional studies 
to the evidence base (one study unique to Gray and nine unique to Rodgers). In 
some cases a lack of overlap should be recognised to be caused by differences in 
(or deviation from) inclusion criteria, with Gray citing four animal or in vitro 
studies, and all the reviews except Park citing some studies that do not provide 
a risk difference as an outcome. Overall, in a cited evidence base of 58 studies 
in human populations and four animal or laboratory studies, only a single case-
control study was cited by all four reviews. It is also striking that all four reviews 
contributed unique and relevant studies to the evidence base. 
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Overlap was also investigated among reviews that synthesised evidence on 
phthalates, hair dyes, and PCBs. Fu et al. (2017) included four case-control 
studies on phthalates, two of which were included in the Rodgers review. Gera 
et al. (2018) included eight studies in their meta-analysis of hair dyes, of which 
six were published early enough to potentially be included in Takkouche et al. 
(2005). Five of those six studies were included, but Takkouche identified an 
additional 9 case-control studies that Gera et al. appear to have missed or 
excluded. In the narrative reviews that discussed hair dyes, Gray et al. (2017) 
only cite one study (also cited by Gera et al.), and Rodgers cites two, one of 
which is unique to Rodgers. Finally, comparing the three meta-analyses on PCBs 
(Zhang, Zani, and Leng), Zhang includes 25 studies, which encompass all studies 
from Zani plus two Chinese-language studies, one of which is a thesis. Leng 
includes 16 studies, 11 of which are included in Zhang. Of the five studies not 
included in Zhang, one is listed in Zhang’s exclusion table as meeting their 
exclusion criterion of <50 cases and four are unique to Leng.  
Because Leng provided a supplement which lists the excluded studies and 
reasons for exclusion, it is possible to investigate reasons for the gaps in overlap. 
Of the 14 studies included in Zhang but not in Leng, nine were excluded by Leng 
because the analysis was of total PCB exposure and not congener-specific, and 
two were excluded because the genetic polymorphism analysed was not within 
scope. The two Chinese-language studies included by Zhang would have been 
missed due to the English-language restriction in the Leng review. One study 
that is missing from Leng but present in Zhang (Ward 2000) is indexed in 
PubMed, is in English, and discusses PCB congeners in the abstract, so 
presumably represents an error in either the literature search or the study 
screening process. 
6.5.8 Natural experiments in the evidence base on E DCs and 
breast cancer  
This section answers review question 2, what is the contribution of natural 
experiments to the evidence base on the causal role of EDCs in breast cancer? 
and review question 3, how have systematic reviews evaluated and presented 
evidence from different study designs, including natural experiments, in 
reaching their conclusions about EDCs? 
Chapter 6 Page 153 
 
Based on 15 systematic reviews, the contribution of natural experiments to the 
evidence base on EDCs as a cause of breast cancer is very limited, if not non-
existent. None of the reviews specifically identified or described any of the 
included studies on EDCs as natural experiments. As described in table 6.4, the 
11 meta-analyses draw entirely on cohort and case-control designs and offer 
limited information about the included studies, with the exception of Zani et al. 
2013, which provided a detailed narrative synthesis as well as meta-analysis 
(discussed further below). The only distinction among study designs with 
reference to causal inference was the distinction made in some, but not all, 
reviews between nested (within a prospective cohort study) and retrospective 
case-control designs. Generally the meta-analyses described their results 
conservatively as providing evidence of association, not causation. 
The reviews that used narrative synthesis offered more detailed information 
about study characteristics and thereby furnished more examples of studies 
based on exposures that could potentially be analysed as natural experiments. 
All four narrative reviews described cohort studies based on an industrial 
accident in Seveso, Italy in 1976, in which a chemical plant explosion exposed 
people to dioxin (TCDD). Rodgers et al. (2018) note that the Seveso Women’s 
Health Study is “of particular interest” (p. 156) because it involves exposure to 
one specific substance rather than a mixture and uses an unexposed group for 
comparison. The most recent findings from this study reported in Rodgers et al. 
show no statistically significant increase in breast cancer risk in the exposed 
group, but follow-up of this cohort continues and women exposed earliest in life 
are only now entering their fifth decade. Other industrial accidents or exposures 
mentioned in the narrative reviews include dioxin contamination from a 
chemical plant in Chapaevsk, Russia (Revich 2001, cited in Brody et al. 2007) and 
perchloroethylene exposure in Cape Cod, USA caused by a fault in drinking water 
distribution pipes (Aschengrau 2003, cited in Brody et al. 2007).  
As described in chapter 2, geographical locations may be used to identify natural 
experiments, whether by using distance from a relevant location as an 
instrument or by using geographic boundaries or other features to reliably 
differentiate exposed and unexposed groups. The narrative synthesis of Zani 
2013 described one case-control study that was conducted in Slovakia (Pavuk 
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2004) in an area contaminated by PCB manufacturing and another in Mexico City 
where PCB-containing equipment was identified (Lopez-Carillo 2002), which 
could constitute natural experiments depending on how selection and exposure 
were assessed (information not provided by the review). The reviews by Brody et 
al. (2007) and Rodgers et al. (2018) identify a dozen studies in which exposure 
has been assessed by geographic location, such as residence at a hazardous 
waste site or inside an industrial park where chemicals are manufactured. 
However, without reference to the original articles (which is outside the scope 
of this meta-review), the description of these studies is not detailed enough to 
determine whether these are natural experiments or ecological studies.  
One final observation illustrates how some relevant natural experiments could 
be missed by reviews focusing on risk of breast cancer as the outcome. One 
meta-analysis that addresses PCBs and all cancers in humans mentions two 
situations that could constitute natural experiments. The Yusho incident in 
Japan (1968) and Yucheng incident in Taiwan (1979) involved mass poisonings 
caused by rice oil accidentally contaminated by PCBs and polychlorinated 
dibenzofurans (Zani et al. 2013). Follow up of exposed cohorts found statistically 
significant increased risks of liver, stomach, lymphatic, and lung cancers, but 
the review does not report any findings from these cohorts on breast cancer risk. 
If such cohorts are followed up for all cancers, but no increased risk of breast 
cancer is identified, this could be an important source of negative findings which 
may have been missed out from syntheses that focus on reports of breast cancer 
risk only. 
6.5.9 Identification of limitations and gaps within  the evidence 
base 
This section answers review question 5, What have systematic reviews identified 
as the limitations and gaps relating to natural experiments within the evidence 
base on EDCs and breast cancer in humans? 
None of the 15 included reviews comments specifically on limitations or gaps 
relating to natural experiments, but the reviews do offer some observations 
about the evidence base and recommendations for future research that are 
relevant to this question. It is noteworthy that none of the reviews recognised a 
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need for natural experimental studies; the closest such comments might be 
Brody’s suggestion that further research on OCPs “should be a priority only when 
researchers have access to novel data that resolves earlier methodological 
problems” (p. 2706) and Rodgers’ recommendation that “more appropriate 
comparison groups are needed to avoid confounding by differences in baseline 
risk” (p. 175). By contrast, four reviews stated that large prospective cohort 
studies were required (Allam, Gera, Gray, and Rodgers) and three called for 
larger and/or more studies without specifying a design (Fu, Hardefeldt, Leng). 
More specific gaps identified in the reviews include the need for studies to 
address interactions between chemicals and interactions with genetic 
polymorphisms (Khanjani, Leng, Mouly, Rodgers). Two reviews noted a lack of 
evidence examining risk by breast cancer type or hormone receptor status 
(Brody, Leng). Finally, a gap was noted in the ability to assess dose-response 
effects from the evidence base (Leng). 
The reviews were more forthcoming on the limitations of the included primary 
studies. The possibility of confounding was raised in most of the reviews; authors 
noted inconsistency and limitations across primary studies in adjusting for 
confounders, including known risk factors for breast cancer, as well as cancer-
related weight loss (which can change the concentration of chemicals and 
metabolites in the body). Further limitations noted in the evidence base related 
to exposure assessment methods (Brody, Gray, Mouly, Zhang), including 
insufficient information on age at exposure or differentiation between early- and 
later-life exposures (Mouly, Park), misclassification due to changes in biological 
concentrations over time and lag time for cancer development (Zani), the 
possibility of recall bias in retrospective studies, and varying definitions of 
exposure categories across studies (Ingber). 
6.5.10 Map of evidence 
The map of evidence (Figure 6.3) offers a visual summary of the availability and 
quality of systematic reviews and meta-analyses on the topic area. Note that the 
map does not represent effect size or direction. Where this information was 
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Each dot represents a systematic review dedicated to the topic. A larger dot represents a review dedicated to the topic; a smaller dot indicates that a subsection of one 
or more broader reviews addresses the topic. The quality of the systematic review is represented by the shading of the dot. No reviews were assessed as high quality 
so reviews have been categorised as either moderate quality (black dot; one critical flaw according to AMSTAR-2 criteria, namely lack of a reported protocol) or low 
quality (white dot; more than one critical flaw as per AMSTAR-2).  
The strength of evidence within the systematic reviews has been categorised as ‘strong’ if (a) it includes evidence based on prospective follow-up (including nested 
case-control studies) and (b) the review authors assessed the quality of included studies. The strength of evidence is categorised as ‘inconclusive’ if the authors 
provide insufficient information about the design and quality of included studies, do not reach any clear conclusion about the body of evidence, or specifically state in 
their review that the evidence is inconclusive. The strength of evidence is categorised as ‘weak’ if (a) the review is based solely on retrospective, cross-sectional, or 
animal/laboratory evidence or (b) the included studies were assessed by the review authors as poor quality overall. 
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The map of evidence shows that existing systematic reviews address all of the 
categories of EDCs covered in this overview (the excluded categories of 
pharmaceuticals and polyaromatic hydrocarbons were additionally addressed 
within the broad narrative reviews). However, nearly all of this systematic 
review evidence is either inconclusive or weak. The strongest evidence comes 
from two reviews of PCBs, one of phthalates, and one of hair dyes. Despite a 
substantial body of primary studies on DDT, the strength of evidence is 
inconclusive because the systematic reviews did not provide sufficient 
information about the design or quality of included studies. Evidence from 
systematic reviews is lacking on breast cancer risk associated with bisphenol A, 
PFASs, and flame retardants such as PBDE used in household products. 
6.6 Discussion 
This meta-review identified 15 systematic reviews that assemble evidence on 
EDCs and risk of breast cancer and found that natural experiments contribute 
little, if anything, to the body of evidence. The quality of the reviews was low or 
very low, as the appraisals with the AMSTAR-2 tool found that all reviews had 
one or more critical flaws. The reviews were largely confined to cohort and 
case-control studies and focused on more on precision, i.e. quantification of 
risk, than on causality. Due to the poor quality of the reviews and a lack of 
information in many reviews regarding the design and quality of included 
studies, the evidence is largely inconclusive.  
The chapter contributes to the literature the first meta-review on the subject of 
EDCs and breast cancer. This chapter shows that the potential for natural 
experiments to improve understanding of environmental causes of disease will 
be hindered if systematic reviews do not include such studies or fail to integrate 
them into syntheses along with more traditional epidemiological study designs. 
This section discusses the implications of the findings for understanding the 
environmental causes of breast cancer, for the identification and uptake of 
natural experiments, and for public health research, practice, and policy. The 
strengths and limitations of the meta-review are then considered.  
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6.6.1 Interpretation and discussion of evidence on EDCs and 
breast cancer 
The findings of the meta-review are congruent with the change in the IARC 
status of PCBs from probable to known human carcinogen (Lauby-Secretan et al., 
2013) and with ongoing concerns about the toxicity of phthalates (Benjamin et 
al, 2017). From a public health and a consumer perspective, it is reassuring that 
there is little evidence of an association between hair dye or deodorant use and 
increased risk of breast cancer. Furthermore, the reviews did not identify 
statistically significant increased risks of breast cancer associated with exposure 
to DDT, dioxin, or cyclodiene pesticides other than heptachlor, which has been 
banned in many countries (World Health Organization, 2003). However, for many 
EDCs systematic review evidence is lacking or inconclusive. It is surprising and 
somewhat disappointing, given the amount of attention devoted to EDCs and the 
emphasis on related potential health risks, that most reviews were of low quality 
and unable to support greater certainty. 
Although the narrative reviews at least touched on all EDCs of interest, not all 
EDCs were comprehensively addressed by the included reviews. With reference 
to the EDC-2 classification of common EDCs (Gore et al., 2015), the risks of 
breast cancer associated with exposure to atrazine, bisphenols, OCPs (other than 
DDT), PFOA, and the fungicide vinclozolin were not the subject of 
comprehensive systematic reviews or meta-analyses. Additionally, this meta-
review did not encompass polyaromatic hydrocarbons or endocrine active 
pharmaceuticals; all of these types of EDCs may warrant further attention and 
systematic reviews of studies in humans. 
In synthesising the evidence and pooling risk estimates, none of the included 
reviews differentiated between pre- and post-menopausal breast cancer or 
between hormone receptor positive and negative breast cancers. If EDCs have 
different places on the causal pathway to different types of breast cancer, 
which seems plausible, then the reviews and meta-analyses might have 
restricted their ability to detect this by treating all breast cancers as a single 
disease. Similarly, as pointed out by Leng et al. (2016) and demonstrated in the 
phthalate review by Fu et al. (2017), genetic polymorphisms are important 
modulators on the pathway from environmental exposure to carcinogenesis. It 
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will be valuable to have more studies that incorporate genetic polymorphisms 
along with reliable, time-specific assessments of exposure in order to better 
understand the environmental causes of breast cancer. 
6.6.2 The contribution of natural experiments to ev idence-based 
public health 
As randomised trials are unlikely to be feasible or ethical on the environmental 
causes of diseases, including cancer, natural experiments should represent an 
important and valuable source of evidence in this subject area (Academy of 
Medical Sciences and Rutter, 2007). Yet across 15 systematic reviews of a 
relatively prominent public health topic with a substantial evidence base, 
natural experiments did not feature as a source of knowledge. The presentation 
of evidence in the reviews did not distinguish study designs according to their 
ability to address selection and confounding and provided limited information on 
how exposure and comparison groups were identified, or how and why exposure 
was thought to differ between groups. Indeed, many natural experimental 
designs were implicitly excluded from the reviews in the first place when the 
inclusion criteria specified cohort and case-control studies. These observations 
suggest that the traditional hierarchy of evidence, which neither assigns a place 
to natural experiments nor specifically recognises their value, continues to 
shape systematic reviews in public health. 
It could be argued that the absence of natural experiments in these reviews 
accurately reflects an inability to conduct research on this topic with such 
designs – that it is not feasible to identify and analyse natural experiments on 
EDCs. However, some studies could be tentatively identified as potential natural 
experiments from reviews like Rodgers et al. (2018) that described studies in 
which exposure was determined by geographic location. Rodgers et al. 
additionally discussed the possibility of identifying natural experiments where 
changes in regulations create “distinctive exposure scenarios” (p. 172). Such 
situations may have already occurred, for example, in changes to Canadian 
regulations regarding bisphenol A (Government of Canada, 2008). The reviews 
also identified several episodes of industrial contamination which could 
potentially be analysed as natural experiments. Unfortunately, such episodes 
also continue to occur, such as the 2011 phthalate incident in Taiwan, in which 
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food and drink products were contaminated with phthalates by the 
manufacturers as an unsafe substitute for emulsifiers (Li et al., 2015, Mitoma et 
al., 2015). 
Even if natural experiments on EDCs and breast cancer were to be identified and 
analysed, however, they would still face certain challenges given the gaps and 
limitations identified in this meta-review. Assessing the timing and dose of 
exposure relative to an individual’s development, accurately measuring that 
exposure in a contemporaneous manner, understanding interactions between 
and among various chemicals and genetic polymorphisms, all pose challenges for 
researchers, particularly given the ubiquity of EDCs in the environment and their 
persistence over time.  
6.6.3 Implications for research, practice, and poli cy 
The applicability of this meta-review to public health practice and policy is in 
some ways limited because of the low quality of the included reviews and the 
inconclusive nature of much of the evidence. However, a few points relating to 
research and to public health advice relating to breast cancer risk may be in 
order. 
First, the quality assessment of the included reviews serves as a reminder to 
researchers of the importance of adhering to the PRISMA statement when 
conducting and reporting systematic reviews. In particular, reviews need to be 
based on pre-defined protocols, which ideally would be prospectively registered 
and publicly available, and the review needs to make explicit reference to this 
protocol. Providing a list of excluded studies with reasons for exclusion not only 
is good practice, but is also informative when the review and its findings are 
compared with other reviews and differences in overlap require explanation. 
Quality assessment of included studies is crucial and not only should such 
assessments be conducted, but the results reported and incorporated into the 
synthesis. In these respects, the findings of this meta-review are supported by a 
scoping review of the impact of the PRISMA Statement, which found that 
protocol registration and risk of bias assessment were the poorest performing 
areas of adherence, with just over 20% of a sample of 2,382 systematic reviews 
published between 2010 and 2016 based on a registered protocol (Page and 
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Moher, 2017). Systematic reviews are intended in part to reduce research waste, 
but arguably a poor-quality systematic review only increases it. 
Second, the lack of contribution of natural experiments to this evidence base 
has implications for systematic reviewers, primary researchers, and funders. This 
meta-review suggests that the Academy of Medical Sciences advice on 
recognising the value of natural experiments to identify the environmental 
causes of disease, issued more than ten years ago, may not yet have had an 
optimal impact. The Academy’s advice to researchers to consider “the relative 
merits and limitations of different research designs” and “whenever possible, 
use natural experiments” (p. 13) needs to be taken into account, not only by 
those conducting primary studies, but also by systematic reviewers. Limiting the 
inclusion criteria of reviews on environmental causes of disease to cohort and 
case-control studies unnecessarily excludes the potentially valuable evidence 
that natural experiments can provide. However, in order to make use of that 
evidence, reviewers and information scientists will need to become familiar with 
natural experimental study designs and related terminology; literature search 
strategies will need to be expanded and search filters amended; quality 
assessment tools (for both systematic reviews and primary studies) will need to 
consider the design characteristics of natural experimental studies; and 
synthesis methods, including assessments of strength of evidence, will need to 
be developed further. 
Finally, even given the caveat that the reviews had serious limitations, the 
evidence to support assertions that EDC exposure increases risk of breast cancer 
is less compelling than might be expected given the amount of attention 
directed towards EDCs by some stakeholders; the position of Cancer Research 
UK, i.e. that the evidence is poor and inconsistent, is upheld. Although reducing 
the burden of environmental chemicals is desirable on the precautionary 
principle as well as from an ecological standpoint, and considerable uncertainty 
about EDCs persists, based on the findings of this meta-review attention to EDCs 
as a potential cause of cancer should not detract from a strong focus in public 
health advice and policy on established, modifiable risk factors for breast 
cancer, namely body weight, physical activity, breastfeeding, and alcohol 
consumption (Tamimi et al., 2016; Tamimi, Hankinson, and Lagiou, 2018). 
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6.6.4 Strengths and limitations of this overview 
This meta-review was based on a protocol that was prospectively registered in 
PROSPERO and is publicly available. The PRISMA statement has been followed as 
closely as possible, with explicit reporting of comprehensive search strategies, 
inclusion criteria, excluded studies, and quality assessment of included studies 
by two independent reviewers. The meta-review is somewhat innovative in its 
presentation of overlap and its map of evidence, providing new examples of 
application of emerging methods. The main methodological limitation of this 
meta-review is that study screening and selection was performed by a single 
reviewer. It is also possible that, by focusing the search on breast cancer, 
relevant reviews of all cancers which did not mention breast cancer in the title 
or abstract were missed. This is likely to be particularly true of reviews of all 
cancers that had positive findings for other cancers and negative findings for 
breast cancer. However, the initial retrieval of the search was 4745 records for 
breast cancer alone; screening records for all cancers would probably not have 
been feasible. A final limitation is that, as determined at the protocol stage, 
primary studies cited in the included reviews were not retrieved and re-
analysed. Doing so might have provided useful information and increased 
detection of natural experiments, but was not feasible within the scope of this 
thesis. 
6.7 Chapter summary 
This chapter has shown that, despite the putative importance of natural 
experiments in elucidating environmental causes of disease, such studies do not 
feature in a sample of systematic reviews on a prominent public health topic, 
and indeed, if they do exist, were either obscured or missed due to limitations in 
the reviews and conformity to the established hierarchy of epidemiological 
evidence. Thus, the chapter supports an argument that there is scope to improve 
the inclusion and presentation of evidence from natural experiments in public 
health reviews. The evidence for EDCs as a cause of breast cancer is largely 
inconclusive, but opportunities to strengthen the evidence base and analyse 
natural experiments may exist by making use of industrial accidents and 
geographic information about exposures. In the meantime, prevention efforts 
should continue to focus on known modifiable risk factors. 
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7 Discussion 
7.1 Chapter overview 
This thesis has reported the results of three systematic reviews which provide 
illustrations of the contribution of natural experiments to answering questions of 
relevance to public health practice and policy, and examples of how to 
incorporate natural experimental studies in systematic reviews. The purpose of 
this chapter is to bring together findings from the three reviews in light of the 
overall research question and aims of the thesis. First, I consider whether the 
findings support the assertion that incorporating natural experiments into 
systematic reviews can provide better evidence to support public health decision 
making. Second, I consider what changes would need to take place in order for 
the potential of natural experiments to be more fully realised in public health 
and what barriers and facilitators exist in relation to these changes. Finally, I 
discuss the implications of the findings for the conduct and reporting of natural 
experiments, the conduct of systematic reviews in public health, and for public 
health knowledge translation as practised by guideline developers and GRADE.  
7.2 Summary of findings 
7.2.1 Systematic review of regression discontinuity  studies 
The systematic review of RD studies (chapter 3) contributes the most 
comprehensive review on the subject to date. This review searched 32 health 
and social science databases and identified 181 RD studies that investigated the 
effects of interventions or exposures on health outcomes, more than five times 
the number of the only other review of RD which used the same inclusion 
criteria but limited its search to one health database (Moscoe, Bor, and 
Barnighausen, 2015). The topics covered spanned a broad range of areas of 
social policy and public health intervention, including air quality, tobacco and 
alcohol control, early years, health systems, nutrition, and road safety, as well 
as clinical medicine and epidemiology, showing the wide applicability of RD and 
natural experimental studies and designs to public health research questions. 
The analysis of forcing variables and cut-off rules used in the studies provides 
information that can inform the design of future policy evaluation and help in 
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the identification of new natural experiments to be analysed. The quality 
assessment of the studies suggested that overall the design, conduct, and 
reporting of RD studies can be improved by including a narrative explanation of 
the implementation of the assignment rule, reporting density and falsification 
tests, reporting attrition, and pre-specifying a primary outcome.  
The strengths of the RD systematic review include following a registered review 
protocol, conducting an extensive search, double-screening and double-appraisal 
of a 10% sample of studies, detailed quality assessment of included studies, and 
reporting according to PRISMA guidelines. The review could have been improved 
by having all search results, data extraction, and critical appraisal conducted by 
a second reviewer for all studies rather than a sample, but this was not feasible 
within the resource limitations of a PhD project. The last date searched was 
March 2015 and ideally the search could be updated. However, given the number 
of studies already identified and the fact that the review was not a synthesis of 
effect estimates, an update search would be unlikely to change the conclusions 
of the review. 
7.2.2 Systematic review of minimum legal drinking a ge studies 
The systematic review of RD studies on MLDA (chapter 4) contributes a new 
assessment of the effectiveness of this alcohol control intervention and a 
demonstration of the application of systematic review methods to evidence from 
natural experiments. Because individuals cannot choose their age or manipulate 
the legislated threshold, the RD design makes it possible to identify a causal 
effect of MLDA legislation by comparing outcomes for those just above and 
below the threshold. The support for causal inference means that this review, 
which is the first systematic synthesis of RD studies on MLDA, can be argued to 
present the best available evidence on MLDA and support the assertion that 
natural experiments can provide useful evidence (in terms of causal inference, 
external validity, and policy relevance) for decision makers. 
The included MLDA studies (n=17) presented several problems for synthesis, 
resulting in lessons learned that can inform future systematic reviews and 
thereby help to realise the potential for natural experimental studies to be 
usefully incorporated into evidence syntheses. Poor and inconsistent reporting of 
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data would make author contact a likely necessity for conducting meta-analyses, 
which would require additional resources. These studies report multiple model 
estimates and sensitivity analyses and generally do not involve a pre-specified 
model selection method or primary outcome, meaning that selecting an estimate 
for synthesis is potentially open to bias. The modified effect direction plot was 
developed in response to this problem and makes it possible to visualise a 
complex body of natural experimental evidence in one figure. The review 
concluded on this basis that mortality and hospital admissions probably increase 
at the MLDA, meaning that the legislation has a protective effect on those below 
the legal drinking age, but evidence on motor vehicle accidents and drug use is 
inconsistent. The quality of this evidence was moderate to high based on 
assessment against the WWC Standards for RD. 
The MLDA studies were identified within the larger systematic review of RD 
reported in chapter 3 and therefore benefit from the registration of a review 
protocol and the comprehensive search that was conducted. Additional strengths 
of the MLDA review include quality assessment by two reviewers and an update 
search (to June 2018) that identified two new studies, neither of which would 
change the conclusions of the review. Limitations of the MLDA review include 
data extraction that was performed by only one person, lack of time and 
resources to contact study authors for additional data that might have made 
meta-analysis possible for some outcomes, and an inability to assess publication 
bias due to the presentation of multiple model estimates within studies. 
7.2.3 Critical appraisal checklist for RD studies 
A further product of the RD systematic review was the development of a critical 
appraisal checklist for RD studies (chapter 5). Tools specific to natural 
experimental designs will need to be developed in order to incorporate such 
studies into evidence syntheses and ensure that the results of natural 
experiments can be evaluated and used to support decision-making. This chapter 
contributes one such tool which benefited from testing with three users and 
application to 181 studies. However, the checklist is at an early stage of 
development and requires further testing and refinement to ensure good 
interrater reliability. 
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7.2.4 Meta-review on endocrine-disrupting chemicals  and breast 
cancer 
The overview of systematic reviews on EDCs and breast cancer (chapter 6) 
contributes the first meta-review on this subject. Fifteen systematic reviews 
published between 2005-2018 were identified including eleven meta-analyses. 
Overall there was no statistically significant increase in the pooled relative risk 
of breast cancer associated with total exposure to any of the classes of EDCs 
examined, although there was a statistically significant increased risk for 
exposure to some congeners of PCBs and in some subgroup analyses for 
phthalates. The quality of the included reviews was low or critically low 
according to assessment with the AMSTAR-2 tool, chiefly owing to failure to 
report that the review was based on a protocol. A map of the evidence 
identified some strong evidence for PCBs, phthalates, and household or 
consumer products, but for all other EDCs covered in the reviews the evidence 
was inconclusive or weak. 
In terms of assessing the contribution of natural experiments to the evidence 
base on EDCs and breast cancer, the findings of the meta-review were negative. 
None of the reviews identified any included studies as natural experiments; ten 
of the 15 reviews limited the inclusion criteria to cohort and case-control or 
‘epidemiological’ studies. However, the narrative reviews provided some details 
suggestive of natural experiments in descriptions of the exposure mechanisms of 
some studies, which related to industrial accidents or geographical assessments 
of exposure. The decision not to retrieve and re-examine the primary studies 
included in the reviews was made at the protocol stage and was appropriate 
given the project scope and the large number of primary studies included in the 
reviews, but does constitute a limitation in the ability to identify the 
contribution of natural experiments, which was not foreseen at the protocol 
stage. 
Additional limitations of the meta-review include study selection and data 
extraction performed by a single reviewer. Furthermore, it is possible that 
negative findings were missed by limiting the inclusion criteria to reviews of 
breast cancer risk and excluding systematic reviews that examined ‘all’ cancers 
or health outcomes with no mention of breast cancer. However, the findings of 
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included reviews were almost entirely negative in terms of finding a statistically 
significant increased risk. The strengths of the meta-review include a registered 
protocol developed according to the PRISMA-P standard, a comprehensive search 
of six databases and grey literature, and quality assessment by two reviewers 
using a validated tool. 
7.3 Implications for conduct and reporting of natur al 
experiments 
The experience of extracting data for synthesis (chapter 4) and the results of the 
quality assessment (chapter 5) both support the conclusion that reporting of RD 
studies needs improvement in order to allow systematic reviewers and other 
users to assess whether design assumptions and quality criteria have been met 
and to ensure that study results are understood and correctly interpreted. Clear 
reporting of how the threshold rule was implemented is essential in order to 
show that the RD design was valid, that treatment allocation was free of 
selection bias, and that the treatment effect unconfounded. Reports of RD 
studies should also include evidence from appropriate tests of the underlying 
design assumptions, namely density and falsification tests. The latter should 
include tests for spurious discontinuities at the cut-off for outcomes that ought 
not to be affected by the intervention (such as hospital admissions for 
appendicitis at the MLDA) and at values of the forcing variable other than the 
cut-off (such as age 23 for an MLDA of 21). 
The thesis supports the need for improved reporting of RD studies, but as similar 
findings have been reported for IV (Davies et al., 2013) and ITS (Ramsay et al., 
2003), and most if not all analyses of natural experiments depend upon some 
underlying assumptions and some kind of modelling, it seems reasonable to 
conclude that reporting quality is an issue that deserves consideration across 
natural experimental designs. The MRC guidance on natural experiments also 
noted the importance of transparent reporting and the need to follow guidelines 
such as TREND or STROBE. Although many STROBE checklist items are generic 
and applicable to any non-randomised study, others are specific to cohort, case-
control, or cross-sectional studies. Extensions of STROBE have been prepared to 
address specific areas such as nutritional epidemiology, genetic association 
studies, and studies based on routinely collected healthcare data (vol Elm et al., 
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2007, Lachat et al., 2016, Little et al., 2009, Benchimol et al., 2015). An 
extension of STROBE for natural experimental studies might provide an effective 
tool to promote better reporting, incorporating criteria already identified in the 
MRC guidance and elsewhere (Craig et al., 2012, Craig et al., 2017, Lee and 
Lemieux, Dunning). 
Development of reporting standards for natural experiments could be beneficial 
in raising awareness of these designs and disseminating knowledge about good 
practice in study design, conduct, and reporting. However, evidence as to 
whether the publication of reporting standards actually has a positive effect on 
reporting quality is mixed (Page and Moher, 2017). In order to increase the 
likelihood that the effort put into producing such standards resulted in the 
desired improvement in reporting, any such standards should be accompanied by 
dissemination and impact plans and interventions to increase adherence. Ideally, 
the effectiveness of the standards could be evaluated in a prospective controlled 
study. 
7.4 Implications for systematic reviews 
Given the potential demonstrated in the thesis for RD studies and, by extension, 
natural experimental studies, to provide relevant and useful evidence for public 
health, it seems reasonable to conclude that some revision to systematic review 
methods and development of related tools should be considered in order to 
ensure that such studies are identified and incorporated into public health 
reviews. The examples of the application of systematic review methods in this 
thesis, as well as the findings of the meta-review, support several suggestions of 
changes to methods used by Cochrane, HTA and guideline development 
organisations that conduct systematic reviews to inform health system decisions, 
and GRADE. These changes relate to inclusion criteria, literature searching, risk 
of bias assessment, data extraction, and methods for synthesising these studies; 
they also need to be considered during protocol development as well as during 
the execution of the review. 
In terms of the capacity of systematic reviews to enable the uptake of natural 
experimental studies as evidence, this thesis has demonstrated limitations 
within a sample of systematic reviews in terms of their ability to identify or 
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describe in detail the context and findings from these study types. Reviews on 
questions amenable to investigation through natural experiments, such as those 
addressing environmental causes of disease or evaluation of population-level 
interventions and policies, should not be limited to cohort and case-control 
studies and need to search a range of social science as well as health databases. 
However, the chapters on RD and MLDA also demonstrate the utility of 
systematic review methodology in demonstrating how natural experimental 
designs can be applied to a wide variety of public health research questions, 
although some adaptation may be required for critical appraisal, data 
extraction, and synthesis. A comprehensive systematic review in public health 
should be designed at the protocol stage to consider the potential relevance of 
natural experiments to the research question and specify inclusion and exclusion 
criteria, search strategies, quality assessment, and synthesis plans accordingly. 
7.5 Implications for knowledge translation 
The findings of the thesis that are relevant for systematic review methods by 
extension have implications for developers of evidence-based guidelines, which 
use or adapt such methods. Guidelines are an important knowledge translation 
product through which evidence may inform public health practice, health 
service organisation, and health policy. Evidence-based guideline development is 
guided by methodologies which vary in their prescriptiveness. A methods manual 
such as NICE PMG20 is sufficiently flexible to support the incorporation of 
natural experimental studies as evidence (National Institute for Health and Care 
Excellence, 2015); however, anecdotal evidence from colleagues at NICE 
suggests that a lack of familiarity with natural experimental designs is a barrier 
to their inclusion. Other guideline development processes may take a more 
restrictive approach to evidence which may inadvertently prevent the uptake of 
natural experimental studies. For example, the SIGN 50 handbook (Scottish 
Intercollegiate Guidelines Network, 2015) describes the use of design-specific 
search filters and appraisal methods that might act as a barrier to including 
natural experimental designs such as RD, DiD, IV, or synthetic controls, for which 
such tools are lacking.  
The examples of RD evidence identified in this thesis may be of use in 
developing GRADE guideline methods for application in public health. The GRADE 
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approach has been developed to promote transparency in guideline methodology 
and reduce unnecessary variation in methods. Several studies have reported 
challenges in developing public health guidelines using GRADE (Akl et al., 2012, 
Alexander et al., 2016, Rehfuess and Akl, 2013), with the treatment of non-
randomised studies and the strength of recommendations frequently cited as a 
source of concern. Natural experimental studies may provide examples of high 
certainty (without upgrading) in non-randomised evidence that are currently 
lacking in the GRADE literature (Schünemann et al., 2018) and thereby 
demonstrate another way in which strong recommendations can be supported in 
evidence-based public health guidelines. 
7.6 Implications for evidence-based public health 
The implications identified above (sections 7.3 to 7.5) for the reporting, 
synthesis, and translation of evidence suggest action is needed to support better 
reporting of natural experiments, to ensure that they are included in public 
health systematic reviews, and to promote their translation into public health 
policy. The underlying assumption of benefit from these outcomes is that better 
research evidence and syntheses will support the implementation of 
interventions and policy that will in turn result in better health for the public. 
This assumption is simplistic and needs to be tempered by knowledge of the 
barriers and facilitators to evidence-informed policy making (Armstrong et al., 
2014; Ellen et al., 2014) and by the recognition that research is only one, not 
necessarily privileged, source of information and ideas that influence policy 
decisions (Smith, 2013). However, there are further benefits to be realised from 
making these changes to the tools and methods of evidence-based public health 
that go beyond the production of better evidence and syntheses to support 
decision-making.  
These benefits include breaking down disciplinary silos and increasing the 
development of novel and interdisciplinary approaches to public health 
problems, which Hanlon et al. (2012) argue is necessary in order to meet future 
public health challenges. An additional benefit is an increased potential for 
research to be designed and funded to investigate interventions and approaches 
not amenable to randomisation, particularly with regard to investigations of 
equity and transferability across contexts (Waters, 2009), so that actions on 
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populations, social determinants and health inequalities are not less likely than 
actions on a sample of individuals to be supported by strong recommendations.  
Consider, for example, the WHO Guidelines on Integrated Care for Older People 
(World Health Organization, 2017), categorised by the WHO as a guideline for 
health systems. The challenges of providing integrated care for older people 
from a systems perspective include co-ordination of health and social service 
provision, integrated access to medical and social care records, provision of 
welfare benefits and insurance coverage, ensuring safe transitions between 
home and care settings, and significant funding challenges for the health 
system. Evidence to inform approaches to these challenges could well be 
provided by natural experimental studies. Yet the WHO guideline’s 13 
recommendations all relate to interventions delivered to individuals and largely 
evaluated with RCTs: multimodal exercise, oral nutrition supplements, cognitive 
stimulation, and fall prevention. Given that interventions aimed at individuals 
may not produce as great an effect on population health as a population 
approach (Rose 1981, Rose 2001), the conduct, funding, and dissemination of 
natural experimental studies could help to ensure that systems- and population-
level interventions receive better evaluations and more recognition in evidence-
based public health guidelines, with resulting benefits for population health. 
Even though the hierarchy of evidence has been repeatedly challenged and 
revisions proposed, its influence can still be seen in evidence synthesis 
methodologies including Cochrane and GRADE. This influence is seen in ongoing 
debates as to whether and how to include NRS and RS in the same review, the 
approach taken in the ROBINS-I NRS critical appraisal tool of using an imaginary 
randomised trial as a starting point for assessment, and the GRADE approach to 
strength of evidence in which randomised trials start as high quality and NRS 
start as low. It may be timely to ask whether randomisation as a surrogate for 
‘strength of evidence’ should be re-examined and to articulate what it is that 
randomised designs achieve in terms of causal inference, and under what 
assumptions (Deaton and Cartwright, 2018; Gelman, 2018; Cook, 2018).  
In the first instance one could suggest that elements such as unconfoundedness, 
absence of selection effects, and testing and rejection of alternative hypotheses 
should have a more prominent role in judging the certainty or strength of 
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evidence to inform decision-making. Additionally, the potential exists for a 
combined approach to risk of bias assessment of RS and NRS if randomisation is 
‘unpacked’ and assessment focuses on these elements and whether design 
assumptions have been met. A further consideration relates to how evidence-
based or evidence-informed approaches can more meaningfully and usefully 
synthesise the broad range of sources of evidence that are relevant to decision-
making. Ultimately the aim of such developments would be to help achieve the 
goal towards which this thesis has also been directed: the inclusion of a wider 
range of study designs that will enable the production of systematic reviews of 
greater trustworthiness, relevance, and utility to decision making, which in turn 
support actions of greater benefit to the public health.  
7.7 Recommendations for research and methodological  
development 
This thesis concludes by translating the findings (summarised in section 7.2) and 
their implications (sections 7.3 to 7.6) into a set of recommendations. These 
recommendations address three areas of public health research and practice: (1) 
further research relating to RD and other natural experimental study designs, (2) 
additional systematic reviews and related methods research, (3) actions 
guideline developers and others involved in public health knowledge translation 
may take to ensure uptake of natural experimental studies. 
7.7.1 Recommendations for further research: RD and other 
natural experimental study designs 
• Investigation of differences in design, assumptions, and estimates 
between date-based RD and ITS in order to guide the choice of design for 
analysis of natural experiments in which exposure or treatment allocation 
has a time element. 
• Development and dissemination of reporting standards for RD specifically 
and natural experimental studies generally, with prospective evaluation 
of the impact of the standards. 
• Classification of sources of risk of bias in natural experimental study 
designs, with a view to considering whether design assumptions and 
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statistical assumptions should also be part of the assessment of study 
quality. 
• Quantification of risk of bias in natural experimental study designs in 
order to support the development of critical appraisal tools and reporting 
standards with empirical evidence. 
• Replication of RD studies in different contexts using different data 
sources, applying the findings relating to common types of forcing 
variables and cut-off rules to aid in identifying new natural experiments. 
7.7.2 Recommendations for further research: systema tic reviews 
and related methods 
• Methods-based systematic reviews of the application and reporting 
practice of natural experimental designs in addition to RD (such as ITS and 
DiD) in public health in order to assess their quality and identify 
challenges and solutions in synthesising such evidence. 
• Topic-based systematic reviews of common natural experiment scenarios 
(such as natural disasters and legislative changes) in public health in order 
to identify best practices in design and reporting as well as opportunities 
for further replication. 
• Comparison of findings from studies that use different methods to 
evaluate the same natural experiment (either within or across studies), in 
order to determine any association between method and effect estimate 
and to inform which estimates should be extracted for synthesis in 
systematic reviews. For example, how findings differ if a similar research 
question is investigated using difference-in-differences, RD, and ITS 
analyses. 
• Development and user testing of critical appraisal and data extraction 
tools for natural experimental studies. 
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• Development and user testing of the effect direction plot and other novel 
visualisation methods to represent studies which report a range of 
estimates for each outcome. 
• Investigation and development of guidance on translation of outcomes 
from econometric studies into common metrics to aid quantitative 
synthesis. 
• Development of guidance on incorporating natural experimental studies in 
systematic reviews. 
7.7.3 Recommendations for guideline developers  
• Ensure that methodologists and other technical staff have sufficient 
training for their role to identify, appraise, and synthesise results from 
natural experimental studies. 
• Consider providing more detailed methodological guidance and examples 
to facilitate the incorporation of natural experimental studies into 
literature searches, summary of findings tables, and evidence synthesis. 
• Inform and participate in the development of new critical appraisal 
checklists and other evidence synthesis tools to ensure their usability and 
subsequent uptake. 
• Incorporate considerations of causal inference when applying GRADE to 
questions that use nonrandomised evidence, allowing panel members to 
articulate how the evidence base supports causal inference and 
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Evaluation of public health interventions using regression discontinuity 
designs: a systematic review 
Michele Hilton Boon, Peter Craig, Laurence Moore, Hilary Thomson 
Citation 
Michele Hilton Boon, Peter Craig, Laurence Moore, Hilary Thomson. Evaluation of 
public health interventions using regression discontinuity designs: a systematic 




1. How and in what areas of research have regression discontinuity designs been 
applied to evaluate the health impacts of public health interventions and policy? 
2. What is the quality of reporting in studies using regression discontinuity 
designs to evaluate health-related outcomes? 
Searches 
Language: all languages will be included. 
Dates: since 1960 (date of first publication describing regression discontinuity 
methods). 
Search strategy: 
Relevant studies will be identified using the search term “regression 
discontinuity” (title, abstract, keyword) and any equivalent subject index terms. 
Regression discontinuity designs are more commonly used in social sciences 
(particularly economics, education, and political science) than in health 
research; accordingly, the search strategy will include databases from these 
fields in addition to health databases. 
The databases to be searched are: ASSIA, Business Source Premier, CINAHL, 
Cochrane Library, EBSCO Professional Development Collection, EconLit, EMBASE, 
ERIC, EThOS (British Library Electronic Theses Online Service), Google Scholar, 
IDOX, International Bibliography of the Social Sciences, King’s Fund Publications, 
MEDLINE (PubMed), MEDLINE In Process, NICE Evidence Search, NTIS, Open Grey, 
POPLINE, ProQuest Dissertations and Theses Database, PsycINFO, RePeC, Scopus, 
Social Care Online, Social Services Abstracts, SocINDEX, Sociological Abstracts, 
TRIP, US Environmental Protection Agency document repository, Web of Science, 
WHO Institutional Repository, World Bank Documents & Reports. 
Types of study to be included 
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Included studies must use a regression discontinuity design. Included studies may 
also use additional designs, such as difference-in-difference. 
Condition or domain being studied 
All public health policy areas, including but not limited to: air quality, alcohol 
and substance misuse, early years interventions, food policy, nutrition and 
obesity, maternal and infant health, mental health promotion and suicide 
prevention, health service organisation and delivery, housing, transportation, 
tobacco, sexual health, screening, vaccination programmes. 
Participants/population 
Any populations whose eligibility for a public health intervention or programme 
is determined by a cut-off value of a continuous variable, making evaluation of 
the programme suitable for a regression discontinuity design. 
Intervention(s), exposure(s) 
Any public health intervention, programme, or policy involving treatment 
assignment based on a cut-off rule, including but not limited to: age (such as 
minimum legal drinking age or vaccination schedule), income (such as early 
years or housing improvement programmes), time (such as imposition of a 
legislative ban), a clinical score or biological variable (such as birthweight). 
Comparator(s)/control 
Non-exposed control group (below cut-off value of forcing variable). 
Context 
The regression discontinuity (RD) design was first proposed by Thistlethwaite and 
Campbell (1960) based on the intuition that, given an eligibility rule based on a 
cut-off value for a continuous variable whose value cannot be precisely 
manipulated by participants or administrators, treatment assignment will be 
effectively random within a certain bandwidth on either side of the cut-off and 
therefore, differences in an outcome affected by the treatment can be 
estimated as the difference between groups just above and just below the cut-
off, without any bias due to unobservables. 
Moscoe, Bor, and Barnighausen (2015) argue that RD is likely to be useful in 
health research because the use of cut-off rules for treatment assignment is 
common. Their review identified 32 studies from medicine, epidemiology, or 
public health that used an RD design; however, their search was restricted to a 
single database (PubMed). 
We aim to conduct a systematic review that draws on a variety of disciplines and 
sources to determine how RD designs have been used to analyse the health 
effects of natural experiments in the wide range of policy areas relevant to 
public health. 
Primary outcome(s) 




2. Forcing variables, cut-off values, bandwidth, and analytical methods used. 
Secondary outcome(s) 
Assessment of study quality. 
Data extraction (selection and coding) 
One author will perform an initial screen of titles and abstracts, remove 
duplicates, and exclude studies that clearly do not meet eligibility criteria. A 
second author will screen a random sample of studies (10%) to verify that 
eligibility criteria have been consistently and correctly applied. Two authors will 
independently review the full text of the remaining papers and determine 
eligibility. EndNote (version X7) will be used to record reasons for exclusion. 
Disagreement will be resolved by discussion and consensus or, when this is not 
achieved, by having a third author review the paper for eligibility. Where 
insufficient information is provided in the paper to make a decision about 
eligibility or to complete data extraction, one attempt to contact the study 
authors will be made. 
Information will be extracted from each included study relating to: citation 
details (author, date, country); the population under investigation; the 
intervention, event, or change under investigation; the control or comparison 
group; the forcing variable and cut-off used; the health outcome(s) reported; 
the statistical methods used; the main findings; and study quality/risk of bias. 
Risk of bias (quality) assessment 
Two authors will independently assess the quality of each included study using 
the Standards for Regression Discontinuity Designs produced by the What Works 
Clearinghouse. Disagreements will be resolved by discussion and consensus or, 
when this is not achieved, by having a third author complete an additional 
assessment. Results will be presented in tabular and graphical formats to 
provide an overview of study quality. 
Strategy for data synthesis 
This review is designed to integrate studies that address a wide variety of 
research questions from different disciplines and policy areas. Accordingly, 
synthesis methods will be developed iteratively from an initial configurative 
mapping of the literature and tabulation of study characteristics. Extracted data 
will be presented in tables to describe RD design elements, estimates of effect, 
and study quality. Results will be presented by type of intervention and by policy 
area in order to enable readers to identify applications of RD in areas most 
relevant to their research interests. Graphs of the number of studies by year and 
by discipline will enable identification of trends in the use of RD. As the review 
is not designed to identify studies that answer a particular research question, no 
meta-analysis is planned. If, however, several studies do happen to answer 
similar questions, forest plots will be used to demonstrate how estimates of 
effect sizes and directions of effect differ across studies. 
Analysis of subgroups or subsets 
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More detailed analysis of subsets of studies will be conducted if multiple studies 
are identified that evaluate the same intervention or that investigate 
sufficiently similar policy questions. 
Contact details for further information 
Michele Hilton Boon 
m.boon@sphsu.mrc.ac.uk 
Organisational affiliation of the review 
MRC/CSO Social and Public Health Sciences Unit, University of Glasgow 
http://www.sphsu.mrc.ac.uk/ 
Review team members and their organisational affiliations 
Ms Michele Hilton Boon. MRC/CSO Social and Public Health Sciences Unit, 
University of Glasgow 
Dr Peter Craig. MRC/CSO Social and Public Health Sciences Unit, University of 
Glasgow 
Professor Laurence Moore. MRC/CSO Social and Public Health Sciences Unit, 
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Appendix 2. Characteristics of regression discontin uity studies of health outcomes 
 
Table A1.1. Regression discontinuity applications in the evaluation of population-level interventions, by public health policy area. 
Study Context Forcing variable Intervention Outcome(s) 
Air quality (5 studies) 
Chay, K. Y. and M. 
Greenstone. (2003) 





Clean Air Act 
Amendments (1970) 
Infant mortality 
Neidell, M. (2010) USA ozone forecast 
threshold rule for 
issuing smog alerts 
Smog alerts Outdoor activities 
(attendance at 
outdoor venues) 
Noonan, D. S. 
(2014) 
USA Ozone forecast 
level 
Air quality alerts Amount and 
intensity of outdoor 
activity; driving 
Sanders, N. J. and 
C. Stoecker (2015) 





Clean Air Act 
Amendments (1970) 
sex ratio of live 
births as estimate of 
averted fetal losses 





Clean Air Act 
Amendments (1970) 
Infant mortality 
Alcohol and substance abuse (18 studies) 
Boes, S. and S. 
Stillman (2013) 






Study Context Forcing variable Intervention Outcome(s) 
drinking age 
(MLDA) 
Callaghan, R. C., J. 
M. Gatley, M. 
Sanches and M. 
Asbridge (2014) 
American Journal of 
Preventive Medicine 
Canada Age MLDA motor vehicle 
collisions 
Callaghan, R. C., M. 
Sanches and J. M. 
Gatley (2013). 
Addiction 
Canada Age MLDA alcohol-related 
hospital events 
Callaghan, R. C., M. 
Sanches, J. M. 
Gatley and J. K. 
Cunningham (2013) 
Canada Age MLDA alcohol-related 
hospital events 
Callaghan, R. C., M. 
Sanches, J. M. 
Gatley and T. 
Stockwell (2014) 
Drug and Alcohol 
Dependence 
Canada Age MLDA Mortality - all 
causes, external 
causes, MVA 
Carpenter, C. and 
C. Dobkin (2009) 




Carpenter, C. and 
C. Dobkin (2011) 




Study Context Forcing variable Intervention Outcome(s) 
Carpenter, C., 
Dobkin, C. and C. 
Warman (2014) 








Carpenter, C. and 
C. Dobkin (2015) 
USA Age MLDA ED visits and 
inpatient 
hospitalisations 
Conover, E. and D. 
Scrimgeour (2013) 
New Zealand age and date Decrease in MLDA alcohol-related 
hospital admissions 
Crost, B. and S. 
Guerrero (2012) 
USA Age MLDA alcohol 
consumption 
Crost, B. and D. I. 
Rees (2013) 
USA Age MLDA marijuana 
consumption 




Ertan Yoruk, C. and 
B. K. Yoruk (2015) 
USA Age MLDA Risky sexual 
behaviour 
Ertan Yörük, C. and 
B. K. Yörük (2012) 
USA Age MLDA Psychological 
wellbeing 
Lindo, J. M., P. 
Siminski and O. 
Yerokhin (2014) 
Australia Age MLDA MVAs, 
hospitalizations, 
drinking behaviour 
Yörük, B. K. and C. 
E. Yörük (2011) 






Study Context Forcing variable Intervention Outcome(s) 
Yu, B. and D. T. 
Kaffine (2011) 








traffic accidents and 
traffic citations 
Disease prevention and screening (5 studies) 
Kadiyala, S. and E. 
Strumpf (2011) 
USA Age guideline 
recommendations 
regarding age for 
asymptomatic 
screening 




Kadiyala, S. and E. 
C. Strumpf (2011) 
USA and Canada age guideline 
recommendations 
regarding age for 
asymptomatic 
screening 
tests for breast, 
colorectal, and 
prostate cancers 
Rashad, H. (1992) Egypt Year of programme 
implementation 




Smith, L. M., J. S. 
Kaufman, E. C. 
Strumpf and L. E. 
Levesque (2015) 
Canada Quarter of birth HPV vaccination Composite indicator 
of sexual behaviour 
Ziegelhöfer, Z. 
(2012) 










in children under 5 
years 
Early years (9 studies) 
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Study Context Forcing variable Intervention Outcome(s) 
Carneiro, P. and R. 
Ginja (2014) 
USA Family income 
(programme 
eligibility cutoff) 
Head Start  Health measures 
from CNLSY 








Gayer, T., Phillips, 
D. & Dawson, B. 
(2005) 




as measured by 
three subtests of 
Woodcock-Johnson 
Achievement test) 
Lipsey, M. W., D. C. 
Farran, C. Bilbrey, 
et al. (2011) 







Ludwig, J. and D. L. 
Miller (2007) 
USA County poverty rate Head Start mortality rate 








visits and childcare 
centres) for poor 
families) 





Santos, R. G. 
(2006) 
























Study Context Forcing variable Intervention Outcome(s) 
development 
outcomes 
Wong, V.C., Cook, 
T.D., Barnett, W.S. 
& Jung, K. (2008) 








Healthcare organisations and systems (10 studies) 
Almond, D. and J. J. 
Doyle Jr (2011) 
USA Time of birth 
(minutes from 
midnight) 






Coudin, E., A. Pla 
and A.-L. Samson 
(2014) 
France Year (that GP 
commenced 
practice) 
Reform of GP billing 
regulations 
GP care provision, 
fees, prescribing 
behaviour 
Daysal, N. M., M. 
Trandafir and R. 
Van Ewijk (2013) 






7- and 28-day 
mortality, Apgar 
score 
Del Bono, E., M. 
Francesconi and N. 
G. Best (2011) 
UK date health warning 
issued 
UK Committee on 
Safety of Medicines 
health warning re 
combined oral 
contraceptives and 




abortions, and live 
births; neonatal 
health outcomes 
("quality of birth") 
Glance, L. G., T. M. 
Osler, D. B. 
Mukamel, J. W. 
Meredith and A. W. 
Dick (2014) 







Study Context Forcing variable Intervention Outcome(s) 
Koch, S. F. (2013) South Africa Age Policy change in 












Sojourner, A. J., R. 
J. Town, D. C. 
Grabowski and M. 
M. Chen (2012) 




Care quality (based 
on state inspection 
data) 
Williams, S. V. 
(1990) 
USA Year cost-monitoring 
letters to physicians 
from insurer 
mean of total billed 
charges per year 
Zuckerman, I. H., E. 
Lee, A. K. Wutoh, Z. 
Xue and B. Stuart 
(2006) 




review letter to 
prescribers 
Change in monthly 
SAB inhaler 
prescriptions 
Nutrition and obesity (6 studies) 
Capacci, S., M. 
Mazzocchi and B. 
Shankar (2012) 
France Age Vending machine 
ban 
Calorie and nutrient 
intakes reported in 
national nutritional 
surveys (7-day food 
diary)  
Meller, M. and S. 
Litschig (2014) 









Olsho, L. E. W., J. 
A. Klerman, L. 
USA proportion of 
students eligible for 






Study Context Forcing variable Intervention Outcome(s) 
Ritchie, P. 
Wakimoto, K. L. 






Fruit and Vegetable 
Program 
Peckham, J. G. and 
J. D. Kropp (2012) 













Road safety (3 studies) 
Burger, N. E., D. T. 
Kaffine and B. Yu 
(2014) 
USA Time (date of ban) Legislative ban on 
handheld cell phone 
use while driving 
Number of daily 
traffic accidents 
De Paola, M., V. 
Scoppa and M. 
Falcone (2013) 
Italy Date legislation 
introduced 
Penalty points 











Tobacco (5 studies) 
Pieroni, L., M. 
Chiavarini, L. Minelli 
and L. Salmasi 
(2013) 
Italy Year of smoking 
ban 




Pieroni, L. and L. 
Salmasi (2015) 
Italy Year of smoking 
ban 
Indoor smoking ban BMI 
Waller, B. J., J. E. 
Cohen, R. Ferrence, 
S. Bull and E. M. 
Adlaf (2003) 





smoked per day 
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Study Context Forcing variable Intervention Outcome(s) 







Yoruk, C. E. and B. 
K. Yoruk (2014) 





Table A1.2. Regression discontinuity applications in medical and nursing interventions (excluding psychiatry) 
Study Context Forcing variable Intervention Outcome(s) 
Almond, D., J. J. 
Doyle, Jr., A. E. 
Kowalski and H. 
Williams (2010) 
USA Birthweight (VLBW 
threshold of 1500g) 




Bharadwaj, P., K. V. 
Løken and C. 
Neilson (2012) 
Norway and Chile Very low birthweight 
and date surfactant 
therapy introduced 
Extra medical 





Bor, J., E. Moscoe, 
P. Mutevedzi, M. L. 
Newell and T. 
Barnighausen 
(2014) 
South Africa CD4 count ART for HIV mortality hazard 
DISMEVAL 
Consortium (2012) 
Spain CV risk score Nurse-led structured 
telephone interview 
on CVD risk and 
prevention 
Cholesterol, BP, 
BMI, CV risk score 
Garrouste, C., J. Le 
and E. Maurin 
(2011) 






Jensen, V. M. and 
M. Wust (2015) 
Denmark Date (of information 
shock in form of 
Caesarean section 
for breech births 










Sloan, F. A. and B. 
W. Hanrahan (2014) 
USA Year Introduction of 
photodynamic 
therapy and anti-
VEGF therapies for 
ARMD 




term care facility 
Zhao, M., Y. Konishi 
and P. Glewwe 
(2013) 




Dietary intake (fat, 
protein, 
carbohydrates, 




Table A1.3. Regression discontinuity applications in psychology and psychiatry 
Study Context Forcing variable Intervention or 
Exposure 
Outcome(s) 
Høglend et al. 
(1993) 
Norway Score based on 




within brief dynamic 
psychotherapy 





USA trauma score 
(PTSD Reaction 
Index) 
trauma-specific CBT 6-month change in 
trauma score 
Daniels, V., M. 
Somers, J. Orford 
and B. Kirby (1992) 
UK Exeter Alcohol 
Scale (pre-
intervention) 
Advice and self-help 








Study Context Forcing variable Intervention or 
Exposure 
Outcome(s) 
Devitt, T. S. (2006) USA Date (of policy 
change) 
Rescinding zero-
tolerance policy for 
onsite substance 








Elder, T. E. (2010) USA Birthdate (relative to 
state kindergarten 
eligibility cutoff) 
School starting age ADHD symptoms, 
diagnosis and 
treatment 
Evans, M. E., S. M. 
Banks, S. Huz and 
T. L. McNulty (1994) 





Evans, W. N., M. S. 
Morrill and S. T. 
Parente (2010) 
USA Birthdate (relative to 
state kindergarten 
eligibility cutoff) 
School starting age ADHD diagnosis 
and treatment 
Flam-Zalcman, R., 
R. E. Mann, G. 
Stoduto, et al. 
(2013) 












McFarlane, W. R., 
B. Levin, L. Travis, 
et al. 








defined by positive 
symptoms 
Mezuk, B., G. L. 
Larkin, M. R. 
Prescott, et al. 
(2009) 
USA Date (11 
September2001) 
11 September 2001 
terrorist attacks 
monthly suicide rate 
per 100,000 in NYC 
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Study Context Forcing variable Intervention or 
Exposure 
Outcome(s) 
Pesko, M. F. (2014) USA Dates of terrorist 
attacks 
Terrorist attacks Stress, smoking 








Table A1.4. Regression discontinuity applications in the investigation of health outcomes of social policies in developed countries. 
These studies investigate the indirect health effects of policy interventions and programmes that were not specifically designed or intended 
to effect a change in the specified health outcome at the population level (see Table 3) or the individual level (see Tables 4 and 5). 
Study Context Forcing variable Intervention Outcome(s) 
Beuchert, L. V., M. 
K. Humlum and R. 
Vejlin (2014) 







Boheim, R. and T. 
Leoni (2014) 





Deductible of 30% 







and A. C. Gielen 
(2014) 
Netherlands Age (45, threshold 













Guertzgen, N. and 
K. Hank (2014) 
Germany Month (of child's 
birth relative to 
reform) 
Reform of maternity 
leave legislation 
Long-term sickness 
Johansson, P. and 
M. Palme (2005) 
Sweden Date of reform National sickness 
insurance 
Incidence and 
duration of work 
absences 
Lammers, M., H. 
Bloemen and S. 
Hochguertel (2013) 





Rieck, K. M. E. 
(2012) 




Snyder, S. E. and 
W. N. Evans (2006) 
USA Quarter of birth Lower income due 





Table A1.5. Regression discontinuity applications in the investigation of health outcomes of social policies in developing countries. 
These studies investigate the indirect health effects of policy  interventions and programmes that were not solely or primarily designed or 
intended to effect a change in the specified health outcome at the population level (see Table 3) or the individual level (see Tables 4 and 
5). 
Study Context Forcing variable Intervention Outcome(s) 
Alam, A. and J. E. 
Baez (2011) 

















rates of overweight 
and obesity 
Bor, J. (2013) South Africa Date of birth Extension of 
eligibility for Child 
Support Grant 
Time to first 
pregnancy from age 
14 (teenage 
pregnancy) 
Carneiro, P., E. 
Galasso and R. 
Ginja (2014) 










Ecuador Selben welfare 
index 





breastfeeding in first 
six months of life 
Chen, Y., A. 
Ebenstein, M. 
China latitude relative to 
Huai River 
boundary 
coal for winter 
heating 




Study Context Forcing variable Intervention Outcome(s) 
Greenstone and H. 
Li (2013) 








national boundaries children's height-for-
age, access to safe 
water 
Crost, B., J. Felter 
and P. Johnston 
(2014) 









Number of conflict 
casualties 
de Brauw, A. and A. 
Peterman (2011) 








birth at health 
facility 
Filmer, D. and N. 
Schady (2014) 






Gordon, D. and D. 
L. Miller. (2012) 















et al. (2008) 





Study Context Forcing variable Intervention Outcome(s) 
Medina, C., J. 
Nunez and J. A. 
Tamayo (2013) 






height, BMI, Apgar 
score 
Nabernegg 2012 Ecuador Selben welfare 
index 









McKernan, S. & 
Latif, M.A. (1999) 









Rahman, M. M. 
(2014) 








of young adults in 
household 
Sun, A. and Y. Zhao 
(2014) 






Sex ratio of second 
children following 






Tibone, K. L. (2013) Ethiopia Month and year of 
conception 







Study Context Forcing variable Intervention Outcome(s) 
Urquieta, J., G. 
Angeles and T. 
Mroz (2009) 























Table A1.6. Regression discontinuity applications in the evaluation of health insurance schemes in developed countries. 
Study Context Forcing variable Exposure Outcome(s) 
Palangkaraya, A. 
and J. Yong (2007) 
Australia Age Lifetime Health 
Cover scheme 
Private health insurance 
coverage 
Guthmuller, S. and 
J. Wittwer (2012) 






Number and probability 
of visits to 
GP/specialist/any doctor 
Hullegie, P.G.J. & 
Klein, T.J. 2010 




Doctor visits, nights in 
hospital, self-assessed 
health 




Tamiya and I. 
Kawachi (2012) 
Japan Age Reduced 
copayment for low-
income elderly 
Physical and mental 
health scales; out-of-
pocket medical spending 






Ai, E. C. Norton and 
Yang (2011) 
USA Age (eligibility for 
Medicare) 
health insurance Hospital admissions and 
costs 
Anderson, M. L., C. 
Dobkin and T. 
Gross (2014) 
USA Age (loss of 
parental insurance 
coverage at age 23) 
health insurance ED visits, inpatient 
admissions 
Anderson, M. L., C. 
Dobkin and T. 
Gross (2012) 
USA Age (loss of 
parental insurance 
coverage at age 19) 
health insurance ED visits, inpatient 
admissions 
Belenkiy, M. (2010) USA Age (loss of 
parental insurance 
coverage at 19) 




Study Context Forcing variable Exposure Outcome(s) 
Beuermann, D. W. 
(2010) 
USA Age (eligibilility for 
Medicare) 
health insurance Healthcare 
utilisation/access/service 
quality measures 
Burns, M. E., L. 
Dague, T. Deleire, 
M. Dorsch, D. 
Friedsam, L. J. 
Leininger, G. 
Palmucci, J. 
Schmelzer and K. 
Voskuil (2014) 











Card, D., C. Dobkin 
and N. Maestas 
(2009) 






Card, D., C. Dobkin 
and N. Maestas 
(2008) 






Card, D. and L. D. 
Shore-Sheppard 
(2004) 





Cardella, E. and B. 
Depew (2014) 
USA Age Health insurance Self-reported health 
Chay, Kim, 
Shailender (2010)  
USA Age Medicare Hospital utilisation, 
restricted activity, 
mortality 
Dague, L. (2014) USA Family income as % 
of Federal Poverty 
Level 




Study Context Forcing variable Exposure Outcome(s) 
De La Mata, D. 
(2012) 
USA Family income as % 
of Federal Poverty 
Level 
Medicaid uptake, crowdout, 
healthcare utilisation, 
health status, obesity, 
school sickness 
absence 
Decker, S. L. (2005) USA Age Medicare eligibility Access to 
mammography, stage of 
diagnosis, survival of 
breast cancer 
Dugan, J., S. S. 
Virani and V. Ho 
(2012) 
USA Age (65, eligibility 
for Medicare) 
Medicare Physician visits, access 
to care, supplementary 
insurance coverage 
Hu, T., S. L. Decker 
and S.-Y. Chou 
(2014) 
USA Age Medicare Part D 
(introduction of drug 
coverage) 
Quantity and type of 
drugs prescribed 
Koch, T. G. (2013) USA Family income as a 






utilization and spending 
Muhlestein, D. B. 
and E. E. Seiber 
(2013) 




Medicaid eligibility Crowdout of private 
insurance 
Nikolova, S. and S. 
Stearns (2014) 







Witman, A. (2015) USA Age Spousal Medicare 
eligibility 






Table A1.7. Regression discontinuity applications in the evaluation of health insurance schemes in developing countries. 
Study Context Forcing variable Exposure Outcome(s) 
Camacho, A. and E. 
Conover (2013) 





insurance for the 
poor 
Newborn health (LBW, 
VLBW, Apgar 5), 
prenatal care 
Miller, G., D. Pinto 
and M. Vera-
Hernández (2013) 
Colombia Simulated SISBEN 
index 
Subsidised Regime 
of health insurance 
for the poor 
Service use, health 
status, health 
behaviours 
Bauhoff, S., D. R. 








Program for the 
Poor (MIP) 
Healthcare utilisation, 
out of pocket 
expenditure, individual 
health status and 
behaviours 
Hou, X. and S. 
Chao (2008) 
Georgia Welfare score Medical Assistance 
Program for the 
poor 
Acute surgeries and 
inpatient care 
Sood, N., E. 
Bendavid, A. 
Mukherji, Z. 
Wagner, S. Nagpal 






care for households 




Bernal, N., M. A. 
Carpio and T. J. 
Klein (2014) 








Yang, T.-T., H.-W. 
Han and H.-M. Lien 
(2014) 







Palmer, M., S. Mitra, 
D. Mont and N. 
Groce (2014) 












Table A1.8. Regression discontinuity applications in epidemiological questions of cause and effect. 
These studies investigate the health effects of exposures that were not part of a social, clinical, or public health intervention, programme, or 
policy. 
Study Context Forcing variable Exposure Outcome(s) 
Bhalotra, S., I. 
Clots-Figueras, G. 
Cassan and L. Iyer 
(2014) 
India Vote margin in close 
elections 
Rise in share of 
elected officials who 
are Muslim 
Neonatal and infant 
mortality 
Conley, D. and J. 
Heerwig (2012) 
USA Lottery number 





Cullen, K. W., L. M. 
Koehly, C. 
Anderson, et al. 
(1999) 
USA years from age 18 Transition from high 
school 
diet, physical 
activity, tobacco and 
alcohol use, sexual 
behaviour 
Dell, M. (2010) Peru latitude and 
longitude 
the mita, a forced 
labour system in 
operation 1573-
1812 
stunted growth in 
children 
Dickert-Conlin, S. 
and T. Elder (2010) 
USA Date (state cutoff for 
school eligibility) 
Cutoff dates for 
starting school 
Share of annual 
births by calendar 
day 
Eibich, P. (2014) Germany Age Retirement Physical and mental 
health, smoking, 
alcohol, exercise, 
diet, sleep, social 
support, healthcare 
utilization 
Fé, E. and B. 
Hollingsworth 
(2012) 
UK Default retirement 
age 





Study Context Forcing variable Exposure Outcome(s) 
utilisation, BP, 
migraine 
Fletcher, J. M. 
(2014) 





Huang, W. and Y. 
Zhou (2013) 




Johnston, D. W. and 
W. S. Lee (2009) 
UK Age Retirement GHQ-12 mental 
health, BMI, 
hypertension 
Kong, A. (2011) Canada Age Retirement Self-reported 
physical and mental 
health 
Pierce, L., M. S. 
Dahl and J. Nielsen 
(2013) 

























Table A1.9. Regression discontinuity applications in the causal impact of education on health. 
These studies investigate the health effects of education programmes, exposure to education, and changes in educational policy. 
Study Context Forcing variable Exposure Outcome(s) 
Albouy, V. and L. 
Lequien (2009) 






rates at age 50 and 
80) 
Anderson, P. M., K. 
F. Butcher, E. U. 
Cascio and D. W. 
Schanzenbach 
(2011) 
USA Birthdate (cutoff for 
starting school) 
Years of early 
primary education 
BMI 
Arcand, J. L. and E. 
D. Wouabe (2010) 
Cameroon Number of 
secondary schools 








Banks, J. and F. 
Mazzonna (2012) 
UK Birthdate 1947 policy change 
in minimum school 
leaving age 




19, social and 
cultural activity 
index 
Behrman, J. A. 
(2015) 
Malawi and Uganda Birth cohort Universal Primary 
Education 
HIV status 
Clark, D. and H. 
Royer (2013) 
UK birthdate (month 
and year) 








USA Year College opening Births to teenage 
mothers 
Jakobsson, N., M. 
Persson and M. 
Svensson (2013) 




Study Context Forcing variable Exposure Outcome(s) 
Johnston, D. UK Date of birth Additional year of 
schooling 
Index of health 
knowledge 
Jurges, H., E. Kruk 
and S. Reinhold 
(2010) 





Lindeboom, M., A. 
Llena-Nozal and B. 
van der Klaauw 
(2009) 
UK Year of birth Additional year of 
schooling 










McCrary, J. and H. 
Royer (2011) 
USA Date of birth School starting age Fertility, birthweight 
and prematurity 
Monstad, K., C. 
Propper and K. G. 
Salvanes (2008) 
Norway Age relative to year 
of reform 
Reform that 
increased years of 
compulsory 
schooling 
Number of children 




UK Month and year of 
birth 





Park, W. (2013) South Korea Year of birth College education Smoking behaviour 
Powdthavee, N. 
(2010) 




and R. A. Parinduri 
(2015) 
Indonesia Year of birth Education (longer 






Study Context Forcing variable Exposure Outcome(s) 
Silles, M.A. (2009) UK Unclear (age or 
year) 
Years of schooling Self-reported health 
van Kippersluis, H., 
O. O'Donnell and E. 
van Doorslaer 
(2011) 
Netherlands Birthdate Years of 
compulsory 
schooling 
Mortality after age 
81 













Appendix 3. Detailed critical appraisal results for  chapter 4 
 
This appendix reports the detailed results for quality assessment of the 17 regression discontinuity studies of minimum legal drinking 
age legislation included in chapter 4 using the What Works Clearinghouse Standards for RD. Each study was appraised independently by 
two reviewers. The results shown below are the final consensus assessments agreed upon following discussion. 
 
The study ID is the first four letters of the first author’s name plus the year of publication and first page number (or WP for working 
paper). WWC 1, 2, and 3 are the qualifying questions. Columns labelled with numbers (1a, 1b, etc) refer to criteria and columns 
labelled with S refer to standards. Assessments were coded ‘1’ to mean the criteria or standard was met, ‘0’ to mean it was not met, 
and ‘MWR’ to mean ‘met with reservations’. ‘NA’ means not applicable. 
 
 
Study ID WWC1 WWC2 WWC3 1a 1b S2 3a 3b 
BOES_2013_WP 1 1 1 1 0 0 NA 1 
CALL_2014_788 a 1 1 1 1 0 0 NA 1 
CALL_2013_1590 a 1 1 1 1 0 0 NA 1 
CALL_2013_2284 b 1 1 1 1 0 0 NA 1 
CALL_2014_137 b 1 1 1 1 0 0 NA 0 
CARP_2009_164 1 1 1 1 0 0 1 0 
CARP_2011_133 1 1 1 1 0 0 NA 0 
CARP_2015_WP 1 1 1 1 0 0 NA 0 
CONO_2013_570 1 1 1 1 0 0 NA 1 
CROS_2012_112 1 1 1 1 0 0 NA 1 
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Study ID WWC1 WWC2 WWC3 1a 1b S2 3a 3b 
CROS_2013_474 1 1 1 1 0 0 NA 0 
DEZA_2015_419 1 1 1 1 1 1 1 1 
ERTA_2015_133 1 1 1 1 0 0 1 0 
ERTA_2012_1844 1 1 1 1 0 0 1 0 
LIND_2014_WP 1 1 1 1 1 0 1 0 
YORU_2011_740 1 1 1 1 1 0 1 0 
CARP_2014_WP 1 1 1 1 1 0 1 0 
 
Study ID 4a 4b 4c 4e S1 S3 S4 Overall Notes 
BOES_2013_WP 1 1 1 NA 1 1 1 1  
CALL_2014_788 a 1 1 1 NA 1 1 1 1  
CALL_2013_1590 a 1 1 1 0 1 1 MWR MWR Results not presented by site (Province) when 
could have been - 4e 
CALL_2013_2284 b 1 1 1 NA 1 1 1 1  
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Study ID 4a 4b 4c 4e S1 S3 S4 Overall Notes 
CALL_2014_137 b 1 1 1 1 1 0 1 MWR Because 3b not met 
CARP_2009_164 1 1 1 NA 1 0 1 MWR Because 3b not met 
CARP_2011_133 1 1 1 NA 1 0 1 MWR Because 3b not met 
CARP_2015_WP 1 1 1 NA 1 0 1 MWR Because 3b not met 
CONO_2013_570 1 1 1 NA 1 1 1 1  
CROS_2012_112 1 1 1 NA 1 1 1 1  
CROS_2013_474 1 1 1 NA 1 0 1 MWR Because 3b not met 
DEZA_2015_419 1 1 1 NA 1 1 1 1  
ERTA_2015_133 1 1 1 NA 1 0 1 MWR Because 3b not met 
ERTA_2012_1844 1 1 1 NA 1 0 1 MWR Because 3b not met 
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Study ID 4a 4b 4c 4e S1 S3 S4 Overall Notes 
LIND_2014_WP 1 0 1 NA 1 0 MWR MWR Because 3b not met and 4b graphs don't have 
fitted curves 
YORU_2011_740 1 1 1 NA 1 0 1 MWR Because 3b not met 





Appendix 4. Protocol: Endocrine disrupting chemical s and the 
risk of breast cancer: a systematic review of revie ws 
[CRD42018089344] 
 
Endocrine disrupting chemicals and the risk of breast cancer: a systematic 
review of reviews 
Michele Hilton Boon, Laurence Moore, Hilary Thomson, Peter Craig 
Citation 
Michele Hilton Boon, Laurence Moore, Hilary Thomson, Peter Craig. Endocrine 
disrupting chemicals and the risk of breast cancer: a systematic review of 




1. What is the evidence from systematic reviews that endocrine disrupting 
compounds (EDCs) increase the risk of breast cancer in humans? 
2. What is the contribution of natural experiments to the evidence base on the 
causal role of EDCs in breast cancer?  
3. How have systematic reviews evaluated and presented evidence from 
different study designs, including natural experiments, in reaching their 
conclusions about EDCs?  
4. How do systematic reviews of EDCs and breast cancer vary in their 
methodology with respect to inclusion criteria, appraisal methods, and synthesis 
methods, and how do these variations affect the inclusion and presentation of 
results from natural experiments?  
5. What have systematic reviews identified as limitations and gaps relating to 
natural experiments within the evidence base on EDCs and breast cancer in 
humans? 
Searches 
The databases to be searched are MEDLINE, Embase, the Cochrane Database of 
Systematic Reviews (CDSR), BIOSIS Previews, Scopus, and Web of Science.  
Additionally, Google and OpenGrey will be searched for relevant grey literature, 
and IARC monographs will be searched (http://monographs.iarc.fr/).  
The search strategy for the bibliographic databases will combine terms for 
endocrine disruptors and breast cancer with a filter to identify systematic 
reviews. 
This meta-review will include systematic reviews published on or after 1st 
January 2003, the search cut-off dates for which are no earlier than 1st January 
2002. The year 2002 has been chosen because it was the date of the publication 
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of the first Global Assessment of the State of the Science of Endocrine Disruptors 
(International Programme on Chemical Safety, 2002).  
No language restrictions will be imposed at the search stage. 
Types of study to be included 
This meta-review will include systematic reviews, defined as a review that (1) 
follows a specific, transparently reported, reproducible method of retrieving and 
selecting studies in an effort to comprehensively address its research question, 
and (2) presents the characteristics and results of included papers in some form 
of synthesis (quantitative, qualitative, or narrative).  
‘Empty’ reviews (reviews that identified no studies that met the inclusion 
criteria) will be included, but the protocols of reviews that have not reported 
any findings will be excluded. Primary studies will not be included either. 
In addition, included reviews must have addressed (at least in part, but not 
necessarily exclusively) the PICO question of the effect in humans (P) of 
exposure to EDCs (I) compared with any variation in exposure, degree, or timing 
(C) on the risk of breast cancer (O). 
Condition or domain being studied 
Breast cancer and its environmental causes. 
Participants/population 
Humans exposed to endocrine disrupting chemicals. 
Intervention(s), exposure(s) 
The exposure of interest is endocrine disrupting chemicals.  
The WHO/IPCS definition states “An endocrine disrupter is an exogenous 
substance or mixture that alters function(s) of the endocrine system and 
consequently causes adverse health effects in an intact organism, or its progeny, 
or (sub)populations.”  
Known EDCs include dioxins, polychlorinated biphenyls (PCBs), certain 
pesticides, herbicides, fungicides, and consumer product chemicals such as 
bisphenol A, phthalates, nonylphenols, flame retardants, and organic solvents.  
Environmental, household, and occupational exposures are also included, and 
alcohol and benzene are included in the category of organic solvents, but the 
common routes of exposure to these (alcohol consumption, and benzene in 
tobacco smoke) will be excluded. Pharmaceuticals will also be excluded. 
Comparator(s)/control 
The comparators may be any variation in exposure (including non-exposure), 





The primary quantitative outcome of the review is the risk of breast cancer in 
humans, expressed as relative risk (RR), odds ratio (OR), or hazard ratio (HR), 
associated with a given exposure to an EDC or combination of EDC under a given 
set of circumstances, with 95% confidence intervals.  
The primary qualitative outcome of the review is a map of evidence that 
demonstrates (1) the number and type of natural experimental studies included 
in the evidence base and (2) the amount of overlap of included studies among 
the systematic reviews. 
Secondary outcome(s) 
Sensitivity analyses of the primary outcomes by review characteristics, review 
quality (AMSTAR2 score), and the inclusion of natural experiments. 
Data extraction (selection and coding) 
A data extraction form will be designed and piloted on two systematic reviews 
(one reviewer will pilot the data extraction form and a second will cross-check 
the extracted data for accuracy). The data extraction form will be revised if 
necessary and revisions will be reported with explanations for any changes.  
One reviewer will then extract relevant data from all eligible studies, and a 
second will cross-check the extracted data for accuracy. Any disagreements will 
be resolved through discussion or, if necessary, with the involvement of a third 
reviewer. 
The data to be extracted from each included review will be: 
Review characteristics: the citation, year of publication, objectives, search cut-
off date, databases searched, inclusion criteria, quality appraisal method, 
method(s) of synthesis. 
Details of the included studies: number of studies and population numbers 
included in the review, references of included studies (human populations only), 
number and date range of other included studies (animal and in vitro), designs of 
included studies in humans. 
Details of the review findings: EDCs covered, characteristics of EDC exposure 
covered (doses, timeframes, modifying factors), results of meta-analysis of risk 
of cancer in humans, numeric estimates of risk from included natural 
experiments in human populations, results of narrative synthesis, overall 
assessment of risk of bias and/or certainty of evidence, limitations or gaps noted 
in the evidence base. 
Data will not be extracted from the primary studies included in the reviews. In 
case of any discrepancies between the reviews, (e.g., different reports of study 
characteristics or results for a study included in multiple reviews), all data will 
be recorded but discrepancies will be highlighted and erroneous data excluded 
from further synthesis. If there is found to be data missing from the included 





Risk of bias (quality) assessment 
Included systematic reviews will be critically appraised using the AMSTAR2 
checklist, which has been developed for the appraisal of systematic reviews that 
may include evidence from both randomised and non-randomised studies.  
Two reviewers will appraise each study independently, and any disagreements 
will be resolved through discussion. The appraisal results will be presented in a 
table and in a summary chart.  
The AMSTAR2 checklist is intended for the appraisal of systematic reviews of 
intervention studies in healthcare, so in order to ensure that appropriate 
consideration is given to criteria specific to epidemiological studies which 
examine the effects of exposures rather than interventions, reviews that include 
a meta-analysis of risk of breast cancer in humans will additionally be appraised 
using the MOOSE (Meta-analyses Of Observational Studies in Epidemiology) 
checklist. 
Strategy for data synthesis 
The focus of the synthesis will be on findings from natural experiments in human 
populations because of the potential of these study designs to contribute to 
understanding causality.  
Included systematic reviews are likely to contain a wide range of types of 
evidence, including in vitro data, experiments on animals, and observational 
studies on wildlife. If decisions need to be made about the level of detail or 
depth of the synthesis, the emphasis will be on representing findings from 
studies of human populations. We will describe in tables the characteristics of 
the included reviews and the exposures of interest that they address.  
The primary quantitative outcome (risk of breast cancer) will be presented as a 
forest plot of review results ordered by date, with estimates of risk associated 
with different exposures presented separately where possible.  
The primary qualitative outcome (map of evidence) will be presented graphically 
and narratively.  
Overlaps of primary studies among reviews will be presented in a tabular format 
and described narratively.  
A thematic analysis will be used to further investigate the map of evidence in 
order to identify the contribution of natural experiments, limitations and gaps in 
the evidence base, and points of comparison with the content of policy 
documents. These results will be presented graphically, if feasible, and 
narratively. 
Analysis of subgroups or subsets 
We will separately analyse different groupings of EDCs depending on the review 
coverage (for example, as persistent versus non-persistent EDCs, or groupings 
such as dioxins, organochlorine pesticides, phthalates).  




Contact details for further information 
Michele Hilton Boon 
m.boon@sphsu.mrc.ac.uk 
Organisational affiliation of the review 
MRC/CSO Social and Public Health Sciences Unit, University of Glasgow 
https://www.gla.ac.uk/researchinstitutes/healthwellbeing/research/mrccsosoci
alandpublichealthsciencesunit/ 
Review team members and their organisational affiliations 
Ms Michele Hilton Boon. University of Glasgow 
Professor Laurence Moore. MRC/CSO Social and Public Health Sciences Unit, 
University of Glasgow 
Dr Hilary Thomson. MRC/CSO Social and Public Health Sciences Unit, University 
of Glasgow 
Dr Peter Craig. MRC/CSO Social and Public Health Sciences Unit, University of 
Glasgow 
Anticipated or actual start date 
01 February 2018 
Anticipated completion date 
30 June 2018 
Funding sources/sponsors 
LM is supported by the UK Medical Research Council (MC_UU_12017/14) and the 
Scottish Government Chief Scientist Office (SPHSU14). HT and PC are core 
funded by the UK Medical Research Council (MC_UU_12017/13 & 
MC_UU_12017/15) and the Scottish Government Chief Scientist Office (SPHSU13 
& SPHSU15). MHB is funded by a UK Medical Research Council doctoral 
studentship (Natural experimental approaches to evaluating population health 
interventions: 1517742) 
Conflicts of interest 
None specified. 
Language 
(there is not an English language summary) 
Country 
Scotland 
Stage of review 
Review_Ongoing 
Subject index terms status 
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Subject indexing assigned by CRD 
Subject index terms 
Breast Neoplasms; Endocrine Disruptors; Environmental Exposure; Environmental 
Pollutants; Environmental Pollution; Humans; Risk; Risk Factors 
Date of registration in PROSPERO 
27 February 2018 
Date of publication of this version 





Appendix 5. Literature search strategies for chapte r 6 
 
Search Concepts:  
 
breast cancer + systematic review + endocrine disrupting chemicals 
 
Sources of Terms: 
 
Based on Rodgers et al. (2018) search strategy following Brody et al. (2007) and 
Rudel et al. (2014) with additional synonyms drawn from the following sources: 
 
Rachoń D. Endocrine disrupting chemicals (EDCs) and female cancer: Informing 
the patients. Reviews in Endocrine & Metabolic Disorders. 2015;16:359-364.  
 
Gore AC, Chappell VA, Fenton SE, et al. EDC-2: The Endocrine Society’s Second 
Scientific Statement on Endocrine-Disrupting Chemicals. Endocrine Reviews. 
2015;36(6):E1-E150. doi:10.1210/er.2015-1010. 
 
EU report on EDC identification and categorisation: 
ec.europa.eu/environment/chemicals/endocrine/strategy/substances_en.htm 




Medline (18 March 2018, Ovid platform) 
 
1. exp Breast Neoplasms/   
2. (breast$ or mammary).mp.   
3. (cancer$ or tumo?r or neoplasm$).mp.   
4. 2 and 3   
5. 1 or 4   
6. exp Endocrine Disruptors/   
7. (endocrine adj disrupt$).mp.   
8. *Phenols/   
9. bisphenol A.mp.   
10. ddt/ or dichlorodiphenyl dichloroethylene/ or 
dichlorodiphenyldichloroethane/   
11. exp "DIOXINS AND DIOXIN-LIKE COMPOUNDS"/   
12. dioxin$.mp.   
13. Flame Retardants/   
14. flame retardant$.mp.   
15. exp Fungicides, Industrial/   
16. fungicid$.mp.   
17. exp HERBICIDES/   
18. herbicid$.mp.   
19. exp INSECTICIDES/   
20. insecticid$.mp.  
21. paraben$.mp.   
22. exp PARABENS/  
23. exp Paraffin/   
24. exp Polychlorinated Biphenyls/   
25. PCBs.mp.   
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26. exp PESTICIDES/   
27. pesticid$.mp.   
28. DIETHYLHEXYL PHTHALATE/ or DIBUTYL PHTHALATE/   
29. phthalate$.mp.  
30. exp Surface-Active Agents/   
31. surfactant$.mp.   
32. or/6-31   
33. 5 and 32   
34. limit 33 to (meta analysis or systematic reviews)   
35. limit 33 to "reviews (best balance of sensitivity and specificity)"   
36. 34 or 35   
37. Aldrin.mp. or ALDRIN/   
38. alkylphenol.mp.   
39. Araclor.mp.   
40. Atrazine.mp. or ATRAZINE/   
41. BADGE.mp.   
42. BBMP.mp.   
43. exp BENZENE DERIVATIVES/ or exp BENZENE/ or benzene.mp.   
44. benzophenone-1.mp.   
45. exp Pyrethrins/ or bifenthrin.mp.   
46. BPA.mp.   
47. Captan/ or Captafol.mp.   
48. Carbaryl.mp. or CARBARYL/   
49. carbamate.mp. or exp CARBAMATES/   
50. chlordane.mp. or Chlordan/   
51. Chlordecone.mp. or CHLORDECONE/   
52. chloroparaffin$.mp.   
53. chlorotriazine.mp.   
54. chlorpyrifos.mp. or CHLORPYRIFOS/   
55. cyhalothrin.mp.   
56. DDD.mp.  
57. DDE.mp.  
58. decaBDE$.mp.   
59. DEHP.mp. or Diethylhexyl Phthalate/   
60. deltamethrin.mp.   
61. DEP.mp.   
62. exp Detergents/   
63. detergent$.mp.   
64. diazinon.mp. or DIAZINON/   
65. dicarboximide.mp.   
66. dichlorodiphenyldichloroethane.mp. or 
DICHLORODIPHENYLDICHLOROETHANE/   
67. Dichlorodiphenyl Dichloroethylene/ or dichlorodiphenyldichloroethylene.mp.  
68. dichlorophenyldichloroethylene.mp.   
69. dicofol.mp. or DICOFOL/   
70. exp Phthalic Acids/ or dicyclohexylphthalate.mp.   
71. diethylphthalate.mp.   
72. Dieldrin.mp. or DIELDRIN/   
73. DnBP.mp.   
74. Ethylene Dibromide/ or EDB.mp.   
75. Endrin.mp. or ENDRIN/   
76. epichlorohydrin.mp. or EPICHLOROHYDRIN/   
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77. Ethanol.mp. or ETHANOL/   
78. Fenarimol.mp.   
79. exp Pyrimidines/   
80. fenitrothion.mp. or FENITROTHION/   
81. fenvalerate.mp.   
82. fluorosurfactant$.mp.  
83. Hair dye$.mp. or exp Hair Dyes/   
84. exp Hair Preparations/ or Hair relaxer$.mp.   
85. exp Cosmetics/ or Hair straightener$.mp.   
86. HCB.mp. or Hexachlorobenzene/   
87. HCH$.mp.   
88. HEPTACHLOR EPOXIDE/ or HEPTACHLOR/ or heptachlor.mp.   
89. hexachlorobenzene.mp. or HEXACHLOROBENZENE/   
90. Hexachlorohexane.mp.   
91. ioxynil.mp.   
92. Kanechlor.mp.   
93. lindane.mp. or LINDANE/   
94. malathion.mp. or MALATHION/   
95. mancozeb.mp.   
96. Diethylhexyl Phthalate/ or MEHP.mp.   
97. methoxychlor.mp. or METHOXYCHLOR/   
98. methylene chloride.mp. or Methylene Chloride/   
99. metiram.mp.   
100. metribuzin.mp.   
101. Mirex.mp. or MIREX/   
102. exp Hydrocarbons, Chlorinated/ or nonachlor.mp.   
103. nonylphenol$.mp.   
104. exp Phenols/   
105. exp Halogenated Diphenyl Ethers/ or octaBDE.mp.   
106. ?octylphenol$.mp.   
107. exp Solvents/   
108. Organochlorine.mp.   
109. exp Polycyclic Aromatic Hydrocarbons/   
110. polycyclic aromatic hydrocarbon$.mp.   
111. PARATHION/ or METHYL PARATHION/ or parathion.mp.   
112. PBDE$.mp.   
113. PCB$.mp.   
114. pentaBDE$.mp. or exp Hydrocarbons, Brominated/   
115. pentachlorobenzene.mp.   
116. pentachlorophenol.mp.   
117. Perfluoroalkyl$.mp.   
118. perfluorooctanesulfonic acid.mp.   
119. perfluorooctanoic acid.mp.   
120. *Environmental Pollutants/ or persistent organic pollutant$.mp. or *Water 
Pollutants, Chemical/   
121. PFASs.mp.   
122. (PFOA or PFOS or PHDD$ or PHDF$).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier, synonyms]   
123. picloram.mp. or PICLORAM/   
124. plastici?er.mp. or *Plasticizers/   
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125. (polychlorinated or polybrominated or polyfluorinated).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare disease 
supplementary concept word, unique identifier, synonyms]   
126. Polyfluoroalkyl$.mp.   
127. polyvinyl chloride.mp. or Polyvinyl Chloride/   
128. procymidone.mp.   
129. PVC.mp.   
130. exp Pyrethrins/   
131. (pyrethroid$ or pyretroid$).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier, synonyms]   
132. resmethrin.mp.   
133. simazine.mp. or SIMAZINE/   
134. (TCDD or TCE or TDBPP).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier, synonyms]   
135. Terbufos.mp.   
136. terbutryn.mp.  
137. tetraBDE47.mp.   
138. tetrachloroethylene.mp. or TETRACHLOROETHYLENE/   
139. Toxaphene.mp. or TOXAPHENE/   
140. exp *Chlorobenzenes/ or trichlorobenzene.mp.   
141. trichloroethylene.mp. or TRICHLOROETHYLENE/   
142. vinclozolin.mp.   
143. or/37-142   
144. 5 and 143   
145. limit 144 to (meta analysis or systematic reviews)   
146. limit 144 to "reviews (best balance of sensitivity and specificity)"   
147. 36 or 145 or 146   
148. limit 147 to yr="2003 -Current"   
149. 37 or 38 or 39 or 40 or 41 or 42 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 
51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 
65 or 66 or 67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 or 75 or 76 or 78 or 80 or 
81 or 82 or 83 or 84 or 85 or 86 or 87 or 88 or 89 or 90 or 91 or 92 or 93 or 94 or 
95 or 96 or 97 or 98 or 99 or 100 or 101 or 102 or 103 or 104 or 105 or 106 or 107 
or 108 or 110 or 111 or 112 or 113 or 114 or 115 or 116 or 117 or 118 or 119 or 
120 or 121 or 122 or 123 or 124 or 125 or 126 or 127 or 128 or 129 or 130 or 131 
or 132 or 133 or 134 or 135 or 136 or 137 or 138 or 139 or 140 or 141 or 142   
150. 5 and 149   
151. limit 150 to (meta analysis or systematic reviews)   
152. limit 150 to "reviews (best balance of sensitivity and specificity)"   
153. 36 or 151 or 152   
154. limit 153 to yr="2003 -Current" 
Sources: Ovid MEDLINE(R) without Revisions 1996 to March Week 2 2018 
Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations 






Embase strategy (18 March 2018, Ovid platform) 
 
File: Embase 1996 to 2018 Week 12 
 
1. exp breast cancer/ or breast tumor/  
2. (breast$ or mammary).mp.   
3. (cancer$ or tumo?r or neoplasm$).mp.   
4. 2 and 3   
5. 1 or 4   
6. exp endocrine disruptor/   
7. (endocrine adj disrupt$).mp.   
8. 4,4' isopropylidenediphenol/   
9. bisphenol A.mp.   
10. DDT.mp. or chlorphenotane/   
11. dioxin/   
12. dioxin$.mp.   
13. flame retardant/   
14. flame retardant$.mp.   
15. fire retardant$.mp.   
16. exp fungicide/   
17. fungicid$.mp.   
18. exp herbicide/   
19. herbicid$.mp.   
20. exp insecticide/   
21. insecticid$.mp.  
22. paraben$.mp.   
23. 4 hydroxybenzoic acid ester/   
24. paraffin/   
25. polychlorinated biphenyl/   
26. PCB$.mp.   
27. exp polychlorinated dibenzodioxin/  
28. exp pesticide/   
29. pesticid$.mp.   
30. "phthalic acid bis(2 ethylhexyl) ester"/ or exp plasticizer/   
31. surfactant/ae, it, to, ec [Adverse Drug Reaction, Drug Interaction, Drug 
Toxicity, Endogenous Compound]   
32. surfactant$.mp.   
33. or/6-32   
34. 5 and 33   
35. MEDLINE.tw.   
36. exp systematic review/   
37. systematic review.tw.  
38. meta-analysis/   
39. limit 34 to (meta analysis or "systematic review")   
40. 35 or 36 or 37 or 38   
41. 34 and 40   
42. 39 or 41   
43. alkylphenol.mp.   
44. BADGE.mp.   
45. BBMP.mp.   
46. benzophenone derivative/ or exp benzene derivative/   
47. exp pyrethroid/   
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48. detergent/   
49. dimpylate/ or exp pyrimidine derivative/   
50. exp phthalic acid derivative/   
51. exp 1,2 dibromoethane/   
52. exp alkane derivative/   
53. epichlorohydrin/ or exp epoxide/ or exp organochlorine derivative/   
54. hair dye/   
55. Hair dye$.mp.   
56. exp cosmetic/   
57. exp phenol derivative/   
58. chlorinated hydrocarbon/   
59. dichloromethane/ or exp organic solvent/   
60. diphenyl ether derivative/   
61. exp polybrominated diphenyl ether/   
62. PBDE$.tw.   
63. pentaBDE.mp.   
64. brominated hydrocarbon/   
65. pentachlorobenzene.mp. or pentachlorobenzene/   
66. pentachlorophenol.mp. or pentachlorophenol/   
67. perfluorooctanesulfonic acid/ or perfluorooctanoic acid/   
68. *pollutant/   
69. polyvinylchloride/   
70. PVC.tw.   
71. 2,3,7,8 tetrachlorodibenzo para dioxin/   
72. dibenzodioxin derivative/ or 3,7,8 trichloro 2 iododibenzo para dioxin/ or 
polybrominated dibenzodioxin/ or polychlorinated dibenzodioxin/  
73. (TCDD or TCE or TDBPP).tw.   
74. tetrachloroethylene/   
75. tetrachloroethylene.tw.   
76. *persistent organic pollutant/   
77. trichloroethylene.tw.   
78. or/43-77  
79. 5 and 78   
80. 40 and 79   
81. 41 or 80   
82. limit 81 to yr="2003 -Current" 
 
Cochrane Library (March 2018) 
 
1. "breast cancer":ti,ab,kw (Word variations have been searched) 
2. hormone disrupt* 
3. endocrine disrupt* 
4. environment* 
5. chemical* 
6. #4 and #5 
7. #2 or #3 or #6 





Scopus (March 2018) 
 
 ( ( TITLE-ABS-KEY ( "endocrine disrupt*"  OR  bisphenol  OR  dioxin*  OR  
pesticid*  OR  insecticid*  OR  herbicid*  OR  fungicid* )  OR  TITLE-ABS-KEY ( 
solvent*  OR  plasticiser*  OR  plasticizer*  OR  surfactant*  OR  paraben* )  OR  
TITLE-ABS-KEY ( "DDT"  OR  "PCB*"  OR  "flame retardant*"  OR  "consumer 
product*" ) ) )  AND  ( ( ( breast*  OR  mammary )  AND  ( cancer*  OR  tumor*  OR  
tumour*  OR  neoplasm* ) ) )  AND  ( ( "systematic review"  OR  "meta analysis"  
OR  "meta-analysis" ) ) 
 
Web of Science (March 2018) 
 
# 1 TS=((breast* OR mammary) AND (cancer* OR tumor* OR tumour* OR 
neoplasm*)) 
 
# 2 TS=("systematic review" OR "meta analysis" OR "meta-analysis" OR "Medline") 
 
# 3 #2 AND #1 
 
# 4 TS=((endocrine OR hormon*) AND (disrupt*)) 
 
# 5 TS=(bisphenol OR dioxin* OR pesticid* OR insecticid* OR herbicid* OR 
fungicid*) 
 
# 6 TS=(solvent* OR plasticiser* OR plasticizer* OR surfactant* OR paraben*) 
 
#7 TS=("DDT" OR "PCB*" OR "flame retardant*" OR "consumer product*") 
 
#8  #7 OR #6 OR #5 OR #4 
 





Open Grey (March 2018) 
 
endocrine disrupt* breast cancer (2 results) 
OR 
breast cancer environment* chemical* (1 result) 
OR 
breast cancer environment* (26 results) 
 
No systematic reviews identified 
 
Google (March 2018) 
 
endocrine disruptor breast cancer review site:.int (403 results) 
 
endocrine disruptor breast cancer review site:.eu (1980 results; reviewed first 




endocrine disruptor breast cancer review site:.org (1980 results; revised search 
to “systematic review” which produced 24,600 results; reviewed first 100) 
 







Appendix 6. Detailed critical appraisal results for  chapter 6 
 
This appendix reports the detailed results for quality assessment of the 15 
reviews included in chapter 6 using the AMSTAR-2 appraisal tool for systematic 
reviews. Some of the criteria apply only to meta-analyses (11/15 included 
reviews); where these criteria did not apply, “N/A” has been recorded (not 
applicable). Each study was appraised independently by two reviewers. The 










1. PICO Yes No Yes Yes Yes 
2. Protocol No No No No No 
3. Inclusion criteria Yes Yes Yes Yes Yes 






5. Duplicate selection Yes No No No No 
6. Duplicate extraction Yes No No Yes Yes 
7. List of excluded studies No No No No Yes 
8. Included studies described Yes No Partial 
Yes 
Yes Yes 







10. Study funding reported No No No No No 
11. Appropriate meta-analysis N/A N/A N/A N/A Yes 
12. Impact of RoB on meta-
analysis  
N/A N/A N/A N/A Yes 
13. RoB in 
interpretation/discussion 
Yes No Yes Yes Yes 
14. Heterogeneity investigated  N/A N/A N/A N/A Yes 
15. Publication bias 
investigated  
N/A N/A N/A N/A Yes 
16. COI and funding disclosed Partial 
Yes 
Yes No No Yes 
      









Highlighted domains are 
"critical" 








Zani 2013 Allam 
2016 
Fu 2017 Gera 
2018 
1. PICO Yes Yes Yes Yes Yes 
2. Protocol No No No No No 
3. Inclusion criteria Yes Yes Yes Yes Yes 




5. Duplicate selection Yes No No No No 
6. Duplicate extraction Yes Yes Yes Yes No 
7. List of excluded studies No No No No Partial 
Yes 
8. Included studies described Yes Yes Partial 
Yes 
Yes Yes 
9. RoB assessed Yes No No Yes No 
10. Study funding reported No No No No No 
11. Appropriate meta-analysis Yes Yes Yes Yes No 
12. Impact of RoB on meta-
analysis  
Yes No Yes Yes No 
13. RoB in 
interpretation/discussion 
Yes No Yes Yes No 
14. Heterogeneity investigated  Yes Yes No Yes No 
15. Publication bias 
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